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Summary 
Skin and organs in the body are innervated by primary afferents that respond to 
both noxious and non-noxious stimuli. The sensory information from the 
surrounding structures is transmitted into the dorsal horn by these afferents 
following their sensory modality and the region of the body that they innervate. 
The information is interpreted by neuronal circuits involving excitatory and 
inhibitory interneurons that lie in the dorsal horn of the spinal cord.  
This current study involves characterisation of a specific population of inhibitory 
neurons that are presumably involved in presynaptic inhibition towards central 
terminal of non-peptidergic C fibres that terminate in a complex known as 
synaptic glomeruli (type I) in the middle of lamina II of the dorsal horn. The 
inhibition is formed through axoaxonic synapses on the central axons of these 
primary afferent fibres. A preliminary work carried out by Dr David I Hughes 
using CR::eGFP mouse line found that calcium binding protein, calretinin (CR) is 
expressed mostly by excitatory interneurons and a small percentage by 
inhibitory interneurons. Electron microscopic study was performed in these 
animals and he found that axonal boutons originated from dorsal horn calretinin 
cells were presynaptic to the central axon of type I glomeruli, which belong to 
CMrgD afferents. He also found that these cells have islet morphology which 
suggested that they are inhibitory cells.  
The main objective of the project was to characterize a population of inhibitory 
CR interneurons in the superficial dorsal horn (SDH) and their synaptic 
connection with CMrgD primary afferent fibres. To achieve this several transgenic 
mouse lines that labelled inhibitory interneurons in the dorsal horn were used 
including lines in which Nociceptin and RorB transgenes were either expressed 
under the control of the regulatory elements of the Nociceptin gene or knocked 
into the RorB locus, respectively. Using Nociceptin::eGFP mice it was found that 
93% of the cells that expressed eGFP were positive for Pax2 thus showed that 
these animals labelled inhibitory interneurons in the dorsal horn. In this mouse 
lines it was found that inhibitory CR cells in lamina II formed a band of dendrites 
and axons that perfectly overlapped with non-peptidergic C fibres plexus that 
were labelled with Isolectin B4 (IB4). The great majority of inhibitory 
interneurons (78%) in the SDH of Nociceptin::eGFP mice were immunoreactive 
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for eGFP.  Based on this result, Nociceptin::eGFP mice were then crossed with 
CRCre and Ai9 mice to allow reconstructions of individual neurons. It was found 
that inhibitory CR interneurons resemble islet cells and had dendrites projecting 
extensively in the rostrocaudal axis with a limited dorsoventral extent that 
arborized within lamina II. Due to a few limitations with Nociceptin::eGFP mice, 
this project was then continued with a knock-in mouse line, RorBeGFP mouse that 
also labelled inhibitory interneurons in the dorsal horn. It was found that more 
of lamina II inhibitory CR-immunoreactive cells were labelled in RorβeGFP mouse 
line than the Nociceptin::eGFP mouse, thus showed that RorBeGFP mice appeared 
to be a better choice for investigating the inhibitory CR cells than 
Nociceptin::eGFP mice.  
In this study it was found that inhibitory CR cells do not co-expressed other 
neurochemical markers of the inhibitory interneurons such as galanin, nNOS, NPY 
and PV. This showed that CR represent another neurochemically distinct group 
of inhibitory interneurons in the dorsal horn. To investigate the synaptic 
connection between CR islet cells with CMrgD afferents, the third part of the 
study was carried out using the RorBCreERT2 mouse line with tamoxifen induction. 
In this study, it was found that intraperitoneal injection of tamoxifen in early 
stage of postnatal life resulted in more labelling of cells, meanwhile less cells 
were labelled if tamoxifen were given at the later stage of postnatal life. 
Surprisingly, under optimal conditions, only a quarter of the inhibitory CR cells 
in lamina II were immunoreactive for tdTomato. However, the majority of 
tdTomato cells in the SDH are inhibitory interneurons and immunoreactive for 
CR, thus showed that this mouse line was highly selective for inhibitory CR cells. 
Using this mouse line, it was found that most of CMrgD afferents central terminals 
were in contact with axonal boutons of inhibitory CR cells and the excitatory 
synapses on the dendritic trees of inhibitory CR cells were derived from CMrgD 
afferents. About 40% of the inhibitory CR axonal boutons are in contact with 
non-peptidergic C-nociceptors and electron microscopic revealed that the axons 
belonged to the inhibitory CR cells formed axoaxonic synapses with CMrgD 
afferents. A few studies claimed there is a loss of these cells after peripheral 
nerve injury. However, in this study there were no loss of cells seen following 
sciatic nerve transection with no alteration on the rostrocaudal and dorsoventral 
extent of inhibitory CR cells in the affected area on RorBCreERT2; Ai9 mice.   
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The results from this study suggest that a subset of lamina II inhibitory 
interneurons that express CR form axoaxonic synapses on the central boutons of 
type I synaptic glomeruli which belong to CMrgD afferents and they also receive 
excitatory inputs from these primary afferents. As a conclusion, results from this 
study are in parallel with the recommendation that different neurochemical 
populations of inhibitory neurons have distinct functional roles and also 
emphasize the important of presynaptic inhibition on central terminals of CMrgD 
primary afferents in maintaining normal somatosensation.   
iv 
 
 
 
Acknowledgement 
نﻣﺣرﻟا ﷲ مﺳﺑ مﯾﺣرﻟا  
   
  
In the name of God, the Most Compassionate, Most Merciful. 
I would like to express my gratitude to God for sending me the best supervisor 
that anyone can have, Professor Andrew Todd for his endless encouragement and 
support. He is indeed a very hardworking person that I have ever meet in my 
life, and because of this, he inspired me to always learn and do well. Thank you, 
Professor Andrew, for this great opportunity to be able to do PhD project under 
your supervision. I would also like to thank Dr David Hughes, my second 
supervisor for his assistance and constant advice throughout the time I am here.  
This work would not be completed without Drs Allen Dickie and Noboru Iwagaki 
great contribution for carried out the whole-cell patch-clamp recordings. I would 
like to thank Mrs Christine Watt and Mr Robert Kerr for their superb technical 
support. I am grateful to all members of the Spinal Cord Group whom I have had 
the pleasure to work during this project. Each of you has given of your time, 
energy and expertise: Dr Erika Polgár, Dr John Riddell, Dr Maria Gutierrez-
Mecinas, Dr Robert Ganley, Dr Kieran Boyle, Dr Patricia del-Rio, Dr Andrew Bell 
and Olivia Davis. To Dr Anne Bannatyne and Dr Nur Aishah binti Che Roos, thank 
you for your supportive words throughout my time in Glasgow. 
Nobody has been more important to me in the pursuit of this project than the 
members of my family. To my parents, thank you for your positive words and 
encouragement throughout my life. To my caring and beloved husband, Wan 
Khairul Akmal, no words can describe the sacrifices you have made for your 
children and me, only God can pay you back. To my beautiful children, 
Muizzuddin and Nusaibah, thank you for being there with me…you are the love of 
my life! 
I would also like to thank all my friends for listening, offering me advice and 
encouraging me to strive towards my goal. Finally, a special thanks to the 
Ministry of Higher Education Malaysia for providing the funds and support for this 
study.  
v 
 
 
 
Author’s Declaration 
I declare that the work presented in the thesis is my own work, except where 
explicit reference is made to the contribution of others. Drs Allen Dickie and 
Noboru Iwagaki performed the whole-cell patch-clamp recordings, and Dr David 
Hughes performed the sciatic nerve transection. This thesis has not been 
submitted in any previous application for any other degree in the University of 
Glasgow or any other institution. 
 
 
Marami binti Mustapa 
November 2018 
  
vi 
 
 
 
List of Abbreviations 
AAV  adeno-associated virus 
AMHs  A-fibre mechano-heat-sensitive 
CCI  chronic constriction injury 
CGRP  calcitonin gene related peptide 
CMHs  C-fibre mechano-heat-sensitive 
CR   calretinin 
Cre  cre-recombinase 
CTb  cholera toxin B subunit 
DAB  3,3’ diaminobenzidine 
DH   dorsal horn 
DRG  dorsal root ganglia 
DV  dorsoventral 
eGFP  enhanced green fluorescence protein 
EM   electron microscope or electron microscopy 
GABA  gamma-aminobutyric acid 
Gal   galanin 
GFP  green fluorescent protein 
HRP  horseradish peroxidase 
vii 
 
 
 
IB4   Bandeiraea simplicifolia isolectin IB4 
LTMR  low threshold mechanoreceptor 
LTP  long term potentiation 
MrgprD mas-related G protein coupled receptor D 
NK1r  neurokinin-1 receptor 
nNOS  neuronal nitric acid synthase 
NPY   neuropeptide Y 
PB  phosphate buffer 
PBS  phosphate-buffered saline 
PV  parvalbumin 
RC  rostrocaudal 
SDH   superficial dorsal horn 
SNI  spared nerve injury 
SNT   sciatic nerve transection  
sst2A  somatostatin receptor 2A 
TRPM8 transient receptor potential receptor melastatin 8 
TRPV1  transient receptor potential receptor vanilloid 1 
VGAT  vesicular GABA transporter 
VGLUT3 vesicular glutamate transporter 3  
viii 
 
 
 
Table of Contents 
1 Introduction 1 
1.1 Spinal cord .................................................................... 2 
1.1.1 Anatomy of the spinal cord 2 
1.1.2 Spinal grey matter organization 2 
1.2 Primary afferent fibres ...................................................... 5 
1.2.1 Myelinated nociceptors 7 
1.2.2 Unmyelinated nociceptors 8 
1.2.3 Low threshold mechanoreceptors 10 
1.2.4 Neurochemical properties and receptors of primary       afferents 12 
1.2.5 Synaptic glomeruli 15 
1.2.5.1 Type I and type II glomeruli 16 
1.3 Projection neurons .......................................................... 20 
1.4 Excitatory and inhibitory interneurons of the dorsal horn ............ 28 
1.4.1 Interneuron classification 30 
1.4.1.1 Morphology 30 
1.4.1.2 Firing pattern 37 
1.4.1.3 Neurochemical markers 37 
1.5 Aims of the project ......................................................... 49 
2 General Methods 51 
2.1 Transgenic mouse lines and crosses ...................................... 52 
2.3 Perfusion fixation ........................................................... 56 
2.3 Tissue processing and immunocytochemistry ........................... 56 
2.4 Antibody characterization ................................................. 57 
2.5 Confocal microscopy and analysis ........................................ 58 
2.6 Statistical analysis .......................................................... 58 
3 Morphological features of CR islet cells within dorsal horn 60 
3.1 Introduction .................................................................. 61 
3.2 Materials and methods ..................................................... 63 
3.2.1 Morphology and analysis of recorded neurons 63 
3.2.2 Animals and tissue processing for other anatomical parts of the study
 65 
3.2.3 CR and eGFP expression in Nociceptin::eGFP mouse 65 
3.2.4 Distribution of inhibitory CR interneurons in laminae I-III of 
Nociceptin::eGFP and RorBeGFP mice 66 
3.3 Results ........................................................................ 67 
3.3.1 Morphology of the cells in the Nociceptin::eGFP; CRCre; Ai9 mice 67 
3.3.2 The proportion of dorsal horns neurons that are labelled with 
CR+/eGFP+ in Nociceptin::eGFP mice 74 
3.3.3 Quantitative analysis of inhibitory CR+/eGFP+ cells in 
Nociceptin::eGFP and RorBeGFP mice 79 
3.4 Discussion .................................................................... 85 
ix 
 
 
 
3.4.1 Morphological features of recorded cells 85 
3.4.2 CR+/eGFP+ cells in Nociceptin::eGFP mice 86 
3.4.3 Comparison between Nociceptin::eGFP and RorBeGFP mouse lines 89 
4 Expression of neurochemical markers of inhibitory interneuron populations 
in CR+/eGFP+ cells in Nociceptin::eGFP and RorBeGFP mice 91 
4.1 Introduction .................................................................. 92 
4.2 Materials and method ...................................................... 93 
4.2.1 Animals and tissue processing 93 
4.2.2 Expression of 4 distinct inhibitory markers and sst2A in CR+/eGFP+ in 
Nociceptin::eGFP mice 93 
4.2.3 Assessment of co-localisation of the 4 distinct inhibitory markers in 
CR+/eGFP+ in RorBeGFP mice 94 
4.3 Results ........................................................................ 95 
4.3.1 Expression of galanin, nNOS, NPY, PV and sst2A among CR+/eGFP+ cells 
in Nociceptin::eGFP mice 95 
4.3.2 Neurochemical markers in RorBeGFP and their expression by CR+/eGFP+ 
and CR-/eGFP+ cells 105 
4.4 Discussion ................................................................... 108 
4.4.1 Expression of neurochemical markers for inhibitory neurons in 
CR+/eGFP+ cells in Nociceptin::eGFP and RorBeGFP 108 
4.4.2 Expression of the sst2A receptor in CR+/eGFP+ neurons in 
Nociceptin::eGFP mice 110 
4.4.3 Association of other inhibitory neurochemical markers with CR-/eGFP+ 
cells in RorBeGFP mice 112 
5 Synaptic connections between tdTomato+ cells in RorBCreERT2; Ai9 and 
RorBCreERT2; Ai34 mice and non-peptidergic C-fibres 113 
5.1 Introduction ........................................................................ 114 
5.2 Materials and methods ........................................................... 116 
5.2.1 Tamoxifen optimization in RorBCreERT2; Ai9 116 
5.2.2 Animals and tissue processing for confocal microscopy 117 
5.2.2.1 Proportion of tdTomato cells that are CR- and Pax2-
immunoreactive   in the RorBCreERT2; Ai9 mouse 118 
5.2.2.2 Contacts between IB4-binding primary afferents and tdTomato-
axonal boutons in RorBCreERT2; Ai34 mice 118 
5.2.2.3 Contacts between non-peptidergic primary afferents and 
tdTomato-positive axons and dendrites in RorBCreERT2; Ai9 mice 119 
5.2.3 Animals and tissue processing for electron microscopy 120 
5.3 Results .............................................................................. 123 
5.3.1 Effects on tamoxifen dosage on tdTomato expression in RorBCreERT2; Ai9 
mice 123 
5.3.2 Inhibitory CR cells in RorBCreERT2; Ai9 mice 123 
5.3.3 Contacts between IB4-labelled primary afferents and RorB axonal 
boutons in RorBCreERT2; Ai34 mice 127 
5.3.4 Contacts between non-peptidergic C-nociceptors and tdTomato cells 
in RorBCreERT2; Ai9 mice 130 
5.3.4 Electron microscopy findings 136 
5.4 Discussion .......................................................................... 140 
x 
 
 
 
5.4.1 Tamoxifen-induced tdTomato in RorBCreERT2; Ai9 mice 140 
5.4.2 The RorBCreERT2 mouse line 143 
5.4.3 Contacts between tdTomato-axonal boutons and non-peptidergic C-
nociceptors in RorBCreERT2; Ai9 and RorBCreERT2; Ai34 mice 145 
5.4.4 Discovery from EM study 148 
6 The effect of sciatic nerve transection on inhibitory CR islet cells in 
RorBCreERT2; Ai9 mice 151 
6.1 Introduction ................................................................. 152 
6.2 Materials and methods .................................................... 157 
6.2.1 Animals and operative procedures 157 
6.2.2 Tissue processing of RorBCreERT2; Ai9 mice 157 
6.2.3 The number of inhibitory CR+/tdTomato+ cells on the injured and 
intact side of the spinal cords 158 
6.2.4 Proportion of inhibitory CR+ cells among all neurons in lamina II 164 
6.2.5 Morphology of CR+/tdTomato+ cells after SNT 165 
6.3 Results ....................................................................... 166 
6.3.1 Quantitative analysis of the inhibitory CR+/tdTomato+ cells following 
SNT 166 
6.3.2 Quantitative analysis of the inhibitory CR cells following SNT 167 
6.3.3 Morphological analysis of CR+/tdTomato+ cells 168 
6.4 Discussion ................................................................... 175 
6.4.1 No loss of cells after PNI 175 
6.4.2 No change in the morphology of the cells 177 
7 Concluding remarks 179 
8 References 187 
9 Publication 223 
  
xi 
 
 
 
List of Figures 
Figure 1-1 Rexed’s laminae and the termination of primary afferents in 
different laminae of the spinal cord. ........................................... 19 
Figure 1-2 Anterior and lateral spinothalamic tract (Anterolateral system) ..... 25 
Figure 1-3 Dorsal column-medial lemniscus pathway (DCML) ....................... 27 
Figure 1-4 Four main morphological classes of interneurons in lamina II of dorsal 
spinal cord ............................................................................ 36 
Figure 3-1 Morphology of the CR+/eGFP+ recorded cells in 
Nociceptin::eGFP;CRCre;Ai9 mice .................................................. 70 
Figure 3-2 Neurobiotin filled cell from Nociceptin::eGFP;CRCre;Ai9 mouse ....... 72 
Figure 3-3 CR and Noc::eGFP cells immunostaining in the dorsal horn ........... 76 
Figure 3-4 Lamina II CR-Noc::eGFP cells form a tight band in the middle of 
lamina II ............................................................................... 78 
Figure 3-5 CR and RorBeGFP cells immunostaining in the dorsal horn ............... 84 
Figure 4-1 Lack of co-localisation of CR-Noc::eGFP, nNOS and galanin in laminae 
I-III ...................................................................................... 99 
Figure 4-2 Lack of co-localisation of CR-Noc::eGFP, NPY and PV in laminae I-III.
 ......................................................................................... 101 
Figure 4-3 CR-Noc::eGFP and sst2A in the superficial dorsal horn ................ 104 
Figure 5-1 Tissue processing for Electron microscopy .............................. 122 
Figure 5-2 tdTomato, CR and Pax2 immunostaining from the dorsal horn of 
RorBCreERT2; Ai9 that have the high numbers of tdTomato cells labelling ... 126 
Figure 5-3 IB4-labelled central terminals contacting tdTomato axonal boutons 129 
Figure 5-4 IB4 labelled primary afferents synaptic inputs to RorB cells.......... 133 
Figure 5-5 Axoaxonic contacts formed by RorB cells ................................ 135 
Figure 5-6 Electron microscopic images of axoaxonic synapse on central bouton 
of type I glomeruli from tamoxifen treated RorBCreERT2; Ai9 mice ........... 139 
Figure 6-1  Transverse section of RorBCreERT2; Ai9 mice that had undergone SNT on 
the left side .......................................................................... 161 
Figure 6-2 The effect of sciatic nerve transection on the SDH neurons in 
RorBCreERT2; Ai9 mice ................................................................ 163 
Figure 6-3 A typical islet cell morphology of RorB cell found in the middle of 
lamina II on the side ipsilateral to the nerve injury ........................... 174 
Figure 7-1 Neuronal circuits in the dorsal horn of the spinal cord. ............... 186 
xii 
 
 
 
 
List of Tables 
Table 2-1 Summary of the different mouse lines and crosses used in various 
chapter of this study ................................................................ 55 
Table 2-2 Primary antibodies used in this study ...................................... 59 
Table 3-1 Dendritic dimensions of reconstructed eGFP+/tdTomato+ .............. 73 
Table 3-2 Percentages of neurons in laminae I-III that were CR+/eGFP+ in 
Noc::eGFP mice ...................................................................... 81 
Table 3-3 The numbers of neurons that were eGFP, Pax2- and/or CR-
immunoreactive in Nociceptin::eGFP and RorBeGFP mice ...................... 82 
Table 4-1 Expression of other neurochemical markers with CR and eGFP in       
Nociceptin::eGFP mice ............................................................. 102 
Table 4-2 Colocalization of neurochemical markers with CR and eGFP in RorBeGFP 
mice ................................................................................... 107 
Table 6-1 Number of tdTomato cells counted on the side ipsilateral and 
contralateral to the nerve injury ................................................. 170 
Table 6-2 Numbers of NeuN, Pax2 and inhibitory CR+ cells in laminae I- II on the 
side ipsilateral and contralateral to the nerve injury ......................... 171 
Table 6-3 CR+/tdTomato+ cells dendritic dimensions on the side ipsilateral and 
contralateral to the nerve injury ................................................. 172 
  
1 
 
1 Introduction 
  
2 
 
 
 
1.1 Spinal cord 
1.1.1  Anatomy of the spinal cord 
 
The spinal cord is part of the central nervous system and contained within the 
vertebral canal. It extends from the base of the skull to the level of the first 
lumbar vertebra in human and third lumbar vertebra in the rat. The spinal cord 
is enlarged in cervical and lumbar regions, which corresponds to increased 
innervation of upper and lower extremities respectively. The spinal cord is 
protected by surrounding vertebral column and meninges. The meninges also 
protect the brain, and are composed of dura, arachnoid and pia mater. In the 
human, there are 31 spinal nerves that emerge from both side of the spinal cord 
and are divided into 8 cervical, 12 thoracic, 5 lumbar and 1 coccygeal nerve on 
each side. In the rat, the spinal cord comprises 34 pairs of spinal nerves: 8 
cervical, 13 thoracic, 6 lumbar, 4 sacral and 3 coccygeal. The lumbar and sacral 
nerves extend as long roots called the cauda equina. 
The internal structure of spinal cord comprises surrounding white matter and 
inner grey matter. The grey matter contains nerve cell bodies and glial cells. On 
transverse section, it appears H-shaped. The butterfly or H-shaped grey matter 
is further divided into a smaller dorsal and larger ventral horn. The neurons of 
the dorsal horns receive sensory information through ‘pseudounipolar’ neurons 
situated in dorsal root ganglia (DRG) that enters the spinal cord via the dorsal 
roots of the spinal nerves. The ventral horns contain cell bodies of motor 
neurons that send axons via the ventral roots of the spinal nerves to terminate 
on striated muscles.  
1.1.2  Spinal grey matter organization 
Estimation using a stereological method, found about 4 million neurons in the 
spinal grey matter of the mouse (Bjugn, 1993). The highest number of neurons 
was found in the thoracic region, followed by cervical and lumbar region and the 
least is in sacro-coccygeal region with 1.4 million, 1.2 million, 0.9 million and 
0.4 million neurons respectively. These numbers showed that we need a proper 
classification or organization of the grey matter to enhance our understanding 
on the functions of the cells that are present in the grey matter of the spinal 
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cord.  Usually, the grey matter of the spinal cord is classified into a dorsal horn, 
intermediolateral horn, ventral horn and intermediate zone (Afifi and Bergman, 
1986) before a laminar scheme was introduced by Bror Rexed in the 1950s. Since 
then, the Rexed laminae are widely used by many neuroanatomists to describe 
the organization of the grey matter.   
A study by Rexed (1952) proposed that the spinal grey matter can be divided into 
10 laminae (layers) which were first identified in transverse sections of the 
spinal cord of the cat. Later, this classification was extended to other species 
such as human, monkey, dog, mouse and rat (Liu and Chambers, 1964, Buxton 
and Goodman, 1967, Sidman et al., 1971, Molander et al., 1989, Schoenen and 
Faull, 2004). However, only studies involving rodent and human have a complete 
description of the cytoarchitectural organization of the grey matter (Schoenen 
and Faull, 2004, Sidman et al., 1971). The Rexed laminae were divided based on 
neuronal size, shape, cytological features and density. The laminae were 
arranged in the dorso-ventral axis (laminae I-IX) with lamina X (substantia grisea 
centralis) being located around the central canal. The dorsal horn consists of 
laminae I-VI, lamina VII is the intermediate grey matter and laminae VIII-IX are 
part of the ventral horn. In each lamina, the neurons within have distinct 
functions, dendritic shape, chemoarchitecture and connection arrangements 
(Rexed, 1952). According to Rexed (1952), the basic principles of the layering of 
the grey matter are comparable across species. Below is a description of each 
lamina of the spinal grey matter based on finding in various species (Rexed, 
1952, Schoenen and Faull, 2004, Sengul and Watson, 2012).  
The thinnest layer lamina I, also known as the marginal layer is located at the 
most dorsal region of Rexed’s laminae, and curves around the lateral edge of the 
dorsal horn. It appeared reticulated due to the penetration of several small and 
large nerve fibres. It consists of neurons of variable sizes and is loosely 
organized. Large elongated and smaller triangular, multipolar and fusiform 
neurons have been identified. The boundary between lamina I and the white 
matter is less visible due to penetration of small and large nerve fibres. Lamina I 
cells include excitatory and inhibitory interneurons. Projection neurons 
constitute 5% of all the cells in this region (Todd et al., 2002, Spike et al., 2003).  
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Lamina II is also known as substantia gelatinosa of Rolandi because it looks more 
gelatinous than the rest of grey matter, due to the lack of myelinated fibres. 
Lamina II can be subdivided into outer (dorsal) lamina IIo and inner (ventral) 
lamina IIi based on the density and distribution of cells. The lamina II cells are 
generally small. It is closely packed apart from the medial side, where it broken 
up by the crossing of many large fibres from dorsal funiculus. The outer lamina II 
has more closely packed cells, whereas lamina II inner has a lighter appearance 
due to fewer cells. Lamina II contains large numbers of excitatory and inhibitory 
interneurons. Among these interneurons, the excitatory stalked (vertical) cells 
and inhibitory islet cells are commonly found in lamina II (Gobel, 1975, Gobel, 
1978). These will be discussed in detail below. Laminae I-II, also known as the 
superficial dorsal horn (SDH), is a major termination site for Aδ and C fibres 
(Light and Perl, 1979, Zylka et al., 2005).  
Lamina III lies parallel to laminae I-II, broader than the first two laminae with 
lighter appearance because the neurons are less densely packed than in lamina 
II. However, the cells in lamina III are larger with a wider distribution of cell 
sizes. Myelinated afferent fibres are more numerous here than lamina II. Apart 
from that, projection neurons also frequently found here (Burstein et al., 1990). 
Lamina III and IV are collectively known as nucleus proprius.  
Lamina IV is larger than laminae I-III, extends straight across the dorsal horn 
with the same thickness without a ventral bend. It consists of loosely packed 
cells with various sizes. A distinct characteristic of lamina IV is the presence of 
large and small cells side by side.  
Lamina V is the widest layer and extends across the narrowest part of the dorsal 
horn. It has reticulated appearance laterally due to many longitudinally running 
fibre bundles. It is divided into lateral and medial part by the present of thick 
bundles of nerve fibres on the lateral side. The neurons in lamina V vary in shape 
and size.  
Lamina VI forms the base of the dorsal horn. It has a straight dorsal border and a 
convex ventral border with the broadest part lies near the medial side. Similar 
to lamina V, lamina VI too can be divided into lateral and medial zone. The cells 
in the medial part are smaller and tightly packed than the cells in lateral zone 
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part. Lamina III-VI consist of interneurons and projection neurons and serve as 
the termination sites for large myelinated Aβ and small myelinated Aδ primary 
afferent fibres (Light and Perl, 1979, Woodbury et al., 2008). The deeper lamina 
cells also consist of excitatory and inhibitory interneurons that use glutamate 
and GABA/glycine as neurotransmitters, respectively (Todd and Sullivan, 1990). 
The intermediate zone of spinal grey is formed by lamina VII. The shapes of the 
cells vary, including multipolar, triangular and fusiform and these are evenly 
distributed, thus giving the lamina a homogeneous appearance. It has a concave 
dorsal border and medially it has an unclear border with area X. Ventrally, 
lamina VII is adjacent to lamina VIII and motor nuclei of lamina IX on the medial 
and lateral side, respectively. Lamina VIII is confined to the medial side of the 
ventral horn and consists of small and large cells. Both laminae VII and VIII do 
not contain any motor neurons. Meanwhile lamina IX is in the ventral horn and 
several motor nuclei that innervate skeletal muscle lie within the area. The 
largest nerve cells across all laminae can be found in lamina IX. Lamina X is the 
grey matter surrounding the central canal and consists of small interneurons.  
1.2 Primary afferent fibres 
The primary somatosensory afferent axons transmit information from the 
peripheral tissue to the dorsal horn of the spinal cord. These fibres respond to 
various types of stimuli such as noxious, thermal, itch and innocuous tactile, 
received by the peripheral terminals. The primary afferents encode stimuli into 
electrical signals and transmit those signals to the central nervous system. 
Primary afferents are pseudo-unipolar neurons with their somata located in the 
trigeminal ganglion and dorsal root ganglia (DRG). The axons of these afferent 
fibres have a peripheral process that innervates the skin, muscles, joint capsules 
or viscera and contain receptors specialized for each type of innocuous or 
noxious stimulus. The central branches terminate in the spinal cord or trigeminal 
nuclei by making axodendritic and axosomatic synapses with second order 
neurons, before this information is transmitted to higher centres in the brain. 
Most primary afferents axons enter the dorsal horn near their level of origin with 
a few fibres ascending or descending one or two spinal segments before they 
penetrate the dorsal horn (Traub et al., 1986). Primary afferent fibres terminate 
in the dorsal horn depending on their sensory modalities (Figure 1-1), with 
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nociceptive and thermoreceptive Aδ and C fibres terminating in the superficial 
laminae of the dorsal horn, while Aδ and Aβ mechanoreceptors innervate the 
deeper part of the dorsal horn (Todd, 2010). Non-nociceptive C fibres such as 
transient receptor potential receptor melastatin 8 (TRPM8) expressing C-
thermoreceptors were found to terminate in lamina I (Dhaka et al., 2008). In 
addition, C-LTMR (low threshold mechanoreceptor), which express vesicular 
glutamate transporter 3 (VGLUT3), terminate in lamina IIi of the dorsal horn of 
the spinal cord (Seal et al., 2009). 
According to anatomical and functional criteria, primary afferents can be 
categorized into Aβ, Aδ and C fibres depending on their cell body sizes, axon 
diameter, degree of myelination and axonal conduction velocities. It is known 
that, the larger the diameter of primary afferent fibres and the thicker the 
myelin sheath, the faster the conduction speed. For example, myelinated Aβ and 
Aδ fibres have medium and large soma sizes with conduction velocities of 35-75 
m/s and 5-30 m/s respectively. Meanwhile, unmyelinated C fibres are the 
smallest and slowest, with conduction velocities of 0.5-2 m/s. In addition, 
muscle afferents fibres can be divided into group IV, III, II and I fibres based on 
their conduction velocity.  
Some of the subset of thinly myelinated Aδ and slow conducting unmyelinated C 
fibres such as Aδ-LTMRs (also known as D-hair afferents) and C-LTMRs exhibit 
thresholds below the nociceptive range. However, most of these primary 
afferent fibres are nociceptors and thermoreceptors, and based on their 
response to noxious mechanical, thermal or chemical stimuli, many are 
considered to be polymodal nociceptors (Abraira and Ginty, 2013). The 
nociceptors are a specialized primary afferent nerve fibre type that respond to 
intense (noxious) stimuli, thus providing protection from potential injury by 
conveying information to the central nervous system on the location and 
intensity of noxious stimuli. They are not activated by innocuous stimuli such as 
warming or touch (Burgess and Perl, 1967). Nociceptors comprise both 
myelinated A-fibres and unmyelinated C primary afferent fibres.  
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1.2.1  Myelinated nociceptors 
The A-fibre nociceptors include most of thinly myelinated Aδ and a few fast 
conducting cutaneous Aβ fibres (Burgess and Perl, 1967, Djouhri and Lawson, 
2004). A-fibre nociceptors conduct fast pricking and sharp pain with more 
discrete information regarding stimulus (Slugg et al., 2000). A-fibre nociceptor 
receptive fields are small; thus they provide precise localization of pain. The 
strongest response by noxious-stimulated A-fibre primary afferent is generated 
following damaging of the tissue in the contact area by pinching of the skin using 
serrated forceps (Perl, 1968). The A-fibre nociceptors can be subdivided into 
those with high (type I) and low (type II) thresholds to heat (Treede et al., 
1998). Type I are A-fibre mechano-heat-sensitive (AMHs) nociceptors, also known 
as polymodal nociceptors, which respond to heat, mechanical and chemical 
stimuli. These type I A-fibre nociceptors were previously identified as high 
threshold mechanoreceptors, due to their high heat threshold following short 
duration stimuli (Burgess and Perl, 1967). Their conduction velocity is between 
that of Aδ (5-30 m/s) and Aβ fibres (35-75 m/s). These type I AMHs can be found 
in the hairy and glabrous skin. Meanwhile, type II A-fibre nociceptors, found only 
on a hairy skin, and have a slower conduction velocity compared to type I AMHs. 
Furthermore, type I fibres show a gradual increase in response to heat, whereas 
type II fibres have a slow adapting response to heat, and this pattern is similar 
to that of C-fibre mechano-heat-sensitive nociceptors (CMHs) (Treede et al., 
1995). Type I fibres are activated by burn and chemical injury and thus may play 
a role in the development of hyperalgesia, while type II fibres probably initiate 
the first pain sensation from heat, and contribute to pain due to the application 
of capsaicin to the skin (Ringkamp et al., 2001). 
In the spinal cord, Aδ nociceptors innervate lamina I, IIo and V and some of these 
fibres project in the Lissauers tract or the dorsal column upon entering the 
spinal cord (Light and Perl, 1979). Light and Perl also found that some of the 
nociceptive Aδ fibres passing ventrally before terminating in lamina V and some 
had collateral branches that project to the ventral part of lamina IV by 
penetrating deeply to the dorsal horn before making a dorsal turn. Meanwhile, 
large diameter Aβ nociceptors projected throughout lamina I-V with flame-
shaped central arbors (Woodbury et al., 2008). We have little knowledge on the 
neurochemical properties of A-fibres nociceptors. Studies using guinea pig have 
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shown that some Aδ-afferents that carry nociceptive information contain 
neuropeptides such as substance P and calcitonin gene-related peptide (CGRP) 
(Lawson et al., 1997, Lawson et al., 2002). 
Injection of Cholera toxin B subunit (CTb) into the intact peripheral nerves 
allows visualisation of the central termination of myelinated afferent fibres in 
the dorsal horn of the spinal cord. The CTb protein binds to the GM1 ganglioside 
and is taken up and transported mostly by A-fibres after injection into the 
nerves (Shehab and Hughes, 2011). This protein labelled axonal boutons in 
lamina I as well as in deeper laminae. The central terminals in lamina I 
presumably belong to Aδ nociceptors, whereas those in the deeper laminae, 
mainly belongs to Aδ and Aβ low threshold mechanoreceptors (Light and Perl, 
1979, Lamotte et al., 1991).  
1.2.2  Unmyelinated nociceptors 
Most C-fibre nociceptors are polymodal fibres which respond to noxious 
mechanical, chemical and thermal stimuli (Perl, 1996, Cain et al., 2001). They 
give rise to unpleasant, poorly localized and burning sensations and they greatly 
outnumber Aδ nociceptors. C-nociceptive fibres can be divided into broadly two 
major subclasses depending on their expression of neuropeptides and on their 
growth factor dependence (Snider and McMahon, 1998, Julius and Basbaum, 
2001). The neuropeptides calcitonin gene related protein (CGRP), substance 
P/Neurokinin A (NKA), somatostatin and galanin are expressed by peptidergic 
nociceptors, while non-peptidergic C nociceptive fibres lack these peptides 
(Hökfelt et al., 1975, Bennett et al., 1996). Furthermore, these two distinct C 
primary afferent fibres that are involved in nociceptive pathways depend on 
different protein signalling for their survival. Nerve growth factor 
(NGF)/Tropomyosin receptor kinase A (TrkA) signalling is needed by peptidergic 
nociceptive fibres, whereas non-peptidergic neurons depend on glial cell line-
derived neurotropic factor (GDNF) and receptor tyrosine kinase (c-Ret) 
signalling. In addition, non-peptidergic C fibres binds Griffonia simplicifolia 
isolectin IB4 and possess the purinergic receptor P2X3 (Snider and McMahon, 
1998, Bennett et al., 1998, Zylka et al., 2005). Non-peptidergic and peptidergic 
primary afferents differ in response to nerve injury. Using an animal model of 
constriction neuropathy, Bailey and Ribeiro-da-Silva (2006) found a transient loss 
of axonal boutons that bind to IB4 following nerve injury, with normal 
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immunoreactivity of CGRP-labelled axons . This study also used electron 
microscopy and found degenerative changes of central terminal of type I 
glomeruli, which originate from non-peptidergic unmyelinated primary afferents. 
These finding suggest that there is loss of these non-peptidergic fibres, and not 
only loss of IB4 binding.    
A study by Zylka et al. (2003) showed that Mas related G protein-coupled 
receptors (Mrgprs including MrgprAs, MrgprBs, MrgprC and MrgprD) are expressed 
in small diameter neurons, which presumably include nociceptors. This is further 
supported by electrophysiological evidence showing that MrgprD neurons have 
some properties typical of nociceptors such as prolonged action potentials, 
tetrodotoxin resistant Na+ current and Ca2+ currents that are inhibited by mu 
opioids (Dussor et al., 2008). Expression of Mrgprd is restricted to non-
peptidergic neurons that innervate the specific layer of epidermis, stratum 
granulosum and this termination site is distinct from that of peptidergic neurons 
(Zylka et al., 2005). Mrgprd-expressing cells in the mouse contain the ATP-gated 
ion channel receptor P2X3 and only a small subset (9%) expressed TRPV1 
receptor (the capsaicin and noxious heat-gated receptor), whereas all Mrgprd 
positive cells in the rat contain the TRVP1 receptor (Zylka et al., 2003). In 
addition, most of Mrgprd afferents do not contain substance P or CGRP, and 
MrgprD is confined to the subset of nociceptors that express GDNF, and these 
represent ~75% of IB4 binding neurons (Dong et al., 2001, Zylka et al., 2003, 
Zylka et al., 2005). Almost all (99.6%) Mrgprd expressing neurons are labelled 
with IB4, however, IB4 binding was not specific for non-peptidergic C fibres, as it 
can overlap with peptides such as CGRP (Dong et al., 2001, Wang and Zylka, 
2009, McCoy et al., 2013). These finding show that Mrgprd is a specific marker 
for non-peptidergic C nociceptors and for that reason, they will be referred to as 
CMrgD afferents.  In order to determine the two major classes of C-fibres, the 
peptidergic and non-peptidergic that express MrgprD, Cavanaugh et al. (2009) 
tested the behavioural response by pharmacological and genetic ablation each 
populations respectively. Cavanaugh and colleagues found that ablation of 
MrgprD expressing neurons only affected behavioural response to noxious 
mechanical stimuli (the effect on peptidergic population will be discuss below), 
although it was found that MrgprD-expressing neurons respond to thermal and 
mechanical stimuli (Rau et al., 2009). A later study found that mechanical 
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stimulation to the skin by pinching but not gentle stroke of a brush causes 
activation of Mrgprd-positive fibres (Vrontou et al., 2013). 
After rhizotomy, the CGRP immunoreactivity in the dorsal horn will disappear, 
thus showing its primary afferent origin (Noguchi et al., 1990, Hökfelt et al., 
1994). CGRP labelled primary afferents contain noxious heat receptor TRPV1 and 
pharmacological ablation of the central terminals of TRPV1-positive neurons 
leads to selective deficits in behavioural response to noxious thermal stimuli 
(Cavanaugh et al., 2009). A study by McCoy et al. (2013) using mice lacking 
CGRPα-expressing neurons revealed that these fibres contribute to perception of 
noxious heat and itch but are not needed to sense noxious mechanical or β-
alanine itch stimuli. Moreover, these mice become more sensitive to cold and 
prefer warmer temperatures.  
Centrally, unmyelinated C-nociceptors terminate in different laminae with 
peptidergic fibres innervating mainly lamina I and IIo, while CMrgD primary 
afferent fibres arborize in the middle of lamina II of the SDH with little overlap 
between these two fibre types (Plenderleith et al., 1990, Averill et al., 1995, 
Snider and McMahon, 1998, Woodbury et al., 2000, Zylka et al., 2005). The 
peripheral axons of the non-peptidergic fibres innervate the skin, meanwhile the 
peptidergic fibres terminate within joints, viscera and skin (Taylor et al., 2009). 
1.2.3  Low threshold mechanoreceptors 
Neurons that respond to innocuous touch of the skin are called low threshold 
mechanoreceptors (LTMRs), and these include A and C fibres. These LTMRs will 
be classified as Aβ, Aδ or C fibres depending on their action potential conduction 
velocities (Horch et al., 1977). LTMRs are stimulated by non-noxious weak 
mechanical force including vibration, stretch of the skin, movement or bend of 
hair follicles and indentation on the skin. However, some fibres are also 
activated by phasic cooling or thermal stimuli (Abraira and Ginty, 2013). LTMRs 
can be classified as slowly adapting (SA), intermediate (IA) or rapidly adapting 
(RA), based on their firing pattern to sustained mechanical stimuli (Burgess et 
al., 1968). Most of Aβ-fibres are LTMRs, and these were shown to terminate 
within laminae III-V of the cat dorsal horn, with some giving branches to the 
gracile and cuneate nuclei (Rexed, 1952, Willis and Coggeshall, 2004). 
Meanwhile, in the rat, low-threshold Aβ mechanoreceptive afferents can extend 
11 
 
 
 
into lamina IIi (Woolf, 1987). They can be divided into rapidly adapting and 
slowly adapting fibres, referring to the response of these fibres to skin 
indentation. The SA-fibres will continuously discharge action potential 
throughout the stimulus and are associated with Merkel cells and Ruffini endings, 
whereas RA only fire on the onset and offset of indentation of the skin and are 
associated with Pacinian and Meissner corpuscles (Willis and Coggeshall, 2004). 
Aβ RA- and SA-LTMRs bifurcate into branches that extend rostrally and caudally 
with collateral axons that terminate deep in the dorsal horn (Brown et al., 
1981). Some of the rostral branches of these fibres form a direct connection 
from the periphery to the brain without terminating in the spinal cord. They 
extend straight through the dorsal column and form synapses with the dorsal 
column nuclei neurons (Brown and Fyffe, 1981). The central projection of the 
SA-fibres terminates in the more superficial part of the dorsal horn and also the 
deeper part of the dorsal horn, meanwhile the RA-fibres have a flame shaped 
axonal arborisation which innervate the deeper regions (Woodbury et al., 2001, 
Woodbury and Koerber, 2007). 
The Aδ D-hair afferents are located in hairy skin and are found to be sensitive to 
the slow movement of hairs (Light et al., 1982). Unlike Aβ-fibres, Aδ-LTMRs 
project via the dorsal column to the dorsal horn without giving long rostral or 
caudal branches (Traub and Mendell, 1988). The central terminals of these fibres 
terminate in the inner part of lamina II and in lamina III (Light and Perl, 1979) 
and are found to be part of the type II synaptic glomeruli (see below) (Light et 
al., 1982).   
C-LTMRs were first described by  Zotterman (1939). He mentioned that these 
fibres are believe to be related to tickling and itching sensations. In the cat, a 
subset of C-fibres is found to be activated by low threshold mechanical and 
thermal stimulation but not by noxious stimuli (Bessou and Perl, 1969, Bessou et 
al., 1971). Meanwhile, in the human, these fibres are reported to be involved 
with pleasant touch sensations (Löken et al., 2009). Olausson et al. (2002) found 
that the human insular cortex is activated by stimulation of these fibres, 
suggesting that they are required in developing positive emotions. C-LTMRs 
fibres are more numerous than A-LTMRs and are very sensitive to indentation of 
the skin, similar to A-fibres, except that they are activated by stimuli that move 
slowly across their receptive field (Li et al., 2011). Apart from using VGLUT3, 
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tyrosine hydroxylase (TH) can be used to specifically label C-LTMRs in the dorsal 
root ganglia (Seal et al., 2009, Li et al., 2011).  More than 80% of TH-
immunoreactive neurons co-express VGLUT3 mRNA and they do not express 
CGRP, TrkA or TRPV1, which are markers for peptidergic nociceptors and do not 
bind to IB4 or express MrgprA1, MrgprA3, MrgprA4, MrgprB4, MrgprC11 or MrgprD, 
which are markers for non-peptidergic nociceptors (Li et al., 2011). These fibres 
are only found in hairy skin and their central boutons are absent from the medial 
part of the dorsal horn in the lumbar and cervical enlargement which are 
innervated from glabrous skin. Study done recently in human, found that 
stimulation of C-LTMRs causes reduce in heat pain but this was not seen in 
patients with impaired C-LTMRs, as in small fibre neuropathy (Habig et al., 
2017). Another distinct subset of non-peptidergic C-fibres that express Mas-
related G protein coupled receptor B4 (MrgprB4) are found to innervate hairy 
skin alone and are also associated with pleasant touch (Liu et al., 2007). 
Massage-like stroking of hairy skin but not pinching of the skin causes activation 
of these fibres (Vrontou et al., 2013). 
1.2.4 Neurochemical properties and receptors of primary       
afferents 
The neurotransmitter glutamate is very important in maintaining spinal 
excitatory synaptic transmission in normal or pathological pain conditions 
through activation of glutamate receptors. Primary afferents use glutamate as 
their fast neurotransmitter, thus they will have excitatory effect on their 
synaptic targets (Broman et al., 1993). They act via glutamate receptors, 
including N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)/kainate and metabrotropic glutamate receptors 
(mGlus) (Tao et al., 2005, Bardoni, 2013). Glutamate is packed into synaptic 
vesicles by vesicular glutamate transporters (VGLUTs) before its release. There 
are three VGLUTs that have been discovered, namely VGLUT1, VGLUT2 and 
VGLUT3 (Takamori, 2006, Fremeau et al., 2002). Likewise, VGLUTs have been 
widely used as a marker for glutamatergic axons and were mainly expressed by 
excitatory interneurons in the dorsal horn (Todd et al., 2003). However, these 
glutamatergic neuronal markers are also found to be expressed by primary 
afferents that terminate in the dorsal horn. Central terminals of low threshold 
mechanoreceptors in laminae IIi-VI contain VGLUT1, whereas a low level of 
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VGLUT2 is found in many unmyelinated primary afferents in the rodents, and 
they do not express VGLUT1 (Todd et al., 2003, Brumovsky et al., 2007). 
However, VLGUT1 is also express by descending neurons from the pyramidal cells 
of neocortex and corticospinal fibres (Du Beau et al., 2012). VGLUT3 is 
expressed by unmyelinated low threshold mechanoreceptor C fibres that 
innervate the inner layer of lamina II (Seal et al., 2009). Seal et al also found 
that VGLUT3-immunoreactivity do not overlap with the IB4 band but lies 
exclusively among cells that express protein kinase C gamma (PKCγ). Each of the 
VGLUTs is expressed by different population of primary afferents suggesting that 
they have distinct functions in transmitting different stimuli from the periphery 
to the brain.  
Substance P is found in the dorsal ganglia, dorsal roots of the spinal nerves and 
primary afferent central terminals in the superficial part of the dorsal horn, 
consistent with its role as a sensory neurotransmitter involved with the 
perception of pain (Cuello et al., 1977, Douglas and Leeman, 2011). In the dorsal 
horn, substance P is also expressed by local neurons and descending serotonergic 
pathways (Hökfelt et al., 1978, Gilbert et al., 1982). It is a member of 
tachykinin family of neuropeptides, which act through the neurokinin-1 receptor 
(NK1r), a seven transmembrane domain G-protein coupled receptor. Other 
members of tachykinin family are neurokinin A and B, which act on the 
neurokinin 2 and 3 receptors respectively (Maggi, 1995). Substance P and 
neurokinin A are expressed by both primary afferent and interneurons, 
meanwhile neurokinin B is only present in SDH interneurons (Ogawa et al., 
1985). Substance P is expressed by Aδ-fibres and unmyelinated C fibres that 
terminate in lamina I-II of the dorsal horn, which are involved in transmitting 
noxious stimuli to the spinal cord dorsal horn (Cao et al., 1998, Lawson et al., 
1997, Kantner et al., 1985). There have been several reports that most of SP-
containing primary afferents also co-express CGRP (Wiesenfeld-Hallin et al., 
1984, Lee et al., 1985, Gibbins et al., 1985). Substance P is thought to 
contribute to nociceptive transmission through central hyperexcitability, thus 
increasing the sensitivity to pain (Salter and Henry, 1991). Substance P was 
thought to be upregulated by Aβ fibres after nerve injury or inflammation 
(Fukuoka et al., 1998, Marchand et al., 1994, Neumann et al., 1996), however, a 
study using three nerve injury models: sciatic nerve transection (SNT), spinal 
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nerve ligation (SNL) and chronic constriction injury (CCI) disputed this (Hughes 
et al., 2007). Hughes et al did not see any expression of substance P in Aβ fibres 
in those models. In addition, they also found that no internalization of NK1r in 
the spinal dorsal horn after electrical stimulation of Aβ primary afferent are 
seen in the SNL and CCI models, suggesting that substance P was not released 
from afferents in significant amounts. 
Transient receptor potential (TRP) channels were first identified in Drosophila 
(Minke, 1977). TRPs are ion channels that have six protein families; the vanilloid 
receptor TRPs (TRPVs), the melastatin or long TRPs (TRPMs), the mucolipins 
(TRPMLs), the polycystins (TRPPs), the classical TRPs (TRPCs) and ankyrin 
transmembrane protein 1 (ANKTM1) (Clapham, 2003, Montell et al., 2002). In the 
nervous system, TRPs are involved in the response towards various stimuli 
received from the periphery, neuron outgrowth and receptor signalling (Moran et 
al., 2004). The vanilloid receptor, now known as TRPV1, is important in 
processing heat sensation and is mostly expressed by Aδ- and C-nociceptors 
(Caterina and Julius, 2001). TRPV1 is activated specifically by capsaicin, the 
main pungent ingredient in chili peppers of the genus capsicum (Caterina et al., 
1997). TRPV1 is also activated by noxious heat (>43oC), low pH and lipids such as 
anandamide (Caterina et al., 1997, Tominaga et al., 1998, Caterina and Julius, 
2001). Activation of TRPV1 by binding of capsaicin causes influx of Na+ and Ca2+, 
leading to firing of action potentials, and is associated with the burning 
sensation related with spicy food (Holzer, 1991). Ablation of TRPV1 in knockout 
mice resulted in decreased reactions to noxious heat and vanilloid induced pain 
without any changes in response to noxious mechanical stimuli (Caterina et al., 
2000). Cavanaugh et al. (2011) reported that, in the DRG of adult mice, TRPV1 is 
expressed selectively by peptidergic C primary afferent fibres.  
TRPM8 and TRPA1 are another two family members of TRPs, which that are 
activated by cold stimuli. TRPM8 responds to cooling (<26-28oC) and cooling 
compounds such as menthol and icilin. Meanwhile, TRPA1 is stimulated by 
noxious cold (<18 oC) and icilin with response menthol (McKemy et al., 2002, 
Peier et al., 2002, Story et al., 2003). In rat DRG, TRPA1-expressing neurons do 
not show immunoreactivity for neurofilament 200 (NF200), a neurochemical 
marker for A-fibres, and this receptor is observed only in C-fibres that express 
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TRPV1 mRNA, whereas TRPM8-positive cells do not co-express TRPV1, and can 
have either A- or C- fibres (Kobayashi et al., 2005). This studies also observed 
that TRPA1 and TRPM8 are rarely co-expressed. Peier et al. (2002) reported that 
in mouse, TRPM8-immunoreactive cells in DRG do not contain TRPV1 or CGRP, or 
IB4. This finding strongly suggests that TRPM8 is express by distinct group of 
thermoreceptive neurons. A TRPM8-/- mouse showed abnormal behaviour towards 
cool thermosensation, thus further support that this receptor is responsible for 
detection of innocuous cold (Dhaka et al., 2007).  
1.2.5  Synaptic glomeruli 
Most primary afferents terminate in the dorsal horn of the spinal cord in simple 
synaptic arrangements, but some have a more complex form involving several 
synapses, known as the synaptic glomerulus. Electron microscopy is the best 
method to explore this synaptic arrangement in detail. These complex structures 
consist of a central primary afferent bouton that forms synapses with 
surrounding profiles. Coimbra and colleagues have shown that 70% of the central 
terminals of the glomeruli in lamina II of the rat degenerated 5 days after dorsal 
rhizotomy, thus providing that most of these are formed by primary afferent 
central boutons (Coimbra et al., 1974). The surrounding profiles include 
presynaptic GABAergic axons from local neurons which form axoaxonic synapse 
onto the primary afferent boutons. Other structures are dendrites that are post-
synaptic to the primary afferent boutons and some GABAergic vesicle-containing 
dendrites that can form reciprocal synapses with the central axon (Todd, 1996). 
In addition, surrounding structures can form synapses between themselves, with 
the central axons also forming a synapse onto one of them. This arrangement is 
known as the synaptic triad.  
The synaptic glomeruli indicate that a complex structure is needed to interpret 
incoming sensory information from the periphery. Two types of synaptic 
glomeruli were found in the rat spinal cord by Ribeiro-Da-Silva and Coimbra 
(1982). The classification is based on several criteria mainly focusing on the 
central terminal of a glomerulus; i) electron density of the background 
cytoplasm and size, ii) regularity of contour, iii) number of mitochondria and iv) 
synaptic vesicles uniformity, compactness and diameter.  
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1.2.5.1 Type I and type II glomeruli 
Type I glomeruli are located in the middle and ventral part of lamina II, at the 
termination site for unmyelinated C fibres. Central axons of the type I glomeruli 
are darker and have densely packed synaptic vesicles with variable diameter. 
They are thought belongs mainly to non-peptidergic unmyelinated primary 
afferent fibres (Ribeiro-Da-Silva and Coimbra, 1984, Ribeiro-da-silva et al., 
1989).  
Type II glomeruli are mainly found in the ventral part of lamina II and the dorsal 
part of lamina III, overlapping with the termination site of myelinated primary 
afferent fibres. Central axons of type II glomeruli have electron-lucent 
cytoplasm and vesicles of more uniform size and most probably, the central 
axons of the type II glomeruli are derived from myelinated primary afferent 
fibres (Ribeiro-Da-Silva and Coimbra, 1984). Both Aδ and Aβ fibres terminate in 
lamina II, however the central terminals of these myelinated primary afferent 
fibres can be differentiated by looking at the synaptic complexes that they form. 
The central axons of type II glomeruli are thought to belong to Aδ down hairs 
and are found mostly in lamina IIi and III (Ribeiro-Da-Silva and Coimbra, 1982, 
Light et al., 1982). In addition, myelinated primary afferent fibres such as large 
Aβ hair follicle afferents form non-glomerular synapses (Watson et al., 2002). 
Even though they terminate differently, both of them receive inhibitory 
axoaxonic inputs (Maxwell and Noble, 1987, Todd et al., 1991, Todd, 1996). 
Dendritic spines from islet cells in lamina II of the cat dorsal horn were found to 
be presynaptic to central boutons of lamina II glomeruli (Gobel et al., 1980). 
Presynaptic inhibition of primary afferents is mediated by axoaxonic and 
dendroaxonic synapses in both type I and type II glomeruli. Peripheral 
presynaptic dendrites in type II glomeruli are less numerous compared to type I 
glomeruli, but the former have more peripheral axon terminals (Ribeiro-Da-Silva 
and Coimbra, 1982). A few studies found that peripheral axons and presynaptic 
dendrites in the glomeruli contain γ-aminobutyric acid (GABA) in the rat, cat and 
monkey (Barber et al., 1978, Maxwell et al., 1990, Carlton and Hayes, 1990, 
Todd, 1996). These GABAergic structures are believed to be derived from local 
inhibitory interneurons. A study of GABA and glycine using a quantitative post-
embedding immunogold technique, showed that all of the peripheral axons and 
most of the vesicle containing dendrites are immunoreactive for GABA. However, 
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in type II glomeruli, most of the peripheral axons and few of the vesicle 
containing dendrites contained both GABA and glycine (Todd, 1996). From these 
finding we can conclude that different neurochemical populations of inhibitory 
interneurons are involved in the presynaptic inhibition of myelinated and 
unmyelinated primary afferent fibres. Recently, Hughes et al. (2012) showed 
that parvalbumin (PV) containing neurons found in lamina IIi and III form 
axoaxonic synapses on the central terminals of type II glomeruli and are most 
likely a source of presynaptic inhibition of myelinated primary afferent fibres.  
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Figure 1-1 Rexed’s laminae and the termination of primary afferents in different laminae of 
the spinal cord. 
Rexed (1952) divided the grey matter of the cat into laminae I-X based on the cell size and packing 
density of neurons, and this is applicable across several other mammalian species. The dashed 
lines indicate laminar boundaries. This image also shows the central terminations site of the major 
group of primary afferents. Aδ nociceptors arborize mainly in lamina I with some fibres penetrating 
more deeply. Peptidergic primary afferent fibres including some Aδ nociceptors, innervate lamina I 
and IIo, with some fibres terminating in deeper laminae. Meanwhile, non-peptidergic CMrgD 
nociceptors arborize in the middle of lamina II. Aδ hair follicle afferents end at the border between 
laminae II and III, whereas Aβ hair follicle and tactile afferents terminate in laminae IIi-V. Modified 
from Todd (2010). 
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1.3 Projection neurons 
The sensory information from spinal cord dorsal horn is projected to the brain 
via numerous ascending tracts that are located in the ventral, lateral and dorsal 
funiculi. Many anatomical and electrophysiological studies have been performed 
in the rat to determine the potential brain targets and their origin in the spinal 
cord. Retrograde and anterograde tracing studies allow individual neurons to be 
labelled from specific brain region and their termination site in the brain can be 
mapped, respectively. The three main ascending tracts in the brain are the 
anterolateral tract (ALT), the post-synaptic dorsal column (PSDC) system and 
spino-cervicothalamic (SCT) pathway. This study will be focusing on ALT since 
these are the main ascending pathway for nociception. 
The ALT (Figure 1-2) consists of two separate tracts: anterior spinothalamic tract 
and lateral spinothalamic tract that are located in the anterior funiculus and 
anterior part of the lateral funiculus, respectively. The anterior spinothalamic 
tract transmits crude touch and pressure sensations, meanwhile the lateral 
spinothalamic tract transmit pain and temperature (Martin et al., 1990). In the 
rat, the ALT neurons are located in lamina I, are largely absent from lamina II 
and are distributed throughout lamina III-VI (Todd, 2010). In lamina I, the 
dendritic trees of projection neurons are confined within the same lamina, 
meanwhile, the ALT neurons in laminae III-IV have dendrites that extent dorsally 
into lamina II. 
In the rat, ALT neurons in laminae III-IV expressed NK1r and receive numerous 
contacts from GABAergic cells that contain neuropeptide Y (NPY), as well as 
from dynorphin-expressing excitatory neurons (Baseer et al., 2012, Polgár et al., 
1999, Polgár et al., 2011). The axons of these NK1r positive projection neurons 
project to contralateral brainstem region and thalamus nuclei (Marshall et al., 
1996, Todd et al., 2000, Al-Khater et al., 2008). However, some fibres that 
travel to the brain have a bilateral projection (Spike et al., 2003). These brain 
regions include caudal ventrolateral medulla (CVLM), the nucleus of the solitary 
tract (NTS), lateral parabrachial area (LPb) and the periaqueductal grey matter 
(PAG) (Lima and Coimbra, 1988, Hylden et al., 1989, Lima et al., 1991, Todd et 
al., 2000, Spike et al., 2003, Al-Khater et al., 2008, Al Ghamdi et al., 2009). The 
ALT neurons in laminae III-IV are thought to be wide-dynamic-range (WDR). They 
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are innervated mainly by substance P-containing nociceptors and receive sparse 
synaptic inputs from myelinated low threshold afferents (Polgár et al., 2007, 
Naim et al., 1998). Most of NK1r-immunoreactive cells in lamina III show pERK 
after noxious thermal, mechanical or chemical stimuli (Polgár et al., 2007). The 
morphology of the ALT neurons in lamina I includes fusiform, pyramidal and 
multipolar with dendritic trees confined within the same layer (Spike et al., 
2003, Almarestani et al., 2007). Han et al. (1998) found that pyramidal cells are 
thermoreceptive, fusiform cells are nociceptive, while multipolar cells are 
either polymodal or nociceptive-specific. Some studies found that A retrograde 
labelling study showed about 5% of the total neuronal population in lamina I was 
constitute by projection neurons and that ~80% of projection neurons in lamina I 
express the main receptor for substance P, the NK1r (Spike et al., 2003, Al-
Khater and Todd, 2009). Projection neurons are not the only cells that express 
NK1r, as some interneurons in lamina I also express this receptor. These two 
populations of cells can be distinguished by their soma size. Generally, most of 
the NK1r expressing projection neurons in lamina I have a larger soma size cross 
sectional area (>200µm2) in horizontal sections, whereas most NK1r-positive 
interneurons have a soma area that is smaller than this (Al Ghamdi et al., 2009). 
The ALT neurons that expressed NK1r in lamina I are densely innervated by 
substance P containing primary afferents and they upregulated Fos (the protein 
product of the immediate early gene c-fos) after noxious stimulation 
(subcutaneous injection of formalin) (Todd et al., 2002). Neurons that express 
NK1r in the dorsal horn can be selectively destroyed by intrathecal injection of 
substance P conjugated to the cytotoxin saporin (Mantyh et al., 1997, Nichols et 
al., 1999). In inflammatory and neuropathic pain models in rats that had been 
treated with the above toxin, the signs of hyperalgesia were dramatically 
reduced. However, in mice without NK1r or the gene coding for substance P 
formation (preprotachykinin), there was no change in hyperalgesia in 
inflammatory and neuropathic pain models (Cao et al., 1998, De Felipe et al., 
1998). These findings showed, most probably glutamate released by the 
substance P expressing primary afferents that act on the NK1r expressing 
projection neurons of the ALT, is responsible for the development of 
hyperalgesia (De Biasi and Rustioni, 1988).  
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About 3% of lamina I projection neurons are very large multipolar cells that are 
either lack NK1r or weakly labelled with NK1r antibody (Puskár et al., 2001). A 
study by Baseer et al. (2014) showed about 40% of NK1r-lacking lamina I 
projection neurons received synaptic input from non-peptidergic type I Aδ 
nociceptors thus strongly suggest it play an important role in perception of fast 
pain. These giant neurons can be distinguished by the dense inhibitory and 
excitatory synaptic input to the cell bodies and dendrites (Puskár et al., 2001, 
Polgár et al., 2008). Retrograde labelling, using injection of cholera toxin B 
subunit into the parabrachial area, labelled the majority of the lamina I giant 
cells and they expressed Fos following noxious stimulation, suggesting they are 
activated by nociceptors (Puskár et al., 2001). GABAergic axons that contained 
nitric oxide synthase (nNOS) formed numerous synapse with these giant neurons 
(Puskár et al., 2001). 
The dorsal column tract includes the dorsal column-medial lemniscus pathway 
(the gracile and cuneate fasciculi) and the PSDC pathway. The dorsal column-
medial lemniscus fibres carry discriminative touch, vibration, conscious muscle 
joint sense, tactile information and conscious information (Figure 1-3). Sensory 
nerve fibres in the dorsal root ganglia enter the white matter of the spinal cord 
and ascend ipsilaterally in the dorsal column to terminate on the cuneate and 
gracile nuclei. The sensory nerve fibres from upper limb enter the spinal cord 
and form the cuneate fasciculus and the fibres from lower limb form the gracile 
fasciculus. The second-order neurons, internal arcuate fibres, cross the midline 
and ascend as the medial lemniscus through the medulla oblongata, the pons 
and the midbrain. The fibres terminate by synapsing on the third-order neurons 
in the ventral posterolateral nucleus of the thalamus which then project to the 
primary somatosensory cerebral cortex.    
The PSDC tract is formed by the axons of dorsal horn neurons that synapse in the 
dorsal column nuclei. These PSDC neurons respond to innocuous mechanical 
stimuli (Giesler and D. Cliffer, 1985)and noxious peripheral stimuli (Bennett et 
al., 1984). The PSDC neurons are mainly located in laminae III-IV and also in the 
deeper laminae V-VI of different mammalian species (Brown and Fyffe, 1981, 
Bennett et al., 1983). The axons of these neurons project through the dorsal 
funiculus before terminating in the junction area between the spinal cord and 
the medulla. The PSDC pathway is organized somatotopically in such that 
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cervical cells terminate in the nucleus cuneatus while neurons in the 
lumbosacral enlargement project to the nucleus gracilis.  
The SCT pathway includes spinocervical and cervicothalamic tracts. These 
pathways transmit light cutaneous touch and noxious stimuli to the thalamus. 
Neurons of the spinocervical tracts are found in lamina I-V. The spinocervical 
axons project in the ipsilateral lateral funiculus and synapses in the lateral 
cervical nucleus. In the rat, the spinocervical tract is organized somatotopically: 
medially lie the sacral fibres and laterally lie the cervical fibres. Axons of the 
lateral cervical nucleus neurons decussate in the ventral white commissure of 
the upper cervical spinal cord and ascend in the medial lemniscus to reach the 
thalamus (cervicothalamic tract) (Berkley et al., 1980).  
Todd (2010) suggested that projection neurons are functionally diverse since 
they have a large number of supraspinal target. For instance, ascending neurons 
in the dorsal horn project to the VPL indicate a feasible role in sensory 
discriminative aspects of pain (Gauriau and Bernard, 2004). The nociceptive 
input from SDH is transmitted to the LPb which then project to the amygdala or 
the hypothalamus. According to Gauriau and Bernard (2002), the parabrachial-
amygdala connection and parabrachial-hypothalamic fibres are believed to have 
a role in the emotional components of pain processing and in motivational 
affective responses during pain states, respectively.      
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Figure 1-2 Anterior and lateral spinothalamic tract (Anterolateral system) 
The ALT neurons convey information such as crude touch, pressure sensations, pain and 
temperature. The sensory nerve fibres (red) give branches to the spinal cord dorsal horn which 
than activate neurons in the spinal cord that belong to the spinothalamic tract (blue). Spinothalamic 
axons cross the midline and ascend in the white matter as the spinothalamic tract. This tract forms 
connection with the medial lemniscus before terminate in the thalamus. The third order neurons in 
the thalamus (green) project to the primary somatosensory cortex.    
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Figure 1-3 Dorsal column-medial lemniscus pathway (DCML)  
These projection neuron carries the sensory modalities of discriminative touch, vibration, conscious 
muscle joint sense, tactile information and conscious information. The name arises from the two 
structures that form the DCML. The first order neurones (red) carry information from fasciculus 
cuneatus (cervical spinal cord) and fasciculus gracilis (lumbar spinal cord) which then synapse in 
the nucleus cuneatus and gracilis of the medulla oblongata. The second order neurons (blue) begin 
in the cuneate nucleus or gracilis which than synapse with the third order neurons (green) in the 
thalamus. These fibres decussate in the medulla oblongata and travel in the contralateral medial 
lemniscus fibres to reach the thalamus. The third order neurons in the thalamus then project to the 
primary somatosensory cortex. 
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1.4 Excitatory and inhibitory interneurons of the dorsal 
horn 
The great majority of laminae I-III neurons have axons that only arborize within 
the spinal cord, and this are known as interneurons (Todd, 2010). Nearly all 
neurons in lamina II are interneurons, and 95% of those are in lamina I (Spike et 
al., 2003, Polgár et al., 2004). Lamina III contains projection neurons from 
several different tracts (Abraira and Ginty, 2013), thus making it difficult to 
estimate the percentage of interneurons in this lamina. However, it is thought 
that most neurons in lamina III are interneurons (Todd, 2017). Interneurons are 
divided into two major functional classes: excitatory and inhibitory cells. They 
receive input from the central terminals of the primary afferents and modify the 
sensory information before projecting it to various part of the brain. In addition, 
they also receive synaptic inputs from the brain and from other interneurons.  
Most of the neurons in laminae I-III are excitatory interneurons which use 
glutamate as their fast neurotransmitter, while inhibitory interneurons use GABA 
and/or glycine. Quantitative immunocytochemical studies in rodents have 
suggested that about 25-40% of neurons in laminae I-III are GABA 
immunoreactive with some using glycine as co-transmitter (Todd and Sullivan, 
1990, Polgár et al., 2003, Polgár et al., 2013a). Inhibitory interneurons is believe 
to play a major role in modifying pain and itch sensation in the dorsal horn 
(Basbaum et al., 2009, Ross et al., 2010, Zeilhofer et al., 2012). They reduce the 
response to nociceptive stimuli, silence the nociceptive neurons during 
innocuous stimulation, prevent crosstalk between sensory modalities and keep 
the neuronal excitation within somatotopically areas of the dorsal horn 
(Sandkühler, 2009). Failure of these functions will lead to pathological pain 
states. 
In the rat, 30% of neurons in lamina III are enriches with glycine and are 
therefore likely to be glycinergic. Glycine enrichment is found in 9% and 14% of 
the neurons in lamina I and II, respectively (Todd and Sullivan, 1990). All of 
these cells were GABA-immunoreactive. Study using in situ hybridization for 
neuronal glycine transporter 2 (GlyT2) and findings from GlyT2::eGFP mice 
demonstrated that glycinergic cells are more numerous in the deeper dorsal horn 
between laminae III-V and are thus most likely involved with tactile stimulation 
29 
 
 
 
(Zeilhofer et al., 2005, Hossaini et al., 2007). However, an electrophysiological 
study by Yasaka et al. (2007) found there are purely glycinergic synapses present 
in laminae I-III. It is possible that these lack of GABAA receptors or that they are 
derived from glycinergic neurons located in deeper lamina (Chéry and De 
Koninck, 1999).  
GABA and glycine are taken up into vesicles at the inhibitory axon terminals by 
means of vesicular GABA transporter (VGAT; also known as the vesicular 
inhibitory amino acid transporter, VIAAT). Therefore, antibodies against this 
molecule can be used to identify the axons of inhibitory interneurons (Sardella 
et al., 2011b). In addition, antibodies against the GABA-synthesizing enzyme 
glutamic acid decarboxylase (GAD) and the neuronal glycine transporter (GLYT2) 
are alternative to labelling the inhibitory boutons (Mackie et al., 2003, Tiong et 
al., 2011). Immunostaining with this antibody allows us to visualise inhibitory 
axons in laminae I-III, which are mostly derived from local interneurons. As 
mentioned before, Aδ and C nociceptors mainly terminate in laminae I and II and 
these can receive synapses from GABAergic interneurons which are thought to be 
located within the same laminae. This type of synapse is known as an axoaxonic 
synapses, and these mediate GABAergic presynaptic inhibition (Magoul et al., 
1987, Todd, 1996). GABAergic neurons also form axodendritic and axosomatic 
synapses in lamina II and this underlie postsynaptic inhibition (Magoul et al., 
1987). Blockage of GABAA receptors in rat spinal cord creates behavioural signs 
of tactile allodynia (Sivilotti and Woolf, 1994). 
The remaining ~75% of the interneurons in laminae I-III that are not GABAergic or 
glycinergic are presumably glutamatergic. There are currently no reliable 
immunocytochemical markers for the cell bodies of glutamatergic neurons. It 
appears that all excitatory interneurons in laminae I-III express vesicular 
glutamatergic transporter 2 (VGLUT2). This means that, axons of these cells can 
be identified using antibody against VGLUTs (Todd et al., 2003). These axonal 
boutons containing VGLUT2, which are mostly derived from local excitatory 
interneurons, are very numerous in laminae I-III. 
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1.4.1  Interneuron classification 
Various attempts have been made to identify distinct functional populations 
among the SDH interneurons, by using cell morphology, electrophysiology 
properties, expression of neurochemical markers and developmental lineage 
(Grudt and Perl, 2002, Maxwell et al., 2007, Yasaka et al., 2010, Heinke et al., 
2004, Wildner et al., 2013, Iwagaki et al., 2013). Sadly, there is still no 
universally accepted classification that can be used for all dorsal horn 
interneurons (Todd, 2010). The most widely accepted scheme is that developed 
by Grudt and Perl for lamina II neurons. This relies mainly on diversity of the 
cells’ dendritic morphology and their firing patterns during injection of 
depolarizing current (Grudt and Perl, 2002). Since the SDH is the first relay site 
for the pain pathway, it is crucial for us to characterise interneurons into 
different functional group. This will help us understand the spinal pain 
processing mechanisms and should lead to the development of new pain 
therapies (Graham et al., 2007). 
1.4.1.1 Morphology  
Initially, the Golgi technique was used to study the morphology of neurons in the 
spinal cord or spinal trigeminal nucleus in various species (Gobel, 1975, Gobel, 
1978, Schoenen, 1982, Lima and Coimbra, 1986, Todd and Lewis, 1986).  These 
studies identified two main cell type among lamina II neurons, based on 
dendritic and axonal characteristics: this were name islet and stalked cells 
(Gobel, 1975, Gobel, 1978). Nevertheless, they found many cells with different 
morphologies, and this could not reliably assign to specific classes. A later study 
by Grudt and Perl (2002) using whole-cell patch-clamp recording from spinal 
cord slices in vitro identified four main morphological classes: islet, vertical, 
central and radial cells (Figure 1-4). Vertical cells by Grudt and Perl overlapped 
with stalked cells described by Gobel 1975, 1978. Their classification scheme 
was based on the laminar location and size of the soma and dendritic tree; the 
size, number, branching pattern and main direction of dendritic tree and axon.  1.4.1.1.1 Islet cells 
 
Islet cells was first identified in spinal trigeminal nucleus of the cat using the 
Golgi method and were described as having large dendritic trees that extended 
in rostrocaudal axis for more than 500 µm (Gobel, 1975).  A morphometric 
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analysis by Yasaka et al. (2007), using quantification of dendritic parameters in 
rat spinal cord, found that the four group of cells, identified by Grudt and Perl 
could be differentiated by this method. According to this study, islet cells had a 
ratio of rostrocaudal to dorsoventral dendritic extent (RC:DV) of more than 3.5, 
and most had rostrocaudal dendritic lengths of more than 400 µm (Figure 1-4). 
Some islet cells had a dendritic extension of between 300-400 µm long, and had 
axons that remained within the dendritic tree. Both the dendrites and axons 
arborize within lamina II and dendritic trees are limited in dorsoventral and 
mediolateral extent (Grudt and Perl, 2002, Yasaka et al., 2007). Gobel et al. 
(1980) reported that, the dendritic tree had long tertiary branches that gave rise 
to recurrent branches that turned 180o towards the cell body. Meanwhile, the 
axons of these cells branch extensively within the volumes of dendritic tree and 
can extend beyond this in rostrocaudal axis (Grudt and Perl, 2002). The cell 
bodies of islet cells are small (less than 15 µm in diameter), found throughout 
lamina II and rarely has axosomatic synapse (Gobel et al., 1980, Yasaka et al., 
2010).  
In terms of their electrophysiological properties, islet cells have a lower resting 
membrane potential other than lamina II neurons. they show a tonic firing 
pattern and have an Ih current (Melnick, 2008). The majority of the islet cells 
receive monosynaptic input from axons conducting at <1ms-1, which therefore 
belongs to C-fibres (Grudt and Perl, 2002). In addition, some islet cells received 
monosynaptic Aδ fibres input. This authors also found that EPSCs and IPSCs 
evoked in islet cells have greater amplitude than those in other recorded 
morphological cell type (Yasaka et al., 2007). More stimulating current was 
needed to evoke action potentials in islet cells compared to other cells that 
show tonic firing (Melnick, 2008).  
All islet cells are immunoreactive for GABA and their axon terminals contain GAD 
and VGAT (Todd and McKenzie, 1989, Maxwell et al., 2007, Yasaka et al., 2010). 
A study using a mouse line that express enhanced green fluorescent protein 
(eGFP) under the control of GAD67 promoter showed that the majority of eGFP-
immunoreactive neurons in lamina II were islet cells (Heinke et al., 2004). In 
support of the finding that all islet cells are GABAergic, a study using 
VGLUT2::eGFP mice showed that none of the VGLUT2::eGFP (glutamatergic) 
cells had islet morphology. These mice are a bacterial artificial chromosome 
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(BAC) transgenic mouse line, in which expression of eGFP is under the control of 
the vesicular glutamate transporter (VGLUT2) gene (Punnakkal et al., 2014). 1.4.1.1.2 Central cells 
 
Central cells and their dendritic arbor remain within the same lamina IIi and they 
have the rostrocaudal extension that is shorter than that of islet cells (Figure 
1-4). The dendritic tree often asymmetrical, being larger either rostral or caudal 
to the cell bodies. They are restricted in the mediolateral and dorsoventral 
planes (Grudt and Perl, 2002). The axons travelled rostracaudally, and they can 
extend into lamina I and the superficial part of lamina III (Grudt and Perl, 2002, 
Yasaka et al., 2010). Cells that have a dendritic tree RC:DV ratio of more than 
3.5 and a rostrocaudal extension of less than 300 µm was identified as central 
cells (Yasaka et al., 2007). Grudt and Perl (2002) further divide these cells into 
two populations, based on their action potential discharge. Those that fired 
action potentials throughout the depolarizing current pulse were classed as tonic 
central cells, while those that fired action potential only at the beginning of the 
current pulse were called transient central cells. Transient central cells were 
further divided based on the presence or absence of potassium current IA. 
Transient central cells in lamina II were found to form excitatory monosynaptic 
inputs to vertical cells in lamina IIo (Lu and Perl, 2005). Dorsal root stimulation 
experiments showed that most of central cells received monosynaptic eEPSCs 
from C fibres and a few cells receive polysynaptic input from Aδ fibres, similar 
to what were seen in islet cells (Yasaka et al., 2007). Central cells are found 
among both excitatory or inhibitory (Yasaka et al., 2010). 1.4.1.1.3 Radial cells 
 
Radial cells have somata that are usually found near the middle of lamina II 
(Grudt and Perl, 2002, Yasaka et al., 2007). They have dense dendritic trees that 
extend in all directions when viewed in sagittal section with restricted 
rostrocaudal (<275 µm) and dorsoventral (<160 µm) plane within lamina II 
(Yasaka et al., 2010). In addition, Grudt and Perl (2002) described that the 
dendritic arbors of radial cells are also very restricted in the mediolateral plane 
and that they had low to moderate density of dendritic spines (Figure 1-4). The 
axons of radial cells normally spread rostrally or caudally for more than 500 µm 
from the cell body. They generally remain within lamina II, with some axons 
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extending into laminae I and/or III (Yasaka et al., 2010). These cells have action 
potential that are delayed from the onset of depolarizing current pulse injection 
and show irregular discharge pattern of action potentials (Grudt and Perl, 2002). 
Dorsal root stimulation experiments revealed that radial neurons received 
monosynaptic input from both C-fibres and Aδ-fibres and as well as IPSCs from 
myelinated and unmyelinated primary afferents (Grudt and Perl, 2002, Yasaka et 
al., 2007). Radial cells usually exhibit a high frequency of spontaneous EPSCs and 
spontaneous IPSCs, thus showing that they received numerous excitatory and 
inhibitory synapses (Grudt and Perl, 2002). Radial cells were found to contain 
VGLUT2 (Yasaka et al., 2010), suggesting that they are excitatory cells. 
Consistent with this, radial cells were also identified in VGLUT2::eGFP mice 
(Punnakkal et al., 2014) but not in Gad67::eGFP (Heinke et al., 2004).  1.4.1.1.4 Vertical cells 
 
Vertical cells population described by Grudt and Perl (2002) includes stalked 
cells which was identified by Gobel (1975). Their dendritic trees spread in the 
rostrocaudal plane with limited mediolateral extension (Figure 1-4). Although 
some cells have many dendritic spines, others have relatively few (Grudt and 
Perl, 2002, Yasaka et al., 2010). The cell bodies are generally found in lamina II 
and they have projecting dendrites which can pass through laminae II-IV. 
Nevertheless sometimes the dendrites can extend dorsal to the soma (Grudt and 
Perl, 2002).  Yasaka et al. (2007) described the vertical cells as having dendritic 
arbors shaped like a fan or cone with soma lying dorsal at the apex. Usually, 
axons of vertical cells extend rostral and caudal to the dendritic arbor, 
remaining within lamina II. However, they often had axons that enter lamina I 
and some travelled into deeper laminae (Grudt and Perl, 2002).  Dorsal root 
stimulation experiment showed that vertical cells receive monosynaptic input 
from Aδ primary afferent fibre and evoked IPSCs from both C-fibre and Aδ fibre 
(Yasaka et al., 2007). Most vertical cells are excitatory however some cells with 
similar morphology have been showed to be inhibitory (Maxwell et al., 2007, 
Yasaka et al., 2010). Some lamina I neurons receive monosynaptic input from 
excitatory vertical cells in lamina IIo (Lu and Perl, 2005). Interestingly, those 
inhibitory vertical cells are generally smaller and have less compact dendritic 
arbor (Yasaka et al., 2010). 
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1.4.1.1.5 Minor classes and unclassified cells 
 
Apart from the four main cell groups, Grudt and Perl (2002) identified one more 
class of cells in lamina II known as medial-lateral neurons. The mediolateral and 
dorsoventral expansion of the dendritic trees of these cells were larger than that 
of islet, radial or central cells. In addition, their dendrites extended from lamina 
I to the superficial part of lamina III in dorsoventral direction. Meanwhile, their 
axons spread further than the dendritic trees in the rostrocaudal plane, and 
extended from lamina I to the superficial part of lamina III. The medial-lateral 
cells exhibited IA-like transient outward current, similar to that of transient 
central cells. However, they were different from transient central cells based on 
their tonic firing pattern and the lack of IPSC evoked by dorsal root stimulation. 
Only three from 157 lamina II cells recorded by Grudt and Perl (2002) belong to 
this group, and therefore it is not considered to be major classes. Furthermore, 
Punnakkal et al. (2014) did not identify any cells belonging to this class.   
The classification scheme by Grudt and Perl (2002) cannot be applied to ~30% of 
lamina II neurons (Yasaka et al., 2007, Maxwell et al., 2007, Yasaka et al., 
2010). The morphology of these neurons does not fit into any of the recognize 
morphological classes, and they may represent more than one cell type.  
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Figure 1-4 Four main morphological classes of interneurons in lamina II of dorsal spinal 
cord 
Islet cells have dendritic trees spread extensively in rostrocaudal direction (> 400 µm) with a limited 
dorsoventral extent. Central cells have less extensive rostrocaudal extension (< 400 µm) that is 
shorter than islet cells with restricted mediolateral and dorsoventral extent. Radial cells have a 
short dendritic trees that extent in all directions, and vertical cells have a projecting dendrites 
shaped like a fan with cell bodies located dorsally. These cells are seen in sagittal section and their 
morphology are similar with the main classes described by Grudt and Perl (2002). D: dorsal, V: 
ventral, RC: rostrocaudal. Scale bar = 100 µm. Modified from Todd (2010). 
  
37 
 
 
 
1.4.1.2 Firing pattern 
Electrophysiological experiments have shown that interneurons can be classified 
according to their firing pattern, in response to injected depolarizing current. 
Islet, central, vertical and radial cells differ in their action potential discharge 
responses during depolarization current injection. They can be categorized as 
tonic firing, delayed firing, initial bursting, single spiking, gap and reluctant 
firing (Grudt and Perl, 2002, Ruscheweyh and Sandkühler, 2002, Heinke et al., 
2004, Prescott and Koninck, 2002, Yasaka et al., 2010). Tonic firing pattern is 
defined as having action potential discharge at regular interval throughout the 
current pulse, meanwhile delayed firing neurons exhibit a long latency before 
the onset of action potential. Initial bursting firing neurons discharge action 
potential only at the onset of current injection. The single spiking firing pattern 
is defined as having only one or two action potentials discharged at the onset of 
current injection. The gap between the first and second action potential is long 
in gap firing neurons, followed by continuous, the regular firing of action 
potentials. No action potentials occur after depolarising current injection in 
reluctant firing neurons.   
Gap, delayed and reluctant action potential firing patterns are probably related 
to the presence of IA current, which is mediated by a voltage–gated potassium 
channel. These A-type firing patterns are associated with excitatory 
interneurons and are mostly confined within this group (Yasaka et al., 2010). In 
addition, tonic or initial burst firing pattern are commonly exhibited by 
inhibitory interneurons. 
1.4.1.3 Neurochemical markers 
As an alternative strategy, neurochemical markers have been widely used to 
distinguish different groups of interneurons (Todd, 2010). Some of these markers 
such as galanin and NPY are expressed mainly by inhibitory interneurons, 
meanwhile some such as somatostatin, neurotensin and neurokinin B (NKB) are 
exclusively found in excitatory interneurons (Rowan et al., 1993, Proudlock et 
al., 1993, Todd et al., 1994, Simmons et al., 1995, Polgár et al., 2006). 
However, others such as nNOS, dynorphin and CR are expressed by both 
inhibitory and excitatory interneurons (Sardella et al., 2011a, Sardella et al., 
2011b, Smith et al., 2015). Interestingly, these neurochemical populations differ 
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in their laminar distribution within the dorsal horn. For example, parvalbumin-
expressing cells are found in lamina IIi-III, meanwhile NPY-immunoreactive cells 
are scattered throughout laminae I-III (Polgár et al., 2011, Hughes et al., 2012). 
This suggest that there is an association between these neurochemical classes 
and functional populations (Todd, 2017).  
1.4.1.3.1 Inhibitory interneurons 
 
Four largely non-overlapping groups of inhibitory interneurons have been 
identified so far in laminae I-III of rat dorsal horn based on the expression of 
neuronal nitric oxide synthase (nNOS), neuropeptide Y (NPY), galanin and 
parvalbumin (Polgár et al., 1999, Tiong et al., 2011, Sardella et al., 2011b, 
Hughes et al., 2012). In addition, there is extensive overlapped between galanin 
and dynorphin among inhibitory interneurons (Sardella et al., 2011a). The 
neurochemical populations are similar in the mouse except that there is some 
overlapped between the populations and in addition some cells contain both 
galanin and NPY (Iwagaki et al., 2013, Kardon et al., 2014, Boyle et al., 2017). 
The cells also differ in their expression of receptors, their responses to noxious 
stimuli and their postsynaptic targets.   
The somatostatin receptor (sst2A) is virtually restricted to inhibitory neurons, and 
in both rat and mouse, about half of the inhibitory interneurons express sst2A 
receptors (Todd et al., 1998, Polgár et al., 2013a). Expression of sst2A receptors 
differs between each of the neurochemical populations mentioned above. 
Almost all inhibitory cells that express nNOS and galanin have sst2A receptor but 
the receptor is expressed by fewer of the NPY-positive cells and not in 
parvalbumin-immunoreactive neurons (Iwagaki et al., 2013, Polgár et al., 
2013b). A recent study using mouse, estimated that more than 90% of inhibitory 
dynorphin cells also expressed sst2A. (Boyle et al., 2017). nNOS and dynorphin are 
present in both excitatory and inhibitory populations, and thus immunostaining 
for the sst2A receptor can help to distinguish between these cell types (Sardella 
et al., 2011a, Sardella et al., 2011b, Polgár et al., 2013b). In addition, 
electrophysiological experiments have shown that somatostatin acting on the 
sst2A receptor causes hyperpolarization of inhibitory cells and thus disinhibition 
(Yasaka et al., 2010). 
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Both phosphorylated extracellular signal-regulated kinases (pERK) and 
transcription factor Fos are a marker for neuronal activation (Gao and Ji, 2009). 
After a variety of noxious stimuli including pinch, heat, capsaicin and the 
formalin test, cells immunoreactive for NPY and galanin show pERK. However, 
only a few of the nNOS cells and none of parvalbumin cells show pERK (Polgár et 
al., 2013b). Even though inhibitory nNOS cells did not show pERK after the above 
stimuli, Fos was seen in the majority of these cells following formalin and 
noxious heat stimulation. In addition, following a pinch stimulus, pERK is seen in 
lamina III NPY-immunoreactive cells (Iwagaki et al., 2016). Capsaicin causes 
activation of the heat sensitive channel TRPV1 (Caterina et al., 1997). However, 
surprisingly in the experiments described above, nNOS-expressing cells did not 
respond to capsaicin. This may be explained by innervation of the nNOS-
immunoreactive cells by TRVP1-lacking heat nociceptors (Polgár et al., 2013b). 
Neurons that contain parvalbumin do not show pERK or express Fos after various 
types of noxious stimulation, which suggest that these cells are only involved in 
innocuous sensations (Polgár et al., 2013b). 
Many studies have shown that, inhibitory cells that express NPY, nNOS, 
parvalbumin or galanin differ in their synaptic contacts. For example in rat, NPY 
immunoreactive boutons selectively innervate NK1r-immunoreactive lamina III 
ALT nociceptive projection neurons. However, this ALT neurons are not 
exclusively innervated by NPY-containing axonal boutons, as they also receive 
input from other GABAergic axons (Polgár et al., 1999). In addition, the other 
synaptic targets of inhibitory NPY-expressing neurons include excitatory PKCγ-
positive interneurons in lamina IIi (Polgár et al., 2011). The present of gephyrin 
puncta as the contacts formed by NPY-expressing boutons on the PKCγ-
immunoreactive cells indicate that these are sites of GABAergic synapses. This 
study also found evidence that lamina III NK1r-expressing projection neurons and 
PKCγ-immunoreactive cells are innervated by different group of NPY-positive 
neurons. The NPY-containing axonal boutons that were in contact with lamina III 
NK1r-expressing projection neurons were larger and had a stronger NPY-
immunoreactivity compared to those axonal boutons that innervated PKCγ-
positive cells. A study using mouse found NPY-immunoreactive axons also 
innervate lamina III spinoparabrachial projection cells that express NK1R as well 
as that and those lack NK1r (Cameron et al., 2015). A recent study that involved 
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both electrophysiological and morphological experiments was carried out using a 
NPY-eGFP transgenic mouse line, to look at the cells that express NPY (Iwagaki 
et al., 2016). However, only 33% of the NPY-immunoreactive cells in laminae I-II 
were GFP positive although GFP was present in 82% of those in lamina III. Using 
dorsal root stimulation, they found that some NPY cells are innervate by C 
primary afferent neurons. These C fibre input were not affected by bath-applied 
capsaicin. In addition, fewer of the cells showed an increase in mEPSC frequency 
in response to capsaicin and none responded to icilin. This suggest that most of 
the NPY-expressing cells do not receive input from TRPV-1-expressing or TRPM8-
expressing primary afferents.  Iwagaki et al. (2016) also found most lamina III 
NPY-expressing cells have dendrites that project into SDH, which is consistent 
with a monosynaptic input. Furthermore, the recorded cells were located in the 
medial part of the lumbar enlargement, which lacks of C-LTMRs, since this 
region receives input from glabrous skin. This suggests that NPY-immunoreactive 
cells are innervated by CMrgD fibres that lack TRPV1. These primary afferent 
neurons are most probably involve in mechanical nociception (Iwagaki et al., 
2016, Cavanaugh et al., 2009).  
Puskár et al. (2001) found that in the rat a quarter of the GABAergic boutons 
synapsing on the lamina I giant projection neurons were derived from cells 
containing nNOS, while only 6% of the inhibitory synapses are from NPY-
expressing boutons (Polgár et al., 2011). Meanwhile, only 3% of gephyrin puncta 
on lamina I NK1r-expressing projection cells associated with nNOS axonal 
boutons (Puskár et al., 2001). Most of parvalbumin-immunoreactive axons 
terminal form axoaxonic synapses with central boutons of A-LTMR and are 
postsynaptic to it, suggesting that these cells is an important source of 
presynaptic inhibition of myelinated (A-LTMR) primary afferent fibres and also 
receive monosynaptic input from these afferents (Hughes et al., 2012). Since 
these cells do not upregulate pERK or FOS and their major synaptic input is from 
A-LTMRs, Hughes et al. (2012) suggest that parvalbumin-expressing cells might 
have a role in inhibiting tactile input. Furthermore, they discovered that 
parvalbumin-positive cells never form presynaptic input on central bouton of 
type I glomeruli, thus supporting the idea that synaptic connections within the 
dorsal horn neurons are specific and well organized. In addition, Petitjean et al. 
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(2015) found that parvalbumin-immunoreactive cells form synapses on PKCγ cells 
in lamina IIi. 
The distribution of NPY-immunoreactive cells distribution is similar in both 
mouse and rat (Rowan et al., 1993, Iwagaki et al., 2016, Boyle et al., 2017). In 
the rat, NPY-positive cells comprise 4-6% of the total population of neurons in 
laminae I-III (Polgár et al., 2011). However, a higher proportion of cells that are 
immunoreactive for NPY is seen in the mouse. NPY-immunoreactive cells 
accounted for about 8-10% of all neurons within laminae I-III (Boyle et al., 2017). 
All NPY-immunoreactive neurons in laminae I-III of the rat and mouse were found 
to be GABA-immunoreactive, and to express inhibitory marker PAX2, respectively 
(Rowan et al., 1993, Boyle et al., 2017). In the mouse, about 30% of the 
inhibitory interneurons within laminae I-II are positive for NPY, as are 25% of 
those in lamina III (Boyle et al., 2017). In addition, NPY is found in 15% and 5% of 
VGAT-positive boutons within laminae I-II, and lamina III, respectively (Polgár et 
al., 2011). The percentages for VGAT terminal boutons are slightly lower than 
the proportions of the inhibitory NPY-immunoreactive cells, probably due to the 
smaller number of axons arising from the NPY-positive cells (Polgár et al., 2011). 
In the mouse lamina II, NPY cells were morphologically heterogeneous but were 
never islet (Iwagaki et al., 2016). The quantitative study on the inhibitory 
interneurons by Boyle and colleagues found that 4-6% of NPY-immunoreactive 
cells in laminae I-III were also nNOS-immunoreactive (Boyle et al., 2017). NPY 
acts through Y1 and Y2 receptors. Both of these receptors can be found on the 
primary afferents, and Y1 receptors are also present on many neurons within the 
laminae I-III (Brumovsky et al., 2007). NPY has an analgesic effect and this may 
result from reducing the amount of substance P that is released by the primary 
afferent C-fibres and/or from an inhibitory effect on dorsal horn neurons 
(Duggan et al., 1991, Polgár et al., 2011).  
The parvalbumin-expressing neuron cell bodies are located within laminae II-III 
and this finding is similar in rat, cat and mouse (Yamamoto et al., 1989, Antal et 
al., 1990, Anelli and Heckman, 2005, Hughes et al., 2012) . The cells that 
expressed parvalbumin are more concentrated within laminae IIi and III. 
However, in the mouse, about 80% of parvalbumin-immunoreactive cells are 
found in lamina III, whereas in the rat ~30% of the cells that expressed 
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parvalbumin are found within lamina II and ~60% of these are within lamina III 
(Antal et al., 1990, Hughes et al., 2012). Most of the parvalbumin-
immunoreactive cells have dendritic trees that extend rostrocaudally, 
resembling islet cells. However, in the mouse, some of parvalbumin-
immunoreactive neurons are found to be central-like cells (Hughes et al., 2012). 
Most parvalbumin cells are enriched with both GABA and glycine (Laing et al., 
1994, Antal et al., 1990, Yamamoto et al., 1989, Abraira et al., 2017). Boyle et 
al. (2017) estimated that about 11% of the inhibitory interneurons within 
laminae I-II expressed parvalbumin. The axons of parvalbumin-expressing cells 
formed a dense plexus mainly within lamina IIi and some of these axons 
extended into lamina III, where they formed axoaxonic synapses on central 
terminals of type II glomeruli. The majority of these axon terminals contain 
VGAT and they rarely express VGLUT1 (Hughes et al., 2012). A marker for glycine 
transporter, GlyT2 is also present in the axon terminals of parvalbumin-
immunoreactive cells (Petitjean et al., 2015). Electrophysiological experiments 
revealed that after depolarizing current injection, the parvalbumin-expressing 
cells showed a high frequency of action potential discharge. These findings 
suggest that parvalbumin-positive cells provide a strong inhibitory control on the 
central terminals of myelinated primary afferent fibres. Parvalbumin cells also 
expressed the hyperpolarization activated cation current (Ih) (Hughes et al., 
2012) and this, together with a tonic firing discharge pattern are typical 
characteristics of islet cells (Grudt and Perl, 2002, Yasaka et al., 2010). It has 
been shown that the activation of parvalbumin-expressing cells reduced 
mechanical allodynia in a neuropathic pain model and that ablation of these 
cells leads to mechanical hypersensitivity (Petitjean et al., 2015). In the mouse, 
the majority of parvalbumin-containing cells within laminae I-III do not express 
with nNOS, although some of these overlap with the NPY cells (Boyle et al., 
2017). 
Galanin is involves in inflammatory pain where it exerts an inhibitory function 
(Wiesenfeld-Hallin and Xu, 1998). Among dorsal horn neurons, the peptide is 
restricted to GABAergic cells that do not use glycine as a co-transmitter 
(Simmons et al., 1995). Galanin cells are seen more within laminae I-IIo than in 
laminae IIi-III (Tiong et al., 2011). The cells in laminae I-II that are 
immunoreactive for galanin do not express nNOS, NPY or parvalbumin. However, 
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in lamina III most of the galanin-immunoreactive cells co-express nNOS. More 
than 90% of galanin cells in laminae I-II co-express κ-opioid peptide dynorphin, 
which can be revealed by using antibody against the dynorphin precursor 
preprodynorphin (PPD (Sardella et al., 2011a, Tiong et al., 2011).) The 
immunostaining of PPD is found mostly in the SDH and a few cells that are 
positive for this peptides are also seen in the deeper laminae (Sardella et al., 
2011a, Boyle et al., 2017). Most of these dynorphin cells in laminae I and II are 
inhibitory cells and dynorphin is present in 4% of the VGAT containing boutons in 
these regions (Sardella et al., 2011a, Boyle et al., 2017).  About 85% of inhibitory 
dynorphin cells are galanin-immunoreactive and this correspond to 96% of 
galanin cells (Boyle et al., 2017). Duan et al. (2014) showed that the ablation of 
inhibitory dynorphin-expressing cells in PdynCre mice causes mechanical allodynia 
with a normal response towards noxious heat and cold stimuli. They suggested 
that dynorphin cells are involved in gating mechanical pain. However, 
interpretation of this finding is complicated since dynorphin is transiently 
expressed during development, and thus cells that were ablated in this study 
might include the cells that transient expressed dynorphin (Todd, 2017).  
In the dorsal horn, most of the nNOS cells are found in lamina II with some of 
these being located in laminae I and III (Sardella et al., 2011b). Around 30%-50% 
of nNOS cells within laminae II and III expressed PKCγ, which is restricted to 
excitatory interneurons. This shows that nNOS is also present in the excitatory 
neurons (Sardella et al., 2011b). The nitric oxide (NO) produce by nNOS cells 
take part in the development and maintenance of hyperalgesia in inflammatory 
and neuropathic pain models (Lam et al., 1996, Guan et al., 2007). 
A few studies using prion promoter-eGFP mouse line (PrP-eGFP) and basic helix-
loop-helix transcription factor (Bhlhb5-/-) mice further linked the inhibitory cells 
that express galanin/dynorphin and nNOS (Ross et al., 2010, Iwagaki et al., 2013, 
Kardon et al., 2014). According to Iwagaki et al. (2013) cells that express eGFP 
under the control of the prion promoter (PrP) contain either nNOS, galanin or 
both neurochemical markers. In this study, eGFP cells accounted for 23% of 
neurons that express galanin, 57% of cells that contain only nNOS and 83% of 
those with both nNOS and galanin. Furthermore this cells did not express NPY or 
parvalbumin (Iwagaki et al., 2013). Iwagaki and colleagues also found that the 
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majority of these cells express sst2A and that application of somatostatin caused 
PrP-eGFP cells to be hyperpolarized through the activation of G protein-gated 
inwardly rectifying potassium channels (GIRK). Initially, all of the PrP-eGFP cells 
were thought to be central cells (Hantman et al., 2004). However, a study by 
Ganley et al. (2015) showed that they are morphologically heterogeneous and 
were never islet cells. PrP-eGFP cells are innervated mostly by non-overlapping 
populations of unmyelinated afferents that express Mrgprd, TRPV1 or TRPM8 
(Iwagaki et al., 2016).  
A study by Ross et al. (2010) reported that in the SDH, some of the interneuron 
populations were found to be involved with the suppression of itch. The 
transcription factor Bhlhb5 is needed for the survival of some populations of 
inhibitory interneurons in the dorsal horn and ablation of Bhlhb5 causes increase 
respond towards pruritogen and the development of skin lesion that results from 
excessive scratching (Ross et al., 2010, Kardon et al., 2014). In Bhlhb5 knockout 
mice, galanin/dynorphin- and nNOS-immunoreactive inhibitory interneurons are 
missing and these cells are called B5-I neurons. They accounted for two thirds of 
sst2A-immunoreactive cells (Kardon et al., 2014). This study also showed that B5-
I neurons that are galanin-immunoreactive expressed the endogenous κ-opiod 
receptor agonist dynorphin which suppress itch in respond to injections of 
various pruritogens. However, it is possible that GABA/glycine mediates the fast 
relief provided by counter stimuli such as scratching since PPD-/- and wild type 
mice have similar respond to intradermal pruritogens injection. Kardon and 
colleagues also found that B5-I neurons are innervated by capsaicin-, mustard 
oil- and menthol-responsive primary afferents, thus suggests that these cells 
inhibit itch by chemical counter stimuli. 
Calretinin (CR) is one of the family members of calcium binding proteins and 
have a similar structure to calbindin (Camillo et al., 2014). Initially it was 
thought that CR is expressed only by excitatory interneurons (Todd, 2010). 
However, Smith et al. (2015) found that 15% of CR-immunoreactive cells in the 
SDH expressed Pax2 and mostly they are islet cells. Details on inhibitory CR will 
be discussed further in chapter 3.  
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1.4.1.3.2 Excitatory interneurons  
 
Even though the excitatory interneurons accounted for 70% of the populations 
within laminae I-III, much less information was available on their organization. 
Through morphological studies, vertical and radial cells are found to be mostly 
glutamatergic (Grudt and Perl, 2002, Maxwell et al., 2007, Yasaka et al., 2010). 
Immunocytochemical markers such that the neuropeptides somatostatin (SST), 
neurotensin, neurokinin B (NKB) and gastrin releasing peptide (GRP) are mainly 
confined within excitatory interneurons and it has been shown that substance P-, 
neurotensin-, NKB- and GRP-expressing cells form distinct populations, which are 
thought to be functionally diverse (Gutierrez-Mecinas et al., 2016a, Gutierrez-
Mecinas et al., 2017). Other markers that are associated with excitatory 
interneurons include the calcium binding proteins calbindin and CR and PKCγ are 
glutamatergic neurons (Antal et al., 1991, Polgar et al., 1999, Smith et al., 
2015). However, about 15% of CR cells in laminae I and II are inhibitory (Smith et 
al., 2015). 
VGLUT-2 has been detected in excitatory interneurons, such as those cells that 
contain substance P, neurotensin, enkephalin and somatostatin (Todd et al., 
2003). This is consistent with previous studies that have shown that none of the 
somatostatin- and neurotensin-immunoreactive cells in the SDH contain GABA 
(Todd and Spike, 1992, Proudlock et al., 1993).Todd and colleagues also found 
that VGLUT2 immunoreactivity was never seen in glycinergic, cholinergic, 
monoaminergic axons and very rarely co-labelled with GAD-immunoreactive 
(GABAergic) boutons within the spinal cord.  
The somatostatin (SST)-positive cells are concentrated in the superficial 
laminae, although scattered cells are seen in lamina III (Proudlock et al., 1993). 
Somatostatin is never found in GABAergic or glycinergic neurons within laminae 
I-II and is expressed by various populations of excitatory interneurons in this 
region (Proudlock et al., 1993, Gutierrez-Mecinas et al., 2016a). However, some 
of the SST-immunoreactive cells in the deeper laminae are found to be inhibitory 
(Proudlock et al., 1993, Duan et al., 2014). SST is extensively co-localized with 
neurotensin, PPTB, GRP and other excitatory neuronal markers such as PKCγ and 
CR (Gutierrez-Mecinas et al., 2016a, Polgar et al., 1999). However, Duan et al. 
(2014) reported that SST and CR are found in two separate populations of cells 
46 
 
 
 
based on their finding that SST mRNA is absent in Cre-expressing neurons in the 
CRCre knock-in mice. On the contrary Gutierrez-Mecinas and colleagues found 
that more than half of the cells that contain SST also express CR and two thirds 
of CR-immunoreactive cells co-express SST (Gutierrez-Mecinas et al., 2016a). 
SST-expressing neurons are morphologically heterogeneous with several distinct 
firing patterns (Duan et al., 2014). This study reported that the ablation of SST-
expressing neurons in the dorsal horn dramatically reduced the mechanical pain 
and this is probably due to the loss of more than one populations of excitatory 
interneurons, parallel to the finding that the majority of excitatory populations 
co-express SST (Todd, 2017). 
The PKCγ-immunoreactive neurons are mainly found in lamina IIi and III (Polgar 
et al., 1999). However, a few of these cells can be seen dorsal and ventral to 
this region. The PKCγ-immunoreactivity is seen in the cell body and extends into 
the dendrites which form a dense plexus within lamina IIi (Gutierrez-Mecinas et 
al., 2016a). These cells are found to play a role in the development of 
mechanical allodynia in a chronic pain state since PKCγ knock-out mice showed a 
normal mechanical threshold for evoking hindpaw withdrawal on the injured side 
to a mechanical stimulus in the partial sciatic nerve injury model (Malmberg et 
al., 1997). A study reported that PKCγ-positive cells receive input from lamina III 
glycinergic neurons and form part of a pathway that contributed to mechanical 
allodynia (Lu et al., 2013). Two years later, Petitjean et al. (2015) reported that 
this lamina III glycinergic neurons correspond to the parvalbumin cells. This 
finding suggested that the feedforward inhibition of A-LTMR input to the PKCγ-
immunoreactive cells is provided by parvalbumin-positive cells, thus leading to 
the prevention of mechanical allodynia.  
The neurotensin-immunoreactive cells are found within lamina IIi and the dorsal 
part of lamina III. More than 90% of neurotensin axons express VGLUT2 and are 
enriched with glutamate (Todd et al., 1994, Todd et al., 2003). In addition, none 
of the cell bodies are found to be GABA-immunoreactive (Todd et al., 1992). 
Mostly, these cells overlap with the dense plexus of PKCγ dendritic trees in 
lamina IIi, and 90% of them co-express PKCγ (Gutierrez-Mecinas et al., 2016a). 
This study also found that NT and GRP cells are separate, although there is some 
overlap with NT and preprotachykinin B (PPTB) in laminae I-II. The neurokinin B 
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(NKB) somata can be reveal by immunostaining for PPTB, which is a precursor for 
NKB (Kaneko et al., 1998, Polgár et al., 2006). PPTB immunoreactivity is 
concentrated in laminae IIi and III of the dorsal horn (Gutierrez-Mecinas et al., 
2016a). In the rat, almost all of the PPTB-immunoreactive axons also expressed 
VGLUT2 (Polgár et al., 2006). Meanwhile in the mouse, cells that contain PPTB 
mRNA within the laminae II-III are immunoreactive for Tlx3, which control the 
expression of VGLUT2, thus suggest that NKB is express mostly by excitatory 
interneurons within this region (Xu et al., 2008). Half of the cells that are 
immunoreactive for PPTB also expressed PKCγ but none of them are overlap with 
GRP  cells (Gutierrez-Mecinas et al., 2016a). Ablation of NKB expressing cells in 
the Tac2Cre mice, did not have an effect on the nerve injury-induced mechanical 
allodynia (Duan et al., 2014). 
GRP and gastrin releasing peptide receptor (GRPR) are believed to be involved in 
modulating itch (Sun and Chen, 2007, Sun et al., 2009). In the spinal cord, GRP is 
seen in the superficial laminae of the dorsal horn and is contained within 
structures resemble axons (Takanami et al., 2014, Gutierrez-Mecinas et al., 
2014). It has been reported that GRP is expressed by the primary afferents based 
on immunocytochemistry study and they did not found GRP mRNA expression in 
the SDH (Sun and Chen, 2007). However, a few groups suggested that, this is due 
to the cross reaction with substance P, since many studies cannot detect mRNA 
for GRP in the dorsal root ganglion (Gutierrez-Mecinas et al., 2014, Michael et 
al., 2012, Solorzano et al., 2015). The most common method to reveal GRP cells 
is through GRP-eGFP transgenic mouse line, in which eGFP is express only by the 
cells with GRP mRNA  (Solorzano et al., 2015, Gutierrez-Mecinas et al., 2016a). 
Mostly GRP axonal boutons also expressed VGLUT2 but usually they are not 
immunoreactive for VGAT, thus support the idea that GRP are expressed in the 
excitatory interneurons (Gutierrez-Mecinas et al., 2014). Even though GRP 
neurons are part of the itch pathway, only a few of these cells express Fos or 
pERK following intradermal injection of chloroquine (Bell et al., 2016). GRPR is 
also involved in normal itch responses, since mice lacking these receptors show 
reduced itch behaviours after administration of histamine-independent 
pruritogens (eg: chloroquine), without alteration in pain threshold (Sun and 
Chen, 2007). Furthermore, the ablation of GRPR-expressing neurons with 
intrathecal saporin conjugated to bombesin reduced behavioural responses to 
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pruritogens (Sun et al., 2009). This authors also found increased pruritogens-
evoke scratching after intrathecal administration of GRPR agonists, and less 
scratching after intrathecal administration of GRPR antagonists. 
The substance P axonal boutons are thought to derive from primary afferents or 
interneurons (Ju et al., 1987, Todd et al., 2003). Recently, a newly identified 
population of excitatory interneurons that express substance P was found in the 
dorsal horn of the spinal cord. These can be identified by using 
immunocytochemistry to reveal the substance P precursor, preprotachykinin A 
(PPTA). However, more reliable method involve the intraspinal injection of 
adenoassociated virus (AAV) coding for a Cre-dependent form of eGFP 
(AAV.flex.eGFP) in mice, which Cre was knocked into the Tac1 locus (Tac1Cre) 
(Gutierrez-Mecinas et al., 2017). These cells are seen in laminae I-III and in the 
deeper parts of the dorsal horn. Surprisingly Gutierrez-Mecinas et al found that 
around 20% of PPTA-immunoreactive neurons in laminae I-III are Pax2 positive, 
indicating that they are inhibitory cells. Injection of AAV.flex.eGFP into 
Tac1Cre;Ai9 mice causes expression of eGFP near the injection sites and around 
10% of the eGFP-immunoreactive cells are labelled with Pax2 (Gutierrez-Mecinas 
et al., 2017). Studies using rat and mouse found axonal boutons that contain SP 
but not CGRP with a strong expression of VGLUT2 (Todd et al., 2003, Gutierrez-
Mecinas et al., 2017). These are likely to be derived from glutamatergic 
interneurons (Todd et al., 2003). However, although some SP cells are found to 
be inhibitory neurons, very few boutons that contain SP and VGAT are identified.  
In addition, Gutierrez-Mecinas et al. (2017) found that SP-expressing cells 
overlapped extensively with somatostatin, but not with GRP, neurokinin B, 
neurotensin or PKCγ. Many of the SP cells responded to noxious or pruritic 
stimuli (Gutierrez-Mecinas et al., 2017).  
CR-expressing cells in the SDH are mostly (85%) excitatory interneurons (Smith et 
al., 2015). In Smith et al. (2016) they calculated about 30% of neurons in laminae 
I and II are labelled with CR. Excitatory CR comprise 25.5% of all neurons in 
superficial laminae. Since 75% of all interneurons are excitatory, therefore about 
34% of excitatory interneurons are CR. The excitatory CR-expressing neurons 
have been shown to be involve in a polysynaptic circuit that links innocuous 
tactile input with nociceptive circuitry by transferring information from VGLUT3-
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expressing interneurons to nociceptive circuits, which causes development of 
mechanical hypersensitivity/allodynia (Peirs et al., 2015). Ablation of CR-
positive cells causes greater threshold of hind paw withdrawal towards noxious 
mechanical stimuli, without changes in motor coordination, light touch, thermal, 
pinprick and pinch stimulation thresholds (Duan et al., 2014).  
1.5 Aims of the project 
The study was based on a preliminary work carried out by Dr David I Hughes. 
Using electron microscopy on Neurobiotin filled CR islet cells patched in 
CR::eGFP mice, he showed that axonal boutons originated from these cells were 
presynaptic to central axon of type I glomeruli, which belong to CMrgD afferents. 
The main objective of the project was to characterize a population of inhibitory 
CR interneurons in the SDH and their synaptic connection with CMrgD primary 
afferent fibres. To carry out this study, we used several transgenic mouse lines 
including lines in which Nociceptin and RorB transgenes were either expressed 
under the control of the regulatory elements of the Nociceptin gene or knocked 
into the RorB locus, respectively. These lines allowed identification of 
populations of inhibitory interneurons in the superficial laminae. The aims of this 
project are to expand our knowledge concerning the inhibitory interneurons that 
are involved in the pain pathway, by testing the following 2 initial hypotheses: 
1. That inhibitory CR neurons do not overlap with four other distinct 
neurochemical populations of inhibitory interneurons that were identified 
in the rat and mouse dorsal horn. These have been defined by the 
expression of neuropeptide Y (NPY), galanin, neuronal nitric oxide 
synthase (nNOS) or parvalbumin (Tiong et al., 2011, Sardella et al., 2011a, 
Sardella et al., 2011b, Hughes et al., 2012). This hypothesis was tested by 
carrying out immunocytochemistry reactions to look at the co-expression 
of CR with the other four neurochemical markers mentioned above. 
2. That Nociceptin and Rorβ are suitable markers to identify inhibitory CR 
interneurons in lamina II. Most CR-expressing cells are excitatory 
interneurons (Albuquerque et al., 1999). However, about 15% of the cells 
are inhibitory cells (Smith et al., 2015). 
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During the course of the study, it was found that Nociceptin and Rorβ were 
expressed in the majority of inhibitory CR neurons. The combination of 
Nociceptin::eGFP; CRCre; Ai9 mouse crossed allowed detection of these cells. 
Subsequently, it was found that Rorβ was a better marker. RorβCreERT2; Ai9 mouse 
line labelled predominantly CR inhibitory interneurons in lamina II. This allowed 
the testing of the following additional hypotheses. 
3. That the inhibitory CR neurons are mostly islet cells (Smith et al., 2015). 
This study was carried out using whole cell patch-clamp recordings on 
parasagittal slices from adult mice with Neurobiotin labelling to allow for 
reconstruction of the neurons.  
4. That they are closely associated with non-peptidergic CMrgD primary 
afferents, and specifically that they are the major source of axoaxonic 
synapse on the CMrgD afferents. This hypothesis was tested by 
immunocytochemistry reactions and electron microscopic study. Electron 
microscopy allowed identification of the axonal boutons of CR islet cells 
within Rorβ cells population and their relation to type I synaptic 
glomeruli.  
5. That inhibitory CR islet cells in RorβCreERT2; Ai9 mice undergo significant 
change following peripheral nerve injury. Previously, it has been reported 
that there is no loss of GABA-immunoreactive neurons after chronic 
constriction injury (Polgár et al., 2004). However, it is possible that 
inhibitory CR islet neurons are affected because boutons belonging to 
CMrgD afferents which are thought to form their major synaptic input are 
lost under this condition. This hypothesis was tested by sciatic nerve 
transection (SNT) experiments.  
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2 General Methods 
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All experiments were approved by the Ethical Review Process Applications Panel 
of the University of Glasgow and were performed in accordance with the UK 
Animals (Scientific Procedures) Act 1986. The perfusion of the mice was 
performed by Dr Erika Polgár. Information on specific techniques will be 
provided in the related chapters. 
2.1 Transgenic mouse lines and crosses 
In order to investigate these inhibitory calretinin populations in superficial 
laminae, we used multiple mouse lines and crosses, which are described below 
and summarized in Table 2-1. 
Nociceptin::eGFP is a bacterial artificial chromosome (BAC) transgenic line in 
which enhanced green fluorescence protein (eGFP) is expressed in the 
prepronociception/orphanin FQ (ppN/OFQ) positive neurons (Zeilhofer et al., 
2002). eGFP was introduced into ppN/OFQ gene by homologous recombination 
(Yang et al., 1997). Then, polymerase chain reaction (PCR) was performed to 
generate 5’ and 3’ homology arms flanking the start codon and exon 2 of 
ppN/OFQ. Southern blot analysis was used to identified BAC clones containing 
the preferred recombination. Purified linearized BAC DNA was injected into the 
male pronuclei of fertilized oocytes. This mouse line is generated by Professor 
Hanns Ulrich Zeilhofer from the University of Zurich. These mice were crossed 
with C57BL/6 mice, and for all experiments, heterozygous animals were used.  
CR-ires-Cre (CRCre) mice were first used by Taniguchi et al. (2011) to genetically 
target GABAergic neurons in the cerebral cortex. The allele of CR-Ires-Cre carry 
Cre recombinase and an internal ribosome entry site in the calretinin locus. Cre 
expression is directed by the endogenous calretinin enhancer components to 
calretinin interneurons in the brain and cortex. Breeding this mice that contain 
Cre-mediated recombination with loxP-flanked sequences containing mice 
causes the offspring to be born without the floxed sequences (The Jackson 
Laboratory, 2018)   .  
 
53 
 
 
 
Ai9 reporter mice contain a loxP-flanked STOP cassette, which prevents CAG 
promoter-driven transcription of the red fluorescent protein variant (tdTomato). 
The targeted mutation was inserted into the Gt(ROSA)26Sor locus. Breeding the 
Ai9 mice with mice that express Cre recombinase, will cause the STOP cassette 
to be deleted in the Cre-expressing cells, which causes the offspring to express 
strong tdTomato fluorescence (Madisen et al., 2010). This allowed the study of 
the structural details of the neurons including dendritic spine and axons by 
confocal microscopy.  
RorβeGFP is a knock-in mouse in which retinoid-related orphan nuclear receptor β 
gene (Rorβ) positive interneuron populations are labelled (Abraira et al., 2017). 
Using Phusion polymerase, 5’ and 3’ homology arm of Rorb gene was isolated 
from embryonic stem (ES) cell DNA before it was inserted into a vector. The 
Rorβ-specific exon was replaced by an eGFP cDNA. Chimeric mice were 
generated using ES cell clones. Chimeras were crossed with C57BL/6J mice, then 
intercrossed to produce homozygous Rorβ mice (Liu et al., 2013). This mouse 
line was generated by Professor David Ginty from Harvard University, who 
provided perfusion fix tissue which was analysed in this study. 
 
RorβCreERT2 is a knock-in targeted mutant mouse, which expresses Cre 
recombinase-estrogen receptor (Cre-ERT2) fusion protein from the mouse Rorβ 
promoter and the activity of this protein depends on the administration of 
tamoxifen. Administration of tamoxifen causes the Cre-ERT2 to enter the nucleus 
of the cells and induce the Cre-ERT2 fusion gene activity in RorBCreERT2 mouse 
line. These mice were produced by means of a targeting vector that was 
constructed using recombineering technology (Liu et al., 2003). Through 
homologous recombination, the Cre-ERT2 fusion-FRT-Neomycin-Frt-loxP cassette 
was introduced to the first coding ATG of exon 1 of the Rorβ gene in embryonic 
stem cells (ES) and the last 4bp of RorB were replaced (Abraira et al., 2017). 
Breeding these mice with mice that expressed loxP-flanked structures results in 
deletion of the floxed sequences in the RorB-expressing cells of the offspring. 
Ai34 reporter mice carry a loxP-flanked STOP cassette, which prevents the 
transcription of CAG promoter-driven synaptophysin-tdTomato fusion gene. This 
promoter was inserted to the Gt(ROSA)26Sor locus. After breeding the Ai34 mice 
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with mice that express Cre recombinase, the STOP cassette will be deleted in 
the Cre-expressing tissues. The offspring will express the synaptophysin-
tdTomato fusion protein which can be found concentrated in the synaptic 
terminals of the Cre-expressing neurons (Madisen et al., 2012). 
Nociceptin::eGFP; CRCre; Ai9 mice: Nociceptin::eGFP mice were crossed with 
CRCre mice and Ai9 mice. In these triple transgenic mice line, calretinin and 
nociceptin cells contain tdTomato and eGFP, respectively, while cells with both 
calretinin and nociceptin contain both fluorescence proteins. These mice lines 
were used to investigate the morphology of inhibitory calretinin cells. For all 
crosses and experiments, heterozygous animals were used. 
RorβCreERT2; Ai9 mice:  RorβCreERT2 mice were breed with Ai9 mice. The Rorβ cells 
expressed strong tdTomato native fluorescence due to the presence of Cre-
recombinase in the cells after administration of tamoxifen. This mouse line was 
used to study the morphology of Rorβ-CR interneurons and their contacts with 
CMrgD primary afferents. Heterozygous animals were used for RorβCreERT2 mice, 
and either heterozygous or homozygous animals were used for Ai9 mice.  
RorBCreERT2; Ai34 mice: RorβCreERT2 mice was breed with Ai34 mice. The 
synaptophysin-tdTomato fusion protein was targeted to the Rorβ axons which 
expressed Cre-recombinase. They were used to analyse contact between IB4-
labelled primary afferents and RorB axonal boutons. This mouse line was also 
generated by Professor David Ginty from Harvard University, who provided 
perfusion fix tissue which was analysed in this study. 
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Table 2-1 Summary of the different mouse lines and crosses used in various chapter of this 
study 
 
  
Mouse line Relevant 
chapter(s) 
Remarks 
Noc::eGFP Chapter 3 and 4 Nociceptin and RorB transgenes were either 
expressed under the control of the 
regulatory elements of the Nociceptin gene 
(Zeilhofer et al., 2002) or knocked into the 
RorB locus (Abraira et al., 2017), 
respectively.  Populations of inhibitory 
interneurons in the superficial laminae can 
be identify using these lines. 
RorβeGFP Chapter 3 and 4 
Noc::eGFP; CRCre; Ai9 Chapter 3 
RorβCreERT2; Ai9 mice Chapter 5 and 6 
RorβCreERT2; Ai34 mice Chapter 5 
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2.3 Perfusion fixation 
Adult mice of either sex (14-32g) were deeply anesthetized using pentobarbitone 
injected intraperitoneally (30 mg). They were then perfused transcardially with 
a brief rinse of Ringer’s solution, followed by perfusion with 250 ml of freshly 
made fixative. The fixative contained 4% de-polymerised formaldehyde in 0.1 M 
phosphate buffer (PB) for confocal study and 4% de-polymerised formaldehyde 
with 0.2%, 0.5% or 1% glutaraldehyde for electron microscopic study. A 
laminectomy was performed to expose the spinal cord. The dura mater was 
removed using curved blades, and lumbar segments L1-L5 were identified based 
on the pattern of input from dorsal roots. A block of tissue consisting of L1-L5 
were removed from the spinal cord and were divided into individual segments. 
The lumbar cord segments were kept in fixative for 2 hours at 4oC and then 
transfer to PB. Lumbar segments that were not used immediately transferred to 
30% sucrose in PB solutions in a liquid nitrogen tank. 
2.3 Tissue processing and immunocytochemistry 
Lumbar spinal cord segments from L1-L5 were used in all the experiments. The 
lumbar segments were cut into 60µm thick sections using a vibrating blade 
microtome (Leica VT 1200, Leica Microsystems Ltd Milton Keynes, UK). Sections 
with different orientation (transverse, sagittal and horizontal) were used 
depending on the purpose of the experiments. For example, transverse sections 
were used to look at the proportion of cells in the different laminae. Meanwhile, 
for the morphology of the cells, sagittal/horizontal sections were used to show 
the rostrocaudal extension of dendritic tree and axons of calretinin islet cells. 
All sections were immersed in 50% ethanol for 30 minutes to enhance antibody 
penetration (Llewellyn-Smith and Minson, 1992). Sections were then rinsed with 
phosphate buffered saline that contained 0.3M NaCl three times. For sections 
used in the electron microscopy study, details of tissue processing will be 
discussed in the corresponding chapter.  
Sections were incubated in primary antibodies at 4oC for five days in most 
experiments unless stated otherwise. The sections were rinsed three times over 
30 minutes in phosphate-buffered saline (PBS) prior to incubation in secondary 
antibodies for one day at 4oC. All secondary antibodies obtain from Jackson 
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ImmunoResearch, West Grove, PA, USA were raised in donkey and were species-
specific. They were conjugated to Alexa 488, Alexa 647, Pacific Blue, Rhodamine 
Red or Biotin. Secondary antibodies were diluted 1:500 for Alexa 488, Alexa 647 
and Biotin, 1:200 for Pacific Blue and 1:100 for Rhodamine Red. Apart from the 
reaction that was done for electron microscopy, primary and secondary 
antibodies were diluted in PBS containing 0.3% Triton-X100 and 5% normal 
donkey serum. Details of the sources and concentrations of primary antibodies 
are given in Table 2-2. Following the immunocytochemistry procedure, sections 
were rinsed again in PBS three times over the period of 30 minutes before being 
mounted on glass slides in anti-fade medium (Vectashield; Vector Laboratories, 
Burlingame, CA, USA) and stored at –20oC. The details on antibodies combination 
will be discussed in relevant chapter. 
2.4 Antibody characterization 
All antibodies used in this study were previously characterised and are shown to 
give specific staining for the antigens that they target. The IB4 antibody was 
raised against the lectin from Bandeiraea simplicifolia and specificity is shown by 
the absence of immunoreactivity in tissue without lectin. For all 3 calretinin 
antibodies staining is absent in the cerebral cortex of mice lacking calretinin 
(manufacturer’s specification). All 3 calretinin antibodies were raised against 
recombinant human calretinin. The eGFP antibody was raised against full-length 
recombinant eGFP, and its staining matches that of eGFP (Iwagaki et al., 2013). 
Galanin immunostaining is absent from the brains of galanin knock-out mice 
(Makwana et al., 2010) and pre-treatment with galanin abolished dorsal horn 
immunostaining with galanin antibody, demonstrating its specificity for the 
peptide (Simmons et al., 1995). 
The Homer antibody was raised against amino acids 1-175 of mouse Homer 1 and 
labels a band at 43-45 kDa in immunoblots of mouse brain (Nakamura et al., 
2004). The mCherry antibody raised against the full-length amino acid sequence 
and also recognizes tdTomato. The mouse monoclonal antibody NeuN reacts with 
a protein in cell nuclei extracted from mouse brain (Mullen et al., 1992). In the 
rat spinal cord, all neurons, but not glial cells are labelled by Neun (Todd et al, 
1998). The nNOS antibody recognizes a single band of 155 kDa in Western blots 
of rat hypothalamus and immunostaining is abolished by pre-incubation with 
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nNOS (Herbison et al., 1996). No specific staining of NPY is present following 
treatment with antiserum in sections that have been incubated with NPY peptide 
(Rowan et al., 1993).  
The PAP antibody immunoreactivity is absent in spinal cord sections from 
knockout mice (Zylka et al., 2008). The antibody against Pax2 was raised against 
amino acids 188 to 385 of the mouse protein and distinguishes bands of the 
appropriate size on western blots of the kidney of the mouse embryo (Dressler 
and Douglass, 1992). The guinea pig parvalbumin antibody was raised against 
mouse parvalbumin and recognizes a protein band of the appropriate size on 
western blot. The sst2a antibody was raised against the C terminal 15 amino 
acids of the mouse sst2a receptor, coupled to keyhole limpet haemocyanin. 
Immunostaining is abolished by incubation with the peptide antigen 
(manufacturer’s specification). The VGAT antibody were raised against amino 
acids 31-112 of the mouse protein and recognized a single band of the 
appropriate molecular weight in blots of brain extracts (Takamori et al., 2000).  
2.5 Confocal microscopy and analysis 
Zeiss LSM710 confocal microscope equipped with argon multi-line, 405 nm diode, 
561 nm solid-state and 633 nm HeNe lasers was used to scan sections. Unless 
otherwise stated, sections were scan from the top to the bottom of the sections. 
Scans were taken through dry (5x, 10x and 20x) and oil immersion (40x and 63x) 
lenses (numerical apertures: 1.3 for 40x objective and 1.4 for 63x objective). 
The pin hole was set to one Airy unit to minimise out of focus light.  
2.6 Statistical analysis 
The statistical tests that were used in this study include: one-way ANOVA 
followed by Holm-Sidak post hoc for multiple–comparisons test and a student’s t 
test. A p value of less than 0.05 was considered significant. 
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Table 2-2 Primary antibodies used in this study 
Antibody Label Species Dilution Source 
BS lectin I Non-peptidergic 
C fibres  
Goat 1:2000 Vector 
CR Interneurons  Goat 1:1000 Swant 
CR Interneurons  Mouse 1:1000 Swant 
CR Interneurons  Rabbit 1:1000 Swant 
eGFP Interneurons  Chicken 1:1000 Abcam 
Galanin Interneurons  Rabbit 1:1000 Bachem 
Homer Glutamatergic 
synapses 
Goat 1:1000 M Watanabe 
mCherry Interneurons  Rabbit 1:2000*/1:10,000*/1:20,000 Abcam 
NeuN Neurons  Mouse 1:1000 Millipore 
nNOS Interneurons  Rabbit 1:2000 Millipore 
NPY Interneurons  Rabbit 1:1000 Bachem 
PAP Non-peptidergic 
C fibres  
Chicken 1:1000 Aves Labs 
Pax2 Inhibitory 
interneurons  
Rabbit 1:1000 ThermoFisher 
Scientific 
PV Interneurons  Guinea pig 1:2500 M Watanabe 
Sst2a Inhibitory 
interneurons  
Guinea pig 1:2000 Gramsch 
laboratories 
VGAT Inhibitory 
interneurons  
Rabbit 1:1000 Synaptic 
systems 
Different concentrations of antibodies against mCherry were used for immunocytochemistry and   
electron microscopy. A high concentration (1:1000) of mCherry antibody was used in confocal 
microscopic studies and dilute mCherry (1:10,000/1:20,000) was used in electron microscopic 
study. 
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3 Morphological features of CR islet cells within 
dorsal horn  
  
61 
 
 
 
3.1 Introduction 
Calcium binding protein calretinin (CR) was first identified in 1987 by genetic 
cloning from the chicken retina from which the name is derived (Rogers, 1987). 
In the spinal dorsal horn, CR-positive cells are mainly found in SDH (Ren et al., 
1993), where most nociceptive fine myelinated Aδ and unmyelinated C primary 
afferents terminate (Light and Perl, 1979, Zylka et al., 2005). This suggests that 
CR-expressing cells are involved in modulating nociceptive transmission from the 
periphery. CR-immunoreactive neurons are also present at a lower density in 
other part of dorsal horn such as laminae V-VIII and X (Ren et al., 1993). 
In 1999, Albuquerque et al investigated CR-expressing neurons using cultures of 
dorsal horn from rat embryos and they concluded that these cells are mostly 
excitatory interneurons based on the absence of GABA and glycine 
immunoreactivity from more than 90% of CR-immunoreactive cells. Since then a 
few studies have used CR as a neurochemical marker for excitatory interneurons 
in superficial dorsal horn (Huang et al., 2005, Torsney et al., 2006, Smith et al., 
2015, Smith et al., 2016). Based on the finding of Albuquerque et al. (1999), CR 
was initially thought to be expressed only by excitatory interneurons (Todd, 
2010). However, recent studies using GAD67eGFP knock-in mice have revealed that 
13% of the eGFP-expressing (GABAergic) neurons in lamina II are positive for CR 
(Huang et al., 2010). In addition, 15% of CR-immunoreactive cells in superficial 
dorsal horn of mouse expressed the inhibitory marker Pax2, and 25% of Pax2 
cells in lamina II were CR-positive (Smith et al., 2015).  
The SDH is known to be densely packed with interneurons, with excitatory cells 
outnumbering the inhibitory neurons by three to one (Polgár et al., 2013a, Todd, 
2010). Smith et al. (2016) calculated that about 30% of neurons in laminae I and 
II are labelled with CR antibody and these are mostly excitatory. Since, 15% of 
CR-immunoreactive cells are inhibitory, these make up ~4.5% of the total 
neurons population in superficial dorsal horn (Smith et al., 2016). More than 95% 
of CR-immunoreactive cells in the SDH were found in lamina II, with the 
remaining ~5% being present in lamina I of the mouse dorsal horn (Smith et al., 
2015). Excitatory CR-immunoreactive neurons had a diverse morphology and 
included central, vertical, radial. Interestingly most of inhibitory CR-
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immunoreactive neurons were islet cells (Smith et al., 2015). This finding is 
consistent with description on CR morphology by Ren et al. (1993). 
Inhibitory CR expressing cells are mainly found in lamina II, thus, they might 
involve in nociceptive pathways. Smith et al. (2015) also studied the 
responsiveness of CR cells to noxious peripheral stimulation in vivo. In the spinal 
cord, under normal conditions, pERK is not induced by innocuous stimuli, but is 
seen following noxious stimuli including mechanical, thermal, chemical and itch 
(Ji et al., 1999, Gao and Ji, 2009, Zhang et al., 2014). They found that over 50% 
of the neurons in laminae I and II that showed pERK following noxious 
mechanical stimulation (pinch) also expressed CR. In addition, 15% of the pERK 
cells expressed both CR and Pax2. Conversely, only 23% of cells expressing pERK 
after noxious chemical stimulation (capsaicin) were found to contain CR, of 
which only 3% of pERK cells contained both CR and Pax2. These findings suggest 
that both excitatory and inhibitory CR cells are preferentially activated by 
noxious mechanical stimuli rather than capsaicin.  
Smith et al. (2015) performed targeted patch clamp recording of eGFP cells from 
a transgenic mouse line that expressed eGFP under the control of the CR 
promoter (CR::eGFP). They found that some cells showed characteristics of 
inhibitory neurons such as tonic and initial bursting firing patterns during 
depolarizing step current injection (Smith et al., 2015, Yasaka et al., 2010). 
Smith and colleagues described this cells as atypical. They showed that atypical 
CR cells exhibited either non-selective cation current (Ih) or low threshold ‘T-
type’ calcium current (ICa,T). The atypical CR cells received low frequency of 
excitatory drive as shown by low frequency and small amplitude spontaneous 
EPSCs (sEPSCs) (Smith et al., 2015). Unlike the typical CR cells, the atypical CR 
cells expressed mu- and delta- opioid receptors. Conversely the typical CR cells 
but not the atypical CR neurons responded to noradrenaline and serotonin (Smith 
et al., 2016). The major inhibitory input to the atypical CR cells derived from 
glycinergic neurons. The examination of Neurobiotin atypical filled cells 
resembles islet morphology.   
Interestingly Hughes et al. (2012) had previously identified a population of 
parvalbumin-expressing cells in lamina III with similar characteristic to atypical  
CR cells. The morphology class of parvalbumin-expressing cells is islet type. They 
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received weak excitatory drive and their action potential discharge profiles are 
mostly tonic firing and initial bursting. Parvalbumin-expressing cells similarly 
receive inhibition that was predominantly glycinergic but not in inhibitory CR-
expressing cells (Smith et al., 2015).  
The aim of this part of the study is to characterise further inhibitory CR-
expressing neurons by looking at the morphology and anatomical characteristics 
of these cells. In this chapter, Nociceptin::eGFP;CRCre;Ai9 mouse lines were used 
to allow reconstructions of individual neurons. In this mouse line, eGFP is 
expressed by many inhibitory cells under the controlled of Nociceptin promoter. 
Meanwhile, the Cre mediated removal of a stop cassette will result in tdTomato 
expression by CR cells. Inhibitory CR cells could be identified by co-expression of 
eGFP and tdTomato. In addition, Nociceptin::eGFP and RorBeGFP mice were used 
to look for other anatomical features. 
3.2 Materials and methods  
3.2.1 Morphology and analysis of recorded neurons 
Nine Nociceptin::eGFP;CRCre;Ai9 mice 4-6 weeks old and of either sex (17-19g) 
were used for the reconstruction of recorded neurons. Sagittal slices were used 
for electrophysiological experiments as described previously and recorded cells 
were labelled with Neurobiotin as in the previous studies (Ganley et al., 2015, 
Iwagaki et al., 2016). At the end of the electrophysiological experiments, slices 
were fixed overnight in 4% formaldehyde dissolved in 0.1M in PB. The slices were 
washed using PBS for 3 times for 10 min and incubated overnight at 4oC in 
avidin-Pacific blue (1:1000) diluted in PBS containing 0.3% Triton-X100. Slices 
were washed again with PBS before being mounted in anti-fade medium on 
microscope slides in a window within a 270-350 µm thick agar spacer so that the 
cover slip will lie flat on the slice and also to avoid the slice from being 
compressed. These slides containing slices were stored at –20oC.  
The recorded cells in the slices were first observed using a fluorescence 
microscope, to examined the general morphology of the cells. If the dendritic 
trees of the cells were beaded or appeared to have been truncated, the cells 
were not analysed further. The selected cells were scanned in detail afterward 
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using confocal microscopy. Scanning was started with 5x lens using 405 nm laser 
and dark field illumination to capture the whole slice and to determine the 
laminar location of the cell within the slice. Laminae I-II were seen as a distinct 
dark band due to the lack of myelinated fibres (Yasaka et al., 2010). Then, the 
lens was changed to 40x oil immersion to reveal eGFP and tdTomato within the 
cell bodies of the recorded filled cells. The entire structure including cell body, 
dendritic trees and axons of the Neurobiotin labelled cells was scanned through 
a 63x oil immersion lens, using the 405 nm laser, at 0.5 µm z-separation with the 
aperture was set to 1 Airy unit. The scans were done through the whole depth of 
the structures of the cells to include all parts of the cells. However, in a few 
cases the deepest processes could not be seen clearly through the thickness of 
the slice. All images taken were saved as Zeiss.lsm 5 files and were viewed using 
Zen 2010 software. The image stacks were used as a template to manually 
reconstruct the cells with the neuron-tracing feature in Neurolucida for Confocal 
Software (MBF Bioscience, Williston, VT, USA). The reconstructed cell drawings 
were saved as Neurolucida.DAT files. Dendrites can be distinguished from axons 
as they have spines and their processes will taper with increasing distance from 
the cell soma. Meanwhile, axons are thinner than dendrites and they have 
varicosities, which were seen as irregularly spaced swellings along the process. 
All the parameters from individual neuron were acquired from the Neurolucida 
Explorer output.  
After the initial analysis, the slice was resectioned by embedding it in 3% agar 
(dissolved in distilled water). The agar was cut into a small block containing the 
slice and the bottom right corner of the agar was notched to reveal the correct 
orientation of the sections when mounted on the slide. The slice was cut into 60 
µm sections using a vibrating blade microtome, and this were then mounted on 
the microscope slides in sequential order with a similar orientation. The cells 
were rescanned using the confocal microscope as described above, in order to 
reveal parts of the dendritic trees and axons that were present deep within the 
slices and were difficult to resolve in the initial scans (Ganley et al., 2015). The 
scanned images were added to the original reconstruction drawing.  
Apart from using dark field illumination to determine the laminar location of 
these cells, sections that contained the recorded cells were also incubated with 
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IB4 to locate the cells relative to the IB4 plexus, which is found in the middle of 
lamina II. The sections containing recorded filled cells were incubated overnight 
in unconjugated IB4 (1:1000) at 4oC followed by incubation in the primary 
antibody, goat anti-IB4 (1:2000) for 3 days. Following that, sections were 
incubated in secondary antibodies conjugated to Alexa 647 (1:500) for 24 hours. 
Sections were mounted in anti-fade medium and rescanned using the confocal 
microscope to reveal Pacific blue and Alexa 647. 
3.2.2 Animals and tissue processing for other anatomical parts of 
the study 
Six Nociceptin::eGFP male adult mice, weighing between 17-28g were deeply 
anesthetised with pentobarbitone and perfused through the left ventricle with 
freshly made 4% formaldehyde. The lumbar spinal cord segments (L1-L5) were 
dissected out from all animals and post-fixed for 2 hours with the same solution 
at 4oC before being transferred to PB. The L4 segments were cut into 60 µm 
thick transverse sections using a vibrating blade microtome followed by 
immersion in 50% ethanol for 30 minutes to enhance antibody penetration 
(Llewellyn-Smith and Minson, 1992). The segments were cut serially into 4 
bottles and these were processed for further analysis. Perfusion fixed spinal 
cords from 3 juvenile RorBeGFP mice of either sex were received from Professor 
David Ginty from Harvard University and were processed in a similar way. All of 
these sections were then processed for multiple immunolabelling as described 
below. 
3.2.3 CR and eGFP expression in Nociceptin::eGFP mouse 
To quantify the eGFP-positive cells and CR-positive cells in the Nociceptin::eGFP 
mouse, transverse sections from the L4 segments of 3 Nociceptin::eGFP mice 
were incubated with chicken anti-eGFP, rabbit anti-CR, mouse anti-Neun. These 
primary antibodies were revealed with Alexa 488, Rhodamine Red and Alexa 
A647, respectively. Following the immunocytochemical reaction, the sections 
were incubated in DAPI for 10 min for nuclear staining. Three sections from each 
mouse were randomly selected and scanned using confocal microscope. These 
were scanned with a Zeiss LSM 710 confocal microscope with a 40x oil immersion 
lens (numerical aperture 1.3), 1 µm z-step and the aperture set to 1 Airy unit. 
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Those sections were scanned to produce a z-stack of 30 optical sections. Tile 
scans were used to capture the whole width of laminae I-III. Scanned sections 
were analysed offline using Neurolucida for Confocal Software. The outline of 
the dorsal horn and the boundaries between laminae I-III were drawn. The 
lamina I/II boundary was drawn 20 µm below the dorsal white matter and the 
ventral extend of the CR-immunoreactive cells was used to determine lamina 
II/III border. The ventral border of lamina III was taken as 100 µm from lamina II. 
Those sections were analysed using Neurolucida software. The outline of the 
dorsal horn and border between laminae I, II and III were drawn as described 
above.  A modified optical disector method was used to obtain an unbiased 
sample of neurons in laminae I-II and lamina III of the scanned sections 
(Gutierrez-Mecinas et al., 2016a, Smith et al., 2016, Tiong et al., 2011). All cell 
nuclei (identified by both Neun and DAPI) that had their bottom surface between 
reference and look up sections (5th and 25th optical sections respectively) were 
plotted onto the Neurolucida drawing and neurons with nuclei present in the 
look-up section were then excluded. Then, the channel corresponding to eGFP 
and CR were then viewed, and the presence or absence of each type of staining 
was documented.   
3.2.4 Distribution of inhibitory CR interneurons in laminae I-III of 
Nociceptin::eGFP and RorBeGFP mice 
To define the population of CR+/eGFP+ cells that were inhibitory in the 
Nociceptin::eGFP and RorBeGFP mice, 3 transverse sections each from L4 
segments of 3 Nociceptin::eGFP and 3 RorBeGFP mice were incubated with 
chicken anti-eGFP, goat or mouse anti-CR and rabbit anti Pax2. Following that, 
primary antibodies that were used in Nociceptin::eGFP mice were revealed with 
Alexa 488, Pacific Blue and Rhodamine Red, respectively. Meanwhile, primary 
antibodies that were used in RorBeGFP mice were revealed with Alexa 488, 
Rhodamine Red and Pacific Blue, respectively. Three sections from each mouse 
were selected randomly and scanned with confocal microscope and analysed 
using Neurolucida for Confocal Software as described before. For the 
Nociceptin::eGFP mice, the 5th optical section was used as the reference 
section and the 25th as the look up section. Meanwhile, in the RorBeGFP mice, the 
5th and 20th optical sections were used instead as reference and look up 
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sections. The size of the disector in the RorBeGFP mice was reduce because the 
immunostaining with the CR antibody was strongest within the first 20th optical 
sections. Therefore, cell bodies that were located deep in the sections could not 
be analysed due to incomplete antibody penetration. All cell bodies of eGFP 
positive neurons in both animals that had their bottom surface of their nucleus 
between the reference and look up sections were plotted onto the drawing. 
Then, the channel for CR and Pax2 were then viewed and the presence or 
absence of both type of staining was documented for each of the selected eGFP 
immunoreactive neurons.   
3.3 Results 
3.3.1 Morphology of the cells in the Nociceptin::eGFP; CRCre; Ai9 
mice 
Eleven of the eGFP+/tdTomato+ cells that were recorded from 9 
Nociceptin::eGFP;CRCre;Ai9 mice that had undergone whole cell recordings and 
been labelled with Neurobiotin were reconstructed manually using Neurolucida 
Confocal software for morphological analysis. Examples of 3 reconstructed cells 
are shown in Figure 3-1. Some of the slices contained more than 1 cell with a 
maximum of 3 cells contained in a slice. When more than one cells present in a 
slice, the cells were sufficiently far apart to allow them to be differentiated and 
reconstructed. The cell bodies of all 11 eGFP+/tdTomato+ neurons were located 
in lamina II and in each case, eGFP and tdTomato were detected in the cell 
bodies. Dendrites of each cells were completely filled with Neurobiotin since the 
labelling was consistent throughout the dendritic length and did not fade at the 
distal ends. All neurons had dendrites projecting extensively in the rostrocaudal 
axis (mean ± SD; 257.65 µm ± 47.35) and confined within lamina II. In most 
cases, the dendritic arborisations of these cells were very complex and 
numerous spines were presented on the whole dendritic length. Even though all 
cells had rostracaudally extensive dendrites, in 1 case, the cell had dendrites 
that arborized mainly to one side of the cell body (Figure 3-1 a). The cell had a 
limited dorsoventral dendritic spread of 51.10 µm ± 13.60 (mean ± SD). In rat, 
the dendritic rostrocaudal and dorsoventral spread of individual neurons were 
measured to determine morphological classes, as defined by Yasaka et al. 
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(2007). Information on the dendritic dimensions with RC:DV ratio of all cells is 
shown in Table 3-1.   
The axonal arborisations could be followed for considerable distances, thus 
suggesting that the labelling of axons was relatively complete in all cells. In 3 
cases, axons were truncated at the surface of the slices. For the remaining 8 
cells, the axons extended further rostrally and/or caudally than the dendrites 
and were limited to lamina II. All the cells have very fine axons with small 
boutons that were evenly distributed along the axons. Sagittal sections 
containing the cells bodies and dendritic trees of Neurobiotin labelled cells were 
reacted with IB4 and the dendritic and axonal branches were found to be largely 
restricted within the IB4 plexus (). The IB4 plexus was confined to lamina II, with 
the most intense labelling in the middle of lamina and the pattern was identical 
to that reported in previous studies (Cavanaugh et al., 2011).  
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Figure 3-1 Morphology of the CR+/eGFP+ recorded cells in Nociceptin::eGFP;CRCre;Ai9 mice 
Three examples (a-c) of Neurolucida reconstructions of recorded neurons. Cell bodies and 
dendritic trees are shown in blue and axons in red. These drawing show that CR+/eGFP+ cells 
appear to be islet type. D: dorsal, V: ventral, RC: rostrocaudal. Scale bar = 100 µm. 
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Figure 3-2 Neurobiotin filled cell from Nociceptin::eGFP;CRCre;Ai9 mouse. Parasagittal section 
is showing 1 neurobiotin filled cell (green) and the dendritic and axonal branches were found to be 
largely restricted within the Isolectin B4 (blue) in the middle of lamina II. All of the reconstructed 
cells resemble islet cell morphology. Scale bar = 50 µm.   
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            Table 3-1 Dendritic dimensions of reconstructed eGFP+/tdTomato+ 
                 recorded cells in Nociceptin::eGFP; CRCre; Ai9 mice 
Cells RC extent (µm) DV extent (µm) RC:DV ratio 
1 193.50 62.80 3.08 
2 211.10 35.60 5.93 
3 221.60 50.80 4.36 
4 229.30 45.00 5.10 
5 241.40 72.60 3.33 
6 246.40 39.30 6.27 
7 263.80 64.80 4.07 
8 264.40 35.50 7.45 
9 288.50 54.90 5.26 
10 337.20 64.30 5.24 
11 342.80 36.50 9.39 
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3.3.2 The proportion of dorsal horns neurons that are labelled 
with CR+/eGFP+ in Nociceptin::eGFP mice 
The cell bodies and dendritic plexus of CR-immunoreactive neurons were located 
mostly in lamina II, although occasionally cells were seen in laminae I and III 
(Figure 3-3). This finding was similar to those of previous studies performed in 
mouse and rat (Smith et al., 2015, Ren et al., 1993). Meanwhile, the somata of 
eGFP-positive cells were scattered throughout laminae I-III and throughout the 
deeper laminae. In addition, a dense plexus of eGFP dendrites was seen in the 
middle of lamina II (Figure 3-4). Most of the cells that were double labelled with 
CR and eGFP were found in lamina II and the dendrites and axons forming a tight 
band in the middle of lamina II. Occasionally these CR+/eGFP+ cells were seen in 
laminae I and III (Figure 3-3). The examination of confocal image stacks revealed 
that those cells that were located in laminae I and III also contributed to the 
band in the middle of lamina II. All CR+/eGFP+ cells were NeuN-positive and this 
showed that they are neurons. The immunostaining of all antibodies used in this 
part of the study could be seen throughout the full thickness of the optical 
sections. Quantitative data obtain using disector method on this part of the 
study are shown in Table 3-2. A total of 2173 (mean 724) and 1578 (mean 526.2) 
neurons was analysed in laminae I-II and lamina III of 3 mice, respectively. Of 
this, 949 (mean 316.2) and 191 (mean 63.4) were CR-immunoreactive cells in 
laminae I-II and lamina III, respectively. The results were consistent across the 
three sets of sections. The total numbers of eGFP-positive cells identified in this 
part of the study were 477 (mean 159.1) in laminae I-II and 370 (mean 123.2) in 
lamina III. eGFP-immunoreactive cells accounted for 21.9% (range 20.9-22.7%) of 
all neurons in laminae I-II and 23.4% (range 21.7-26.3%) of those in lamina III. 
There were 126 (mean 42.3) and 38 (mean 12.8) CR+/eGFP+ cells were found in 
laminae I-II and lamina III, respectively. Quantitative analysis revealed that, 
CR+/eGFP+ cells constituted 5.8% (range 4.6%-6.7%) of neuronal populations in 
laminae I-II and 2.4% (range 1.3%-3.9%) of those in lamina III (Table 3-2).  
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Figure 3-3 CR and Noc::eGFP cells immunostaining in the dorsal horn. a, b show a confocal 
image taken from a transverse section of lumbar 4 that had been immunostained to reveal 
calretinin (CR) and enhanced green fluorescence protein (eGFP). Calretinin immunoreactivity is 
numerous in lamina II with some staining in a deeper lamina. Noc::eGFP cells are present 
throughout laminae I-III. c a merged image. a-c four small boxes contain cells immunoreactive for 
both CR and eGFP. d Insert show a higher magnification view of four lamina II CR-Noc::eGFP 
cells. These neurons form a band of dendrites in the middle of lamina II. The dashed lines 
represents the borders between laminae I-III. Scale bar for main image = 200 µm, scale bar for 
inset = 20 µm.  
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Figure 3-4 Lamina II CR-Noc::eGFP cells form a tight band in the middle of lamina II. a, b 
show a confocal scan of a sagittal section from a Noc::eGFP mouse that had been immunostained 
for calretinin (CR) and enhanced green fluorescence protein (eGFP). CR and eGFP 
immunostaining is present in lamina II. c a merged image. Four cells (arrows) are immunoreactive 
for both CR and eGFP. The dashed lines represents the dorsal and ventral borders of lamina II. 
Scale bar = 20 µm 
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3.3.3 Quantitative analysis of inhibitory CR+/eGFP+ cells in 
Nociceptin::eGFP and RorBeGFP mice 
For this part of the study, two transgenic mouse lines were used to compare 
which line captures most of the inhibitory CR-immunoreactive cells in laminae I-
III and also the extent to which they preferentially labelled this cells. Nine 
sections each from 3 Nociceptin::eGFP and 3 RorBeGFP mice were analysed. 
Tissue from Nociceptin::eGFP mice showed that the distribution of cells that 
were eGFP, CR, and CR+/eGFP+ cells were similar to that described above. In the 
RorBeGFP mice, the distribution of CR-immunoreactive cells were similar to that 
in Nociceptin::eGFP but the penetration of CR antibody was less complete. The 
eGFP cell bodies and dendrites were found in laminae II-III and less frequently 
seen in lamina I. As seen in the Nociceptin::eGFP (see above), the eGFP 
dendrites were found in the middle of lamina II. The double labelled CR and 
eGFP cell bodies and dendrites were located in lamina II and occasional cells 
seen in laminae I and III of RorBeGFP mice.  
Quantitative data for this part of the study is shown in Table 3-3. In 
Nociceptin::eGFP mice, 504 (mean 168.2, n=3) eGFP-positive cells were counted 
in laminae I-II and 374 (mean 124.7) of those were in lamina III. In SDH, 92.6% 
(range 89.1-96.3%) of the cells that expressed eGFP were positive for Pax2. 
Meanwhile, in RorBeGFP mice, 253 (mean 84.2, n=3) eGFP immunoreactive cells 
were counted in laminae I-II and 165 (mean 54.9) of those cells were counted in 
lamina III. Of this, 91.8% (range 90-93.1%) of eGFP cells were labelled with Pax2 
in laminae I-II. In lamina II of both transgenic strains, 93% of eGFP positive cells 
were Pax2 positive. A total of 1094 (mean 364.6) and 811 (mean 270.3) CR-
immunoreactive cells were counted in laminae I-III of Nociceptin::eGFP and 
RorBeGFP mice, respectively. In lamina I-II of Nociceptin::eGFP mice, 15% (range 
13.8%-16.4%) of CR-immunoreactive cells co-expressed Pax2, whereas 15.8% 
(range 15%-17.2%) of the CR-immunoreactive cells were Pax2 positive in RorBeGFP 
mice. Analysis of the expression of the inhibitory neuron marker Pax2 among CR-
immunoreactive neurons showed that in laminae I-II, 24.2% (range 20.4-29.7%) of 
Pax2 expressing cells were immunoreactive for CR. 
Comparison between the two transgenic mouse lines indicated that there was a 
difference in the proportion of inhibitory CR-immunoreactive cells in lamina II 
that were labelled with eGFP. In the Nociceptin::eGFP mouse line, 75% (range 
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69.8%-78.9%) of inhibitory CR-immunoreactive cells were positive for eGFP, 
whereas the proportion for the RorBeGFP line was 90% (range 85.2%-95.8%). In 
addition, the proportion of lamina II eGFP-immunoreactive cells that were 
positive for CR and Pax2 were also different. In the Nociceptin::eGFP mouse 
line, 19% (range 13.7%-22.7%) of these cells were labelled with CR and Pax2 in, 
while the corresponding percentage for the RorBeGFP line was 45% (range 39.5%-
49%).  
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Table 3-2 Percentages of neurons in laminae I-III that were CR+/eGFP+ in Noc::eGFP mice 
Lamina Number of neurons 
counted 
CR cells eGFP cells CR+/eGFP+ cells % of neurons that 
were CR+/eGFP+ 
I 100.8 (90-113) 16.7 (15-19) 25.7 (19-35) 1.8 (1-3) 1.8 (0.9-2.5) 
II 623.2 (586-697) 299.5 (287-323) 133.4 (118-162) 40.5 (30-53) 6.4 (5.1-7.5) 
I-II 724 (677-797) 316.2 (303-342) 159.1 (141-181) 42.3 (31-53) 5.8 (4.6-6.7) 
III 526.2 (498-541) 63.4 (55-70) 123.2 (108-142) 12.8 (6-21) 2.4 (1.3-3.9) 
    Numbers of cells counted or percentages of cells are shown in the table. Values are the mean cell counts for 3 mice with ranges  
     in parentheses. 
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    Table 3-3 The numbers of neurons that were eGFP, Pax2- and/or CR-immunoreactive in Nociceptin::eGFP and RorBeGFP mice 
    Numbers of cells counted or percentages of cells are shown in the table. Values are the mean cell counts for 3 mice with ranges in parentheses
 eGFP cells CR cells CR+ Pax2+ 
cells 
 
eGFP+ Pax2+ 
cells 
CR+ eGFP+ 
Pax2+ cells 
% eGFP that 
were Pax2 
% CR that 
were Pax2 
% eGFP that 
were CR+/Pax2+ 
% CR+/Pax2+ 
that were 
eGFP 
 
Nociceptin::eGFP mice 
         
I 25.6  
(21-32) 
 
14.6 
(9-21) 
4.7  
(3-7) 
22.9  
(19-30) 
4.4  
(3-7) 
89.1  
(81.9-93) 
31.2  
(27.8-35) 
16.6 
(13.7-21) 
96.5  
(89.6-100) 
II 142.5  
(115-167) 
 
303.2 
(283-338) 
43.4  
(37-54) 
132.3  
(112-157) 
32.4  
(26-41) 
93  
(88.4-96.9) 
14.2  
(13.2-16) 
19.1 
(13.7-22.7) 
74.7  
(69.8-78.9) 
I-II 168.2 
(136-177) 
 
317.8 
(292-352) 
48 
(40-58) 
155.2 
(131-177) 
36.8 
(29-44) 
92.6 
(89.1-96.3) 
15 
(13.8-16.4) 
21.8 
(21-23.2) 
76.5 
(71.9-80.6) 
III 124.7  
(102-154) 
46.7  
(45-49) 
18.6  
(17-20) 
89.7  
(74-106) 
9.2  
(7-11) 
72.2  
(69.2-75.1) 
 
39.9 
(37-42) 
7.5 
(5.6-9.6) 
49.5  
(34.9-57.9) 
I-III 292.8 
(238-345) 
364.6 
(338-401) 
66.7 
(57-78) 
244.8 
(205-283) 
56.7 
(39-55) 
83.9  
(82-86) 
18.2  
(16.9-19.4) 
15.7 
(14.9-16.3) 
67.4  
(67.2-67.7) 
RorBeGFP mice          
I 6.9  
(2-11) 
 
8  
(4-10) 
1.9 
(1-3) 
5.7  
(2-9) 
0.3  
(0-1) 
86.4 
(74.8-100) 
25.7  
(18.4-33.3) 
2.5 
(0-7.4) 
10.6  
(0-31.8) 
II 77.2  
(70-84) 
 
250.2 
(235-264) 
38.9  
(35-43) 
71.6  
(63-80) 
35  
(30-41) 
92.6  
(89.7-94.7) 
15.6  
(14.8-17.1) 
45.2 
(39.5-49) 
89.6  
(85.2-95.8) 
I-II 84.2 
(73-92) 
 
258.2 
(245-267) 
40.8 
(37-45) 
77.4 
(65-85) 
35.2 
(31-41) 
91.8 
(90-93.1) 
15.8 
(15-17.2) 
42.1 
(35.4-45.7) 
86.1 
(82.7-91.8) 
III 54.9  
(51-61) 
 
12.1  
(6-17) 
7.3  
(4-11) 
36  
(34-40) 
1.4  
(0-2) 
65.7  
(63.5-69.1) 
59.7  
(56.9-62.7) 
2.7 
(0-4.7) 
15.9  
(0-31) 
I-III 139.1 
(123-150) 
270.3 
(252-280) 
48.1 
(41-56) 
113.4 
(100-121) 
36.6 
(31-43) 
81.5  
(80.9-82.3) 
17.8  
(16.3-20) 
26.5 
(20.9-29.8) 
76.1  
(74.5-77.2) 
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Figure 3-5 CR and RorBeGFP cells immunostaining in the dorsal horn. a, b show a confocal 
image taken from a RorBeGFP mouse that had been immunostained to reveal calretinin (CR) and 
enhanced green fluorescence protein (eGFP). CR immunoreactivity is numerous in lamina II and 
occasionally present in lamina III and in a deeper laminae. eGFP cells are present throughout 
laminae I-III. c a merged image. a-c five small boxes contain cells immunoreactive for both CR and 
eGFP. These neurons form a band of dendrites in the middle of lamina II. The dashed lines 
represents the borders between laminae I-III. Scale bar = 200 µm. 
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3.4 Discussion 
The main findings for this part of the study are: (1) that all reconstructed 
CR+/eGFP+ neurons from Nociceptin::eGFP;CRCre;Ai9 mice; are islet cells; (2) 
that Nociceptin::eGFP and RorβeGFP mouse lines are useful tools for investigating 
inhibitory CR cells in the SDH; (3) that 90% of lamina II inhibitory CR-
immunoreactive cells are positive for eGFP in RorβeGFP mouse line while the 
corresponding percentage for the Nociceptin::eGFP mouse was 75%; and (4) that 
the RorβeGFP mouse line is more suitable than Nociceptin::eGFP for studying the 
inhibitory CR cells in SDH. 
3.4.1 Morphological features of recorded cells 
From the observations of the 11 eGFP+ and tdTomato+ cells that were 
reconstructed in Nociceptin::eGFP;CRCre;Ai9 mice, it was found that all of the 
neurons resembled islet cells. They had dendritic trees that extended mainly in 
the rostrocaudal axis and often had recurrent branches that turned 180o towards 
the cell body (Figure 3-1). In addition, the cells also had limited dorsoventral 
extension. Eight of these cells also have axons that arborized within the volume 
occupied by the dendritic trees and usually, the axons extended further than the 
dendrites either rostrally and/or caudally (Figure 3-1). According to Grudt and 
Perl (2002), islet cells had rostrocaudal dendritic spread > 400 µm long with 
axons that were restricted to the volume of their dendritic arbors. Following 
these criteria for characterizing islet cells, Yasaka et al. (2007) concluded that 
neurons with dendritic trees between 300-400 µm will be classified as islet cells 
if their axons arborize within the volume of the dendritic tree. In addition to the 
above criteria, islet cells were required to have ratio of RC/DV more than 3.5. 
Based on these criteria, only 2 of the reconstructed cells (cell 10 and 11 from        
Table 3-1) in this study would be classified as islet cells. The other 9 cells had 
shorter rostrocaudal dendritic extension between 193.50 - 288.50 µm (mean ± 
SD; 240.00 µm ± 29.60) and 2 of these cells (cell 1 and 5 from       Table 3-1) had 
RC/DV ratios of less than 3.5. However, the study by Yasaka et al. (2007) was 
carried out on cells from the rat and it is likely that there are differences in the 
size of the cells between the species. Polgár et al. (2013a) reported that the 
length of the L4 segment in mouse was 1.45 mm, meanwhile the corresponding 
value was 2.45 mm in rat (Polgár et al., 2004). Given that islet cells had 
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rostrocaudal dendritic extension of more than 300 µm in rat, then the equivalent 
length in mouse would be ~177 µm since the mouse L4 segment was 59% of the 
length of the corresponding rat segment. However, although the dorsoventral 
extent of the SDH in the mouse (~80 µm) is also smaller than that of the rat 
(~100 µm), this difference is smaller (80%) (A.J.Todd unpublished observations). 
A RC:DV ratio of 3.5 in the rat would therefore correspond to ~2.6 in the mouse. 
Based on this adjusted criteria, all the eGFP+/tdTomato+ reconstructed cells in 
the present study would be classified as islet cells.  
Morphological study done on Neurobiotin filled atypical CR cells in lamina II of 
CR::eGFP mice showed that all of the recorded cells (n = 10) had rostrocaudal 
extent between 350-600 µm and RC:DV ratio between 6-14 (Smith et al., 2016). 
Smith and colleagues therefore classified these as islet cells following the 
scheme developed for hamster and rat by Grudt and Perl (2002) and Yasaka et 
al. (2007), respectively. The atypical CR cells that they recorded had dendritic 
trees that were considerably larger in the rostrocaudal axis than those of the 11 
reconstructed cells in this study and this might reflect a selection bias in the 
study by Smith et al. (2016), who may have selected only larger cells for patch 
clamp recording.  In a study using mouse to investigate physiological properties 
of GABAergic dorsal horn neurons, Heinke et al. (2004) found Neurobiotin filled 
lamina II cells with elongated dendritic trees that extended between 150–650 
µm. However, they could not separate the cells into ‘islet’ or ‘central’ based on 
the rostrocaudal dendritic extent. Therefore, they classified their sample as islet 
cells even though some of the cells had relatively short rostrocaudal dendritic 
extent. These findings indicated that it was difficult to apply the classification 
scheme used by previous studies that were carried out in other species (Grudt 
and Perl, 2002, Yasaka et al., 2007). 
3.4.2 CR+/eGFP+ cells in Nociceptin::eGFP mice 
The Nociceptin::eGFP mouse line is a bacterial artificial chromosome (BAC 
transgenic) line that expresses enhanced green fluorescent protein (eGFP) in 
ppN/OFQ neurons. The neuropeptide Nociceptin is also known as orphanin FQ 
(N/OFQ) because the peptide activated a receptor previously known as an 
orphan receptor, whereas the letters F (phenylalanine) and Q (glutamine) 
derived from the first and last amino acid of this peptide (Meunier et al., 1995, 
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Reinscheid et al., 1995). N/OFQ is derived from a larger precursor protein called 
ppN/OFQ (Ikeda et al., 1998). It was named nociceptin due to the 
pronociceptive effect (hyperalgesia) that was seen after the peptide was 
injected intracerebroventricularly (Meunier et al., 1995). However, N/OFQ has 
antinociceptive effects at the spinal level by hyperpolarising the membrane of 
the primary afferents and inhibiting glutamate release at their central terminals 
(Zeilhofer et al., 2002, Zeilhofer and Calò, 2003). 
 To establish whether the Nociceptin::eGFP mouse line provides a reliable way 
of defining inhibitory CR cells, the transcription factor Pax2 was used to confirm 
that eGFP+ cells visualized in this mouse line were inhibitory neurons. Pax2 was 
first used to identify inhibitory neurons in the brain. In the cerebellum, it was 
found that developing GABAergic neurons expressed Pax2 (Maricich and Herrup, 
1999). A few years later, Cheng et al. (2004) showed in the embryonic (E12.5) 
dorsal horn, double staining of Gad1 mRNA and Pax2 protein indicated that 98% 
of Pax2 cells co-expressed Gad1, a gene coding for glutamic acid decarboxylase 
GAD67, an enzyme that synthesis GABA (Cheng et al., 2004). Since then, Pax2 
has been widely used to define inhibitory neurons, as it has been shown to be a 
reliable marker for these cells in the dorsal horn (Huang et al., 2008). 
Furthermore, in SDH of adult rat, 99% of Pax2 positive cells were found to be 
immunoreactive for GABA and effectively all GABA positive cells contained Pax2 
(Larsson, 2017b). Pax2 is commonly used in preference to GABA as a marker for 
inhibitory neurons since there are technical difficulties associated with 
immunostaining for GABA. Glutaraldehyde fixed tissue is required for good 
retention of amino acid and this has a detrimental effect on many types of 
immunostaining. In addition, GABA immunostaining is often restricted to the 
surface of thick tissue sections (Sloviter et al., 2001, Sardella et al., 2011b). 
Multiple antibody  labelling for immunocytochemistry was used to examined the 
cells throughout the various depth of the sections in this study, than the used of  
glutaraldehyde tissue fixation was not a favourable choice due to reduction in 
antibody binding (Van Ewijk et al., 1980).  
In lamina I-II of Nociceptin::eGFP mice, it was found that 93% (89.1%-96.3%) of 
eGFP-immunoreactive cells were Pax2 positive and that 75% of inhibitory CR 
(Pax2+) cells were positive for eGFP. This suggest that the Nociceptin::eGFP 
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mouse line is a reliable method that is used for capturing most of inhibitory CR 
neurons. Previously, Albuquerque et al. (1999) suggested that CR-expressing 
cells in SDH used glutamate as fast neurotransmitters despite the fact that they 
found 12% and 7% of CR-expressing neurons were GABA- and glycine-
immunoreactive, respectively. Subsequently, Smith et al. (2015) found 15% of 
the CR-immunoreactive cells in laminae I-II were labelled with Pax2, and their 
finding is very similar with this study as the corresponding value in this study was 
that 15% of CR-expressing cells in laminae I-II of Nociceptin::eGFP mice were 
Pax2 positive. These observations were also consistent with the finding by 
Albuquerque et al. (1999), that 12% of CR-positive cells were GABA+. However, in 
a recent study that was carried out in rat, Larsson (2017a) found that only 8% of 
the lamina II CR-immunoreactive cells were labelled with Pax2. However, 
Larsson reported that the staining with Pax2 antibody was relatively weak, and 
this might contribute to the lower number of inhibitory CR cells in his study.   
In the present study, quantitative analysis showed that CR-immunoreactive cells 
accounted for 24% of the inhibitory interneurons in laminae I-II, and this result 
was similar (~25%)  to what was found by Smith et al. (2015). On the contrary, 
Huang et al. (2010) reported that CR cells constitute 13% of inhibitory (eGFP+ 
cells) in lamina II of GAD67eGFP mice. This finding was much lower that what was 
found in a present study. This might be due to a technical issue, for example the 
poor penetration of CR antibodies or alternatively because not all GABAergic 
neurons were labelled with eGFP in this mouse line. In addition, Boyle et al. 
(2017) reported that in laminae I-II of the mouse dorsal horn, galanin, nNOS, NPY 
and PV make up about 75% of inhibitory neurons (GABAergic) in these laminae 
and they suggested that the remaining 25% of Pax2-immunoreactive cells 
belonged to the inhibitory CR cell population (Smith et al., 2015).  
In the Nociceptin::eGFP mice, eGFP-positive cells constitute 22% of all neurons 
in SDH and 93% of these cells are inhibitory (Pax2). A previous quantitative study 
of inhibitory interneurons in the mouse spinal cord indicated that GABA-
immunoreactive cells account for 25.8% of all neurons in laminae I-II (Polgár et 
al., 2013a) and therefore the proportion of the inhibitory neurons that were 
eGFP-immunoreactive neurons among all inhibitory neurons in laminae I-II is 
estimated to be 78%. These suggest that the majority of inhibitory cells 
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contained Nociceptin and this is consistent with the finding of Neal et al. (1999) 
who showed that both Nociceptin mRNA and its precursor, ppN/OFQ were highly 
expressed in the superficial laminae of the spinal cord dorsal horn. The 
Nociceptin opioid peptide receptor (NOP) immunoreactivity was also seen in the 
same regions. The expression of the Nociceptin by inhibitory interneurons is also 
consistent with the finding that the Nociceptin selectively inhibits the release of 
glutamate from nociceptive C- and Aδ- fibres without interfering with GABAergic 
or glycinergic neurotransmission at the spinal cord level (Luo et al., 2002). 
Although the Nociceptin::eGFP mice captured most of inhibitory cells, this 
mouse line was not selective of inhibitory CR cells, since it captures around ~80% 
of all inhibitory interneurons in the SDH. 
3.4.3 Comparison between Nociceptin::eGFP and RorBeGFP mouse 
lines  
During the earlier part of the study, observations on the transverse sections from 
the Nociceptin::eGFP mouse line showed that eGFP labelled many inhibitory 
neurons in the SDH. These cells formed a dendritic plexus in the middle of 
lamina II and this could correspond to CR islet cells, which have a narrow 
dorsoventral extent. Immunostaining the sections with CR antibody revealed that 
some of the cells in lamina II were double labelled with CR and eGFP and that 
the dendritic and axonal band seen in the middle of lamina II was also CR-
immunoreactive. The Nociceptin::eGFP mouse could therefore be crossed with 
CRCre; Ai9 (which causes the CR cells to express tdTomato) to allow identification 
of CR/Pax2 cells in spinal cord slices used for electrophysiology experiment. For 
this reason, it is important to validate the Nociceptin::eGFP mouse line. As 
described above, the analysis revealed that the Nociceptin::eGFP mouse line 
captured most of inhibitory CR but also many other inhibitory neurons. These 
results showed that Nociceptin::eGFP mouse line crossed with CRCre; Ai9 was 
suitable for electrophysiology experiments such as to look at the firing patterns 
and synaptic input, and to carry out pharmacological study on the inhibitory CR 
cells. However, there were 2 disadvantages of this approach: (1) 
Nociceptin::eGFP mouse line only captures 75% of inhibitory CR cells; (2) 
Nociceptin::eGFP mouse line labelled most of inhibitory neurons which made it 
more difficult to identify inhibitory CR cells in electrophysiological experiments. 
During the course of this study, spinal cords from RorBeGFP mice were received 
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from Professor David Ginty. Earlier observations on the transverse sections of the 
RorBeGFP mice suggested that fewer eGFP+ cells were seen in the SDH, compared 
to the Nociceptin::eGFP mice and these cells also formed a prominent dendritic 
and axonal band in the middle of lamina II that corresponded to CR 
immunostaining.  
To understand the functions of inhibitory CR cells in the SDH, it is important to 
determine which mouse line would capture most of these cells. In this part of 
the study, a comparison between Nociceptin::eGFP and RorBeGFP mouse line was 
done by doing quantitative analysis on the numbers of inhibitory CR that were 
eGFP in SDH. In addition, the specificity of labelling for inhibitory CR cells was 
also important.  
Quantitative analysis in Nociceptin::eGFP and RorBeGFP mouse lines showed that 
more than 90% of laminae I-II eGFP cells in both animals were labelled with 
Pax2, thus showing that these mouse lines were reliable tools to investigate 
inhibitory CR cells in the SDH. In lamina II of RorBeGFP mice, 90% of inhibitory CR-
labelled cells were immunoreactive for eGFP, whereas only 75% of the same 
cells were stained for eGFP in Nociceptin::eGFP mice. Furthermore, in lamina II 
of RorBeGFP mice, 45% of eGFP-immunoreactive cells were labelled with both CR 
and Pax2, meanwhile the corresponding percentage for Nociceptin::eGFP mice 
was 19%.  
As a conclusion from this part of the study, the results showed that RorBeGFP 
mouse line is more effective than Nociceptin::eGFP mouse for investigating 
inhibitory CR cells in the SDH since: (1) 90% of eGFP cells in SDH were Pax2 
positive; (2) 90% of inhibitory CR-labelled cells were immunoreactive for eGFP in 
lamina II; and (3) the RorBeGFP mouse was more selective than the 
Nociceptin::eGFP mouse since a higher proportion of eGFP-immunoreactive cells 
were labelled with CR and Pax2 antibodies. Interestingly, Wildner et al. (2013) 
reported that the expression of RorB was specific to the subset of inhibitory 
dorsal horn neurons, thus making it as a marker of choice for defining inhibitory 
subpopulations.  
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4 Expression of neurochemical markers of 
inhibitory interneuron populations in CR+/eGFP+ 
cells in Nociceptin::eGFP and RorBeGFP mice 
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4.1 Introduction 
Abraira and Ginty (2013) reported that, around 99% of the neurons within the 
dorsal horn are local interneurons, the majority of which hare excitatory. A 
quantitative study carried out in mouse found that about one quarter of the 
neurons in laminae I-II and ~ 40% of those in lamina III are inhibitory interneurons 
that are GABA and/or glycine immunoreactive (Polgár et al., 2013a). It has been 
suggested that pathological pain states arise due to the loss of function of 
inhibitory cells, which normally suppress pain and itch (Sandkühler, 2009, Kardon 
et al., 2014, Petitjean et al., 2015).  
As noted above, nNOS, NPY, galanin/dynorphin and PV are found to be expressed 
by distinct populations of inhibitory interneurons in the dorsal horn of the rat 
spinal cord  (Sardella et al., 2011b, Polgár et al., 2011, Tiong et al., 2011, 
Hughes et al., 2012, Sardella et al., 2011a). Boyle et al. (2017) reported that in 
the mouse, ~75% of the inhibitory interneurons in lamina I-II are accounted for 
by cells immunoreactive for these four distinct neuronal markers. In addition, it 
appears that, sst2A is virtually restricted to inhibitory neurons (Todd et al., 1998, 
Polgár et al., 2013a, Cameron et al., 2015).  
The quantitative analysis carried out in chapter 3 showed that in laminae I-II, 
15% of CR cells are inhibitory. Meanwhile, CR-positive neurons account for 24% of 
the inhibitory cells. Both findings are similar to those reported by Smith et al. 
(2015). In addition, Smith and colleagues reported that 50% of Pax2 CR-
immunoreactive neurons in laminae I-II are positive for the sst2A receptor. They 
also found that none of the galanin-immunoreactive cells were positive for CR, 
whereas there was minimal expression of CR in NPY and inhibitory nNOS 
populations. However, they did not determine the percentage of inhibitory CR 
cells that expressed galanin, nNOS or NPY. In addition, Smith et al. (2015) did 
not verify the expression of another distinct inhibitory neuronal marker, PV, 
among inhibitory CR cells.  
The aims of this part of the study are to determine: 1) the extent to which 
CR+/eGFP+ cells express four (galanin, nNOS, NPY and PV) other neurochemical 
markers of the inhibitory interneurons in laminae I-II of Nociceptin::eGFP and 
RorβeGFP mice; 2) the proportion of CR+/eGFP+ neurons that express sst2A receptor 
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in Nociceptin::eGFP mice; and 3) expression of the various peptides (galanin, 
nNOS, NPY and PV) by CR-/eGFP+ cells in RorβeGFP mice.  
4.2 Materials and method  
4.2.1 Animals and tissue processing 
Three Nociceptin::eGFP adult mice of male sex, weighing between 28-32g were 
deeply anesthetised with pentobarbitone and perfused through the left ventricle 
with freshly made 4% de-polymerised formaldehyde. Lumbar spinal cord 
segments were dissected out from all animals and post-fixed for 2 hours with the 
same solution at 4oC before being transferred to PB. The L4 segments were cut 
into 60 µm thick transverse sections using a vibrating blade microtome followed 
by immersion in 50% ethanol for 30 minutes to enhance antibody penetration 
(Llewellyn-Smith and Minson, 1992). The segments were cut serially into 4 
bottles and these were processed according to different immunocytochemical 
protocols. In addition, perfusion fixed spinal cords from 3 RorBeGFP young adult 
mice were received from Professor David Ginty from Harvard University and 
were processed in a similar way. Sections were then processed for multiple 
immunolabelling as described in 4.2.2 and 4.2.3.  
4.2.2 Expression of 4 distinct inhibitory markers and sst2A in 
CR+/eGFP+ in Nociceptin::eGFP mice 
To determine the extent to which galanin, nNOS, NPY, PV and sst2A were 
expressed by CR+/eGFP+ cells, sections from L4 segments of 3 Nociceptin::eGFP 
mice were incubated with the following antibodies: chicken anti-eGFP, mouse 
anti-CR, rabbit anti-galanin, rabbit anti-nNOS, rabbit anti-NPY, guinea pig anti-
PV and guinea pig anti-sst2A. The reactions were performed in 3 different sets of 
immunocytochemical protocols: (i) eGFP, CR, galanin and sst2A, (ii) eGFP, CR, 
nNOS and sst2A, (iii) eGFP, CR, NPY and PV. The primary antibodies were 
revealed with appropriate fluorescent secondary antibodies.  
For each immunocytochemical reactions, 4 sections from each Nociceptin::eGFP 
mouse and 3 sections from each RorBeGFP mouse were selected randomly before 
immunostaining for the corresponding peptide was viewed. These sections were 
scanned with a Zeiss LSM 710 confocal microscope with a 40x oil immersion lens 
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(numerical aperture 1.3), 1µm z-step and the aperture set to 1 Airy unit. These 
sections were scanned to produce a z-stack of 30 optical sections. Tile scans 
were used to capture the whole width of laminae I-III. Confocal scans were 
analysed offline using Neurolucida for Confocal Software. The outline of the 
dorsal horn and the boundaries between laminae I-III were drawn. The lamina 
I/II boundary was drawn 20 µm below the dorsal white matter and the ventral 
extent of the CR-immunoreactive cells was used to determine lamina II/III 
border. The ventral border of lamina III was taken as 100 µm below the lamina 
II-III border. 
A modified optical disector method was used to obtain an unbiased sample of 
neurons in laminae I-III of the scanned sections (Gutierrez-Mecinas et al., 2016a, 
Tiong et al., 2011). All cell bodies of eGFP-positive neurons in laminae I-III that 
had their bottom surface between reference and look up sections (10th and 25th 
optical sections, respectively) were plotted onto the Neurolucida drawing. Then, 
the CR channel was viewed to determine the proportion of eGFP-
immunoreactive cells that were positive for CR. Following that, the channel 
corresponding to either galanin, nNOS, NPY, PV or sst2A was then viewed. The 
presence or absence of each type of staining was documented for each of the 
selected CR+/eGFP+ neurons.  
Since the reference and look-up sections were reasonably far apart, every 
optical sections between them were carefully examined to ensure that all 
neurons with nuclei presented between these two planes were included in the 
sample.  
4.2.3 Assessment of co-localisation of the 4 distinct inhibitory 
markers in CR+/eGFP+ in RorBeGFP mice  
To define the co-localization between CR+/eGFP+ neurons with galanin, NPY, 
nNOS and PV, 3 sections from L4 segments of 3 RorBeGFP mice were 
immunoreacted with mouse anti-NeuN, chicken anti-eGFP, rabbit anti-galanin, 
rabbit anti-NPY, rabbit anti-nNOS, guinea pig anti-PV and goat anti-CR. NeuN 
was used to help to distinguish the outline of cells that expressed galanin and 
NPY which were found in patches in the perikaryal cytoplasm (Mullen et al., 
1992, Todd et al., 1998). The reactions were performed in four different sets of 
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immunocytochemical reactions: (i) eGFP, CR, galanin and NeuN, (ii) eGFP, CR, 
nNOS and NeuN, (iii) eGFP, CR, NPY and NeuN, (iv) eGFP, CR, and PV. These 
were revealed with appropriate fluorescent secondary antibodies. For all four 
different immunoreactions, 3 sections from each mouse were selected and 
scanned using the confocal microscope and analysed as described earlier.  
For all the immunoreactions, cell bodies of eGFP cells in laminae I and II with 
the bottom of the nucleus located between 10th and 25th optical sections were 
initially plotted onto the Neurolucida drawing. Then the channel corresponding 
to CR was viewed and CR+/eGFP+ and CR-/eGFP+ cells were identified. Following 
this, the remaining channels were than observed and the presence or absence of 
each type of immunostaining was documented for each of the selected neurons.  
All of the analyses in this part of the study were carried out in laminae I-II only 
because the majority of CR+/eGFP+ cells were seen here. In addition, the 
RorBeGFP spinal cords were not properly fixed and this will give rise to poor 
immunostaining of sst2A antibody. Therefore, the analysis on the expression of 
somatostatin receptor in CR+/eGFP+ cells was not carried out in RorBeGFP mice. 
4.3 Results 
4.3.1 Expression of galanin, nNOS, NPY, PV and sst2A among 
CR+/eGFP+ cells in Nociceptin::eGFP mice 
In all 3 set of immunoreactions from the Nociceptin::eGFP mice, the distribution 
of cell bodies and dendrites that were eGFP+, CR+ and double labelled CR+/eGFP+ 
neurons was similar to previous findings reported in chapter 3. To look at the 
relationship between CR+/eGFP+ and galanin-immunoreactive neurons, sections 
reacted against CR, eGFP, and galanin antibodies were analysed. Quantitative 
data obtain using the disector method on this part of the study is shown in Table 
4-1. A total of 921 (mean 307) eGFP-positive cells and 101 (mean 33.7) 
CR+/eGFP+ neurons were identified in laminae I-III. Of the CR+/eGFP+ cells, 87% 
(range 80-90.3%) were in lamina II. The pattern of galanin-immunoreactive cells 
was similar to what has been reported in previous studies (Todd and Spike, 1993, 
Tiong et al., 2011). The galanin immunoreactivity was seen in the perikaryal 
cytoplasm, and the cell bodies were found in laminae I-III with a dense axonal 
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plexus in laminae I and IIo. Furthermore, 172 (mean 57.3) galanin-positive cells 
were counted in laminae I-III with 93% (range 92.5-94.5%) of these cells being 
found in lamina II. The quantitative analysis showed that none of the CR+/eGFP+ 
cells were galanin-immunoreactive in laminae I-III (Figure 4-1).  
To determine the relationship between CR+/eGFP+ cells and nNOS, sections 
reacted against CR, eGFP, and nNOS were analysed. In laminae I-III, a total of 
826 (mean 275.3) eGFP-positive neurons and 108 (mean 36) CR+/eGFP+ cells were 
counted. About 90% (range 85.7-94.3%) CR+/eGFP+ neurons were found in lamina 
II. The nNOS-immunoreactive cell bodies were found mainly in laminae I-II with 
fewer cells seen in lamina III. The nNOS immunostaining was mainly seen in 
perikaryal cytoplasm with extension into the proximal dendrites. However, there 
was variability in the intensity of the immunostaining between nNOS-
immunoreactive cells. Some cells showed very intense immunostaining and some 
have a weaker labelling. A dense plexus of dendrites and axons of the nNOS-
immunoreactive neurons was seen in laminae I-II. The distribution of cells was 
the same as that reported previously (Sardella et al., 2011b). A total of 633 
(mean 211) nNOS-immunoreactive cells were counted in laminae I-III. Of these, 
81% (range 77.9-82.5%) cells were found in lamina II. Analysis performed on all 
sections showed that, there was no nNOS expression in CR+/eGFP+ cells in 
Nociceptin::eGFP mice (Figure 4-1).  
To look at the extent of overlap between NPY and PV with CR and eGFP, sections 
reacted to reveals CR, eGFP, NPY and PV were analysed (Figure 4-2). A total of 
956 (mean 318.7) eGFP-immunoreactive cells were counted in laminae I-III. 
Meanwhile, 97 (mean 32.3) CR+/eGFP+ cells were counted in lamina I-III with 86% 
(range 82.8-92.3%) of these cells being in lamina II. The somata of NPY-
immunoreactive cells were found more in laminae I-II and were more sparsely 
distributed in lamina III. The immunostaining for NPY was seen in the perikaryal 
cytoplasm and a dense plexus of NPY-immunoreactive axons was found in 
laminae I-II with scattered axons seen in deeper laminae. The distribution of 
these cells was comparable with previous studies carried out in both mouse and 
rat (Rowan et al., 1993, Polgár et al., 2011, Iwagaki et al., 2016). In laminae I-
III, 479 (mean 159.7) NPY-immunoreactive cells were counted. Observations in 
all sections from 3 Nociceptin::eGFP mice showed that 8% (range 3.4-11.9%) of 
the CR+/eGFP+ cells were immunoreactive for NPY (Figure 4-2). A total of 645 
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(mean 215) PV-immunoreactive cells were counted in laminae I-III and a similar 
pattern was seen to that described in a previous study in mouse (Hughes et al., 
2012). The cell bodies of PV-positive neurons were distributed mainly in lamina 
IIi-III and were absent from lamina I. The immunoreactivity for PV was seen in 
the cytoplasm and nucleus of the cells. Most (91%, range 87.9-93.2%) of these 
cells were found in lamina III. Quantitative analysis revealed that none of the 
PV-immunoreactive cells in laminae I-III were CR+/eGFP+ cells (Figure 4-2).  
The analysis of sst2A labelling on CR+/eGFP+ cells was carried out using the same 
sections that were used to look at the relations to galanin and nNOS. The 
distribution of sst2A was similar to that seen in previous studies (Todd et al., 
1998, Polgár et al., 2013a, Shi et al., 2014). The immunostaining of sst2A 
immunoreactivity was observed as a dense band in laminae I-II and the 
immunostaining was rarely seen in lamina III. At high magnification, the 
immunostaining was associated with neuronal cell membranes with minimal 
reactivity in the cytoplasm. In laminae I-II from 8 sections per animal, 184 (25-35 
per mouse) CR+/eGFP+ cells were counted and of these, 90 (13-16 per mouse) 
cells were labelled with sst2A which correspond to 49% (range 42.9-55.2%). In 
lamina II, 48% (range 41.2-53.6%) of the CR+/eGFP+ cells were sst2A-
immunoreactive (Figure 4-3).  
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Figure 4-1 Lack of co-localisation of CR-Noc::eGFP, nNOS and galanin in laminae I-III. 
Confocal images of a transverse section from  lamina II of Noc::eGFP mouse that had been 
immunostained for nNOS (blue), CR (red), eGFP (green) and galanin (Gal) (blue). a-c shows 
nNOS containing cell body (arrow) is not immunoreactive for CR but is labelled with eGFP. b, c 
show CR-Noc::eGFP cell (arrow head)  is lack of nNOS. e-g shows two galanin-immunoreactive 
cells (arrows) are lack of CR but are labelled with eGFP. f, g show neurons immunoreactive for 
both CR and eGFP (arrow heads) are not labelled with galanin. d,h a merged images. a-h are from 
a single optical section. Scale bar = 20 µm.  
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Figure 4-2 Lack of co-localisation of CR-Noc::eGFP, NPY and PV in laminae I-III. Confocal 
images of a transverse section from Noc::eGFP mouse that had been immunostained for NPY 
(blue), CR (red), Noc::eGFP (green) and PV (blue). a-c shows NPY containing cell body (arrow) in 
lamina II is lack of CR but are labelled with eGFP and CR-Noc::eGFP cell (arrow head)  is 
immunoreactive for NPY (weakly labelled). e-g show PV-immunoreactive cell (arrow) in lamina IIi is 
lack of CR but are labelled with eGFP. f, g show neurons immunoreactive for both CR and 
Noc::eGFP (arrow head) is not labelled with PV. d,h a merged images.  a-h are from a single 
optical section. Scale bar = 20 µm.   
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Table 4-1 Expression of other neurochemical markers with CR and eGFP in       
Nociceptin::eGFP mice   
 Lamina GFP+ CR+/GFP+ Galanin+ CR+/GFP+/Galanin+ 
Galanin I 20.7 (19-22) 1 (1) 3.7 (2-6) 0 
 II 162.3 (156-175) 27.7 (24-31) 52 (49-55) 0 
 III 124 (108-149) 5 (2-8) 1.7 (1-3) 0 
 I-III 307 (293-324) 33.7 (30-40) 57.3 (53-64) 0 
      
 Lamina GFP+ CR+/GFP+ nNOS+ CR+/GFP+/nNOS+ 
nNOS I 17 (14-19) 0.3 (0-1) 7.3 (5-9) 0 
 II 156.7 (143-169) 32.3 (30-34) 170 (165-176) 0 
 III 101.7 (78-119) 3.3 (2-5) 33.7 (30-41) 0 
 I-III 275.3 (255-302) 36 (35-38) 211 (200-226) 0 
      
 Lamina GFP+ CR+/GFP+ NPY+ CR+/GFP+/NPY+ 
NPY I 18 (14-21) 1.3 (1-2) 6.7 (4-9) 0 
 II 166.7 (145-206) 28.7 (24-38) 95 (90-102) 2.7 (1-5) 
 III 134 (113-160) 2.3 (1-4) 58.3 (49-71) 0 
 I-III 318.7 (283-385) 32.3 (26-42) 159.7 (154-170) 2.7 (1-5) 
      
 Lamina GFP+ CR+/GFP+ PV+ CR+/GFP+/PV+ 
PV I 18 (14-21) 1.3 (1-2) 0 (0) 0 
 II 166.7 (145-206) 28.7 (24-38) 18.7 (15-24) 0 
 III 134 (113-160) 2.3 (1-4) 196.3 (174-210) 0 
 I-III 318.7 (283-385) 32.3 (26-42) 215 (198-227) 0 
In each case, the mean values for 3 Nociceptin::eGFP mice are shown, with the range in brackets.  
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Figure 4-3 CR-Noc::eGFP and sst2A in the superficial dorsal horn. Confocal image showing a 
single optical section of Noc::eGFP mouse to reveal sst2A (blue), CR (red) and eGFP (green). a-d 
show a neuron that is immunoreactive for sst2a (arrow) is also labelled with CR and eGFP. Not all 
CR-Noc::eGFP cell (arrow head) immunoreactive for sst2A. Scale bar = 10 µm.  
105 
 
 
 
4.3.2 Neurochemical markers in RorBeGFP and their expression by 
CR+/eGFP+ and CR-/eGFP+ cells 
In this part of the study, similar arrangement of cell bodies and dendritic plexus 
of eGFP, CR and CR+/eGFP+ neurons was seen as described in chapter 3. The 
distribution of neurons and the immunoreactivity of galanin, nNOS, NPY and PV 
in RorBeGFP mice was similar to what has been reported in previous studies and in 
present study using Nociceptin::eGFP mice (Tiong et al., 2011, Sardella et al., 
2011b, Polgár et al., 2011, Hughes et al., 2012).  
To determine the relationship between CR+/eGFP+ cells and galanin, sections 
from 3 animals reacted with eGFP, CR, galanin and NeuN were analysed. 
Quantitative data obtain using the disector method on this part of the study is 
shown in Table 4-2. A total of 319 (mean 106.3) and 136 (mean 45.3) eGFP-
positive cells and CR+/eGFP+ neurons were counted in laminae I-II, respectively. 
Of this, 94% (range 91.2-95.2%) of the CR+/eGFP+ cells were counted in lamina II. 
In the SDH, 154 (mean 51.3) galanin-immunoreactive cells were counted and 
none of the CR+/eGFP+ cells were associated with galanin. However, 59% (range 
49.2-69.4%) of the CR-/eGFP+ neurons were labelled with galanin, and this 
accounted for 70% (range 62-77.8%) of the galanin-immunoreactive cells in SDH. 
To look at the presence of nNOS immunostaining in CR+/eGFP+ cells, the sections 
reacted with eGFP, CR, nNOS and NeuN were analysed. In laminae I-II, 339 
(mean 113) eGFP-immunoreactive cells were counted. A total of 142(mean 47.3) 
CR+/eGFP+ neurons in SDH were calculated and 93% (range 87.2-95.8%) of these 
being in lamina II. A total of 437 (mean 145.7) nNOS-IR cells were counted and 
nNOS immunoreactivity was seen in only 2% (range 0-5.1%) of the CR+/eGFP+ 
cells. On the other hand, 17% (range 15.4-18.8%) of the CR-/eGFP+ cells were 
immunoreactive for nNOS in SDH. In addition, 7% (range 6.5-7.8%) of the nNOS-
immunoreactive neurons were labelled with eGFP. 
To establish the relationship between CR+/eGFP+ cells and NPY, 3 sections from 
3 animals that immunoreacted with eGFP, CR, NPY and NeuN were analysed. A 
total of 337 (mean 112.3) and 143 (mean 47.7) eGFP-positive cells and 
CR+/eGFP+ neurons were counted in laminae I-II, respectively. Of this, 95% 
(range 94.2-96.2%) of the CR+/eGFP+ cells were found in lamina II. In the SDH, 
236 (mean 78.7) NPY-immunoreactive cells were counted and 7% (range 2.6-
106 
 
 
 
9.6%) of the CR+/eGFP+ cells were labelled with NPY. Most of the time, NPY-
immunoreactivity seen with CR+/eGFP+ cells was invariably weak. In addition, 
22% (range 15-30.2%) of the CR-/eGFP+ neurons were NPY-immunoreactive and 
18% (range 13-24.1%) of the NPY-positive cells were immunoreactive for eGFP in 
SDH.  
To explore the extent of overlap between PV and CR+/eGFP+ cells, a total of 547 
(mean 182.3) and 165 (mean 55) of eGFP- and CR+/eGFP+ cells were counted in 
laminae I-III, respectively. In laminae I-III, 469 (mean 149) PV-positive cells were 
calculated and the analysis showed that none of the CR+/eGFP+ cells were 
labelled with PV. In addition, 1% (range 0-1.6%) and 9% (range 5.5-11.7%) of the 
CR-/eGFP+ neurons were labelled with PV were seen in laminae I-II and LIII, 
respectively. About 9% (range 0-14.3%) and 4% (range 2.6-4.9%) of the PV-
immunoreactive cells contained eGFP-immunoreactivity in SDH and lamina III, 
respectively. 
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Table 4-2 Colocalization of neurochemical markers with CR and eGFP in RorBeGFP mice   
 Lamina GFP+ CR+/GFP+ Galanin+ CR+/GFP+/Galanin+ 
Galanin I 13.7 (10-20) 3 (2-5) 5 (4-7) 0 
 II 92.3 (89-96) 42.3 (35-52) 46.3 (46-47) 0 
 I-II 106.3 (100-113) 45.3 (37-57) 51.3 (50-54) 0 
      
 Lamina GFP+ CR+/GFP+ nNOS+ CR+/GFP+/nNOS+ 
nNOS I 15.7 (11-24) 3.3 (2-5) 7.7 (2-12) 0 
 II 97.3 (88-109) 44 (34-52) 138 (123-155) 2 (0-2) 
 I-II 113 (107-120) 47.3 (39-55) 145.7 (132-167) 2 (0-2) 
      
 Lamina GFP+ CR+/GFP+ NPY+ CR+/GFP+/NPY+ 
NPY I 10.3 (7-12) 2.3 (2-3) 6.7 (6-7) 0 
 II 102 (97-109) 45.3 (37-50) 72 (62-82) 3.3 (1-5) 
 I-II 112.3 (109-116) 47.7 (39-52) 78.7 (69-88) 3.3 (1-5) 
      
 Lamina GFP+ CR+/GFP+ PV+ CR+/GFP+/PV+ 
PV I 21.3 (18-25) 4.3 (4-5) 0 (0) 0 
 II 97.7 (84-106) 49 (46-52) 7.3 (6-9) 0 
 III 63.3 (56-70) 1.7 (1-2) 91 (80-97) 0 
 I-III 182.3 (173-197) 55 (53-58) 149 (143-157) 0 
  In each case, the mean values for 3 RorBeGFP mice are shown, with the range in brackets. 
 
  
108 
 
 
 
4.4 Discussion 
The main findings of this part of study are that: (1) none of the CR+/eGFP+ cells 
in either Nociceptin::eGFP or RorBeGFP mice expressed galanin or PV, while there 
was minimal overlap with NPY and nNOS; (2) around half of the CR+/eGFP+ cells 
in Nociceptin::eGFP mice are labelled with sst2A antibody; and (3) in the RorBeGFP 
mice, eGFP-immunoreactive cells that lacked CR overlapped with the other four 
inhibitory markers (galanin, nNOS, NPY and PV). Tissues from both mouse lines 
were analysed because initially only Nociceptin::eGFP mice were available. 
However, later in the study, tissues from RorBeGFP mice were received and 
subsequently it was found that it captures more of inhibitory CR cells compared 
to Nociceptin::eGFP mice. 
4.4.1 Expression of neurochemical markers for inhibitory neurons 
in CR+/eGFP+ cells in Nociceptin::eGFP and RorBeGFP  
Smith et al. (2015) reported that none of the galanin immunoreactive neurons 
exhibited CR labelling, however, some of the NPY- and nNOS-positive cells were 
CR-immunoreactive in the SDH. In their study, CR::eGFP mice were used to 
investigate the CR populations in the SDH. As mentioned before, the great 
majority (~85%) of CR cells are excitatory neurons, therefore it is difficult to 
assess the extent to which inhibitory CR cell populations overlap with other 
inhibitory neurochemical markers such as those that expressed nNOS, NPY and 
PV. One way to resolve this issue is to use Pax2 to distinguished inhibitory CR 
cells in the CR::eGFP mice. However, this could not be done since the antibodies 
for Pax2, galanin, nNOS, and NPY were derived from the same species (rabbit). 
Unfortunately, antibodies for these neuronal markers obtain from other species 
were found not to be reliable. Therefore, Smith and colleagues were unable to 
directly determine the extent of overlap between inhibitory CR (Pax2+) cells 
labelled with the other neuronal markers mentioned above. In the current study, 
the need for Pax2 antibody could be avoided by using eGFP-immunoreactivity to 
label inhibitory CR cells in the SDH of Nociceptin::eGFP and RorBeGFP mice, since 
result from previous chapter showed that ~92% of the eGFP-immunoreactive 
cells were labelled with Pax2 antibody in both mouse lines. 
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The results of this study showed that none of the CR+/eGFP+ cells in either 
mouse lines expressed galanin, consistent with the finding of Smith et al. (2015). 
They also lack of PV although there was minimal (1%) overlap with nNOS in the 
SDH of RorBeGFP mice. In both Nociceptin::eGFP and RorBeGFP mouse lines there 
was limited overlap between CR+/eGFP+ cells and NPY populations (8% and 7% of 
CR+/eGFP+ cells, respectively) in the SDH. The lack of overlap between 
CR+/eGFP+ cells with PV populations can be partially explained by their 
difference in laminar locations, since the majority of CR+/eGFP+ neurons were 
found in lamina II, while the PV-expressing cells were mostly located in laminae 
IIi-III. PV is expressed in a different population of islet cells (Hughes et al., 2012) 
and intriguingly both islet cell populations express Ca2+ binding proteins.  
Smith et al. (2015) reported that 1.6% of NPY cells in the SDH were CR-
immunoreactive. As mention before that inhibitory CR cells make up 25% of all 
inhibitory interneurons and this current study found that 7.5% of the CR+/eGFP+ 
cells were NPY-immunoreactive. This represent 1.875% of all inhibitory neurons 
in SDH. Meanwhile NPY-immunoreactive neurons account for 33% of the 
inhibitory interneurons in SDH (Boyle et al., 2017). Therefore, 5.7% (1.875% 
of/33%) of the NPY cells in the SDH were CR-immunoreactive. This prediction is 
higher than what was found by Smith et al. (2015). The likely explanation would 
be that they would have missed cells with weak NPY-immunoreactivity.  
In addition to the peptide listed above, they may also be expression of 
endogenous opioid peptide enkephalin (ENK) that have been investigated by 
Huang et al. (2010) using a mouse in which the eGFP was expressed by ENK-
positive cells. They reported that ~43% of CR-positive cells were eGFP-
immunoreactive and ~48% of eGFP-positive neurons also contained CR-
immunoreactivity. However, they did not specifically look at the inhibitory CR 
cells. Thus, it is possible that the entire eGFP+/CR+ cells in their study falls 
within excitatory CR cells population.  
The present findings suggested that CR+/eGFP+ (inhibitory CR) neurons represent 
another neurochemically distinct group of inhibitory interneurons in the dorsal 
horn. In addition, more than 80% of CR+/eGFP+ neurons were found in lamina II 
and this was consistent in both animals.  
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4.4.2 Expression of the sst2A receptor in CR+/eGFP+ neurons in 
Nociceptin::eGFP mice 
To further examine CR+/eGFP+ cells in the SDH, sst2A immunostaining was applied 
on sections from Nociceptin::eGFP mice. Previously, several studies have used 
sst2A as a marker to define inhibitory interneurons and it was found that virtually 
all sst2A-positive cells were GABA-immunoreactive (Todd et al., 1998, Polgár et 
al., 2013a, Polgár et al., 2013b, Smith et al., 2015, Cameron et al., 2015). 
Studies that were carried out in both rat and mouse reported that around half of 
the inhibitory interneurons in laminae I and II expressed sst2A (Polgár et al., 
2013b, Polgár et al., 2013a).  
Five (sst1-5) somatostatin receptors have been identified (Hoyer et al., 1995, 
Reisine and Bell, 1995) but according to the Allen Brain atlas, it appears that sst2 
is the only receptor that is expressed by neurons in SDH of mouse since only sst2 
mRNA is found there. Somatostatin receptor sst2 have 2 different forms, sst2A 
and sst2B made by carboxy-terminal splicing (Schulz et al., 1998a). As mention 
before, cells that expresses sst2A is distributed mainly in laminae I-II, meanwhile 
sst2B immunoreactivity is observed throughout the spinal gray matter but more 
prominent in the ventral horn. Frequently, immunostaining of sst2A can be seen 
in the cell membrane of a small cell bodies and their dendrites, contrary sst2B is 
seen in cell bodies of bigger neurons and their proximal dendrites (Schulz et al., 
1998a). 
In this current study, 48% of the CR+/eGFP+ cells were labelled with sst2A 
receptor in lamina II. This finding was similar to that of Smith et al. (2015) who 
estimated around half (53%) of inhibitory CR cells in lamina II expressed sst2A 
receptor. Among the four distinct inhibitory neurochemical populations mention 
above, almost all galanin and nNOS expressing cells in the mouse and rat were 
labelled with sst2A (Polgár et al., 2013b, Iwagaki et al., 2013), and galanin and 
nNOS accounted for 44% and 30% of the sst2A cells, respectively (Iwagaki et al., 
2013). However, none of the PV-immunoreactive cells were labelled with sst2A. 
For NPY-immunoreactive cells, slightly different proportion were found in 
different species. Only 16% of the cells that were positive for NPY in the rat 
were labelled with sst2A (Polgár et al., 2013b) and in the mouse, 24% of NPY-
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containing neurons were labelled with sst2A, slightly higher percentage than 
those cells that were found in the rat (Iwagaki et al., 2013).  
Sst2A expressing cells are found mainly in laminae I and II, where they generally 
matched the distribution of the peptide somatostatin, which is present in both 
primary afferents and glutamatergic interneurons in lamina I and II (Hunt et al., 
1981, Hökfelt et al., 1975). Somatostatin released from these neurons causes 
hyperpolarisation of those inhibitory interneurons that express sst2A receptors 
and thus, reduces their excitability leading to disinhibition by reduction in GABA 
release (Yasaka et al., 2010). A study by Iwagaki et al. (2013) reported that 
application of CYN 154806 (a specific sst2 receptor antagonist) or tertiapin Q (a 
blocker of G-protein-coupled inwardly rectifying K+ channels (GIRK)), prevented 
somatostatin from causing membrane hyperpolarisation. These results indicate 
that somatostatin acts through sst2A receptors and by the activation of GIRK 
channels (Kim et al., 2002). Recently, a study that combined chemogenetics, 
pharmacology and cell-specific knockout of somatostatin provided evidences 
that somatostatin contributes to itch by a disinhibitory mechanism at the spinal 
cord level (Huang et al., 2018). Huang and colleagues reported that mice that 
lack somatostatin in both primary afferents and dorsal horn interneurons show 
significantly less itch behaviour in response to several pruritogens. The 
propruritic effect of somatostatin was thought to involve inhibition of inhibitory 
dynorphin cells. Interestingly, loss of somatostatin primary afferents resulted in 
an increased response to noxious heat stimuli and this suggested that 
somatostatin released from these primary afferents suppressed nociceptive 
responses. 
Nothing is known about the role of sst2A receptor expressed by the inhibitory CR 
cells. However, inhibitory CR cells in the SDH are thought to be involved in 
presynaptic inhibition of CMrgD afferents (see next chapter for details). It is 
possible that binding of somatostatin to sst2A receptor on this cells, resulting in 
disinhibition of CR cells may increase response to mechanical pain. However, 
contrary to this prediction, Huang et al. (2018) found that deletion of 
somatostatin from spinal cord interneurons in fact resulting in increased 
sensitivity to mechanical stimuli. At present it is very difficult to explain these 
findings. It is likely that this reflex the action on primary afferent fibres, some 
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of which also express sst2A receptor (Schulz et al., 1998b). Furthermore, half of 
the CR+/eGFP+ cells were immunoreactive for sst2A, but, so far there is no 
evidence to show that they are two different populations of CR+/eGFP+ cells. 
4.4.3 Association of other inhibitory neurochemical markers with 
CR-/eGFP+ cells in RorBeGFP mice 
The present results showed that eGFP-cells that lack CR belong to other 
neurochemical populations such as those that expressed galanin, nNOS, NPY and 
PV. As many as 59% of the CR-negative eGFP-positive cells were labelled with 
galanin, followed by NPY (22%) and nNOS (17%). Despite numerous eGFP-
immunoreactive cells being found in SDH, only 1% of these cells were labelled 
with PV. However, in lamina III, 9% of the CR-negative eGFP-positive neurons 
were PV-immunoreactive. Based on these numbers, the 4 neurochemical markers 
mentioned above accounted for ~99% of the CR-/eGFP+ cells in SDH of RorBeGFP 
mice.  
Despite the fact that eGFP cells in the RorBeGFP mice were highly concentrated in 
the superficial laminae and their processes form a distinct band in the middle of 
lamina II, nonetheless, only half of the cells belonged inhibitory CR cells 
population and the remaining were distributed between galanin, nNOS and NPY. 
The functions of RorB are not widely discussed since not many studies have been 
done to investigate the role of these gene in the spinal cord dorsal horn. A study 
by Wildner et al. (2013) reported that RorB is one of transcription factor gene 
that were seen mainly expressed in the superficial part of the dorsal horn of 
mouse. Nothing is known about the role of RorB in the cells that were 
immunoreactive for galanin, nNOS, NPY, PV and CR.  
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5 Synaptic connections between tdTomato+ cells 
in RorBCreERT2; Ai9 and RorBCreERT2; Ai34 mice 
and non-peptidergic C-fibres   
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5.1 Introduction  
Inhibitory interneurons in the dorsal horn are activated by primary afferent 
fibres and descending tracts originating from the brain (Zeilhofer et al., 2012). A 
few early electron microscopic studies found that primary afferents which were 
identified by being central axons of synaptic glomeruli formed synapses onto 
dendrites of inhibitory interneurons revealed with immunostaining for GABA or 
glycine (Carlton and Hayes, 1990, Todd, 1990). Various studies using patch-
clamp recordings from spinal cord slices also showed synaptic input from 
different types of primary afferents onto inhibitory interneurons (Lu and Perl, 
2003, Heinke et al., 2004, Ganley et al., 2015, Iwagaki et al., 2016).  
Meanwhile, ultrastructural studies on unmyelinated and myelinated primary 
afferents showed that many axonal boutons belonged to these primary afferents 
in the dorsal horn were postsynaptic to axon terminals or vesicle containing 
dendrites (Maxwell et al., 1982, Maxwell and Bannatyne, 1983, Maxwell et al., 
1984). Although most synapses form by GABAergic axons are axodendritic or 
axosomatic, it is known that some of them form synapses onto other axons 
identified as axoaxonic synapses and this are thought to underlie presynaptic 
inhibition (Eccles et al., 1961, Gray, 1962, Eccles et al., 1962a, Eccles et al., 
1962b). Historically, McLaughlin et al. (1975) showed that GAD-immunoreactive 
axons terminal were presynaptic to unknown axonal boutons. Later, it was found 
that following dorsal root rhizotomy, the unknown axonal boutons were 
belonged to primary afferents (Barber et al., 1978). Some of the axoaxonic 
synapses are found to make synaptic contacts with dendrites from other neurons 
that are postsynaptic to primary afferent boutons (Maxwell et al., 1982, 
Bannatyne et al., 1984). This arrangement is known as synaptic triad which allow 
the presynaptic axon terminal to mediate both presynaptic and postsynaptic 
inhibition of primary afferents and second order sensory neurons (Barber et al., 
1978). In the ventral horn, Hughes et al. (2005) found type Ia muscle afferents 
received axoaxonic synapse that originated from a specific population of 
GABAergic neurons. Thus, it is possible that presynaptic inhibitory inputs to 
primary afferents in the dorsal horn originate from a specific types of GABAergic 
interneurons (Todd, 2010).  
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Preliminary work carried out by Dr David I Hughes identified a source of cells 
that give rise to axoaxonic synapses in type I glomeruli, and therefore 
presynaptically inhibit the central axons of CMrgD afferents which are thought to 
be mechanical nociceptors. Electron microscopy study on Neurobiotin filled CR 
islet cells patched in a CR::eGFP mouse showed that three axonal boutons of one 
of the cell were presynaptic to central axon of type I glomeruli. Meanwhile, 
their dendrites received synapses from central boutons of these glomeruli. In 
chapter 3, it has been showed that tdTomato+/eGFP+ cells in Nociceptin::eGFP; 
CRCre; Ai9 mouse corresponds to CR islet cells. The dendritic trees of these islet 
cells are restricted to the IB4 plexus suggesting that they receive synaptic input 
from CMrgD afferents and are important source of presynaptic inhibition on these 
primary afferents. This mouse cross was useful for the study of CR islet cells but 
unfortunately it has some limitation. As mentioned previously, the 
Nociceptin::eGFP; CRCre; Ai9 mouse labelled most of the inhibitory cells in the 
SDH, thus making it very difficult to identify and patch these cells during 
electrophysiology experiments. Another mouse line that was used in previous 
chapter 3 and 4 was Nociceptin::eGFP mouse. It is a BAC transgenic mouse line, 
which could only be used to look at the distribution of cells and determine co-
expression of neurochemical markers within the cells in the spinal cord. 
However, Nociceptin::eGFP mouse did not allow manipulation on the function of 
the cells.  
In this part of the study, inducible RorBCreERT2 mouse line will be used as a tool to 
identify CR islet cells in order to study the neurons that form axoaxonic synapses 
with CMrgD afferents. This mouse line has two advantages over the previous 
alternatives. Firstly, the RorBCreERT2; Ai9 cross labelled a much more restricted 
population, which allows the electrophysiologist to patch the cells without 
having difficulty in finding the cells of interest and also allows many anatomical 
studies to be perform because cells are well labelled. Secondly, because this is a 
Cre-recombinase mouse line, it allows manipulation of the function of desired 
population of cells. One of the long term goal of the study would be to alter the 
function of these cells. For example, if inhibitory CR cells are activated or 
inactivated, it is predicted that this will result in decrease or increase in 
mechanical pain, respectively. Although this is not yet being accomplished, this 
remained a major goal. To achieve this goal, effectively a Cre-recombinase 
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provides a method for manipulation of the cells function in many different ways 
such as the use of toxins, optogenetics or chemogenetics as well as allowing 
anatomical visualisation of the cells (Roth, 2016, Bang et al., 2016, Huang et al., 
2018).    
The objectives of this part of the study are: 1) to validate the RorBCreERT2 mouse 
line as a useful tool to investigate further inhibitory CR cells in lamina II; and 2) 
to explore the excitatory input onto tdTomato cells from non-peptidergic C-
nociceptors that were identified with either IB4 or PAP and also to determine 
whether their axons form axoaxonic synapses onto these primary afferents. To 
achieve the first objective of this study, the RorBCreERT2 mouse was crossed with 
a reporter mouse Ai9 (CAG-floxed tdTomato). In the early part of the study, 
tissues from this mouse line were reacted with Pax2 and CR antibodies to 
determine the percentage of inhibitory CR cells that were labelled with 
tdTomato. The second objective was carried out by using RorBCreERT2; Ai9 and 
RorBCreERT2; Ai34 mouse lines.  Both of these mouse lines require treatment with 
tamoxifen because the activity of Cre-recombinase depends on administration of 
this drug due to the binding of oestrogen receptor fusion protein on Cre-
recombinase. 
5.2 Materials and methods  
5.2.1 Tamoxifen optimization in RorBCreERT2; Ai9 
In this part of the study, RorBCreERT2 were crossed with two different reporter 
lines, Ai9 and Ai34. In these mice, either tdTomato (Ai9) or tdTomato-
synaptophysin fusion protein (Ai34) with the CAG promoter is inserted into the 
Gt(ROSA)26Sor locus downstream of a loxP-flanked STOP cassette. Once this 
STOP cassette is removed by Cre-mediated excision (in RorB expressing cells) 
these cells will express either tdTomato or tdTomato-synaptophysin fusion 
protein. The tdTomato will fill the entire neuronal processes, while the 
tdTomato-synaptophysin fusion protein will be targeted to the axons of RorB 
cells. The activity of Cre-ERT2 depends on the administration of tamoxifen, 
which leads to the entering of this Cre-ERT2 into the nucleus of the cells and 
allowing Cre-ERT2 to control gene activity in RorBCreERT2 mice. Both RorBCreERT2; 
Ai9 and RorBCreERT2; Ai34 mouse lines that were used in this part of the study 
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therefore require treatment with tamoxifen in order to allow expression of 
tdTomato.  
A series of experiments were carried out to develop an effective dosage strategy 
for tamoxifen by giving the drug at difference postnatal ages. In one set of 
experiments, the animals were treated with either a single dose of 1 mg or 2 mg 
tamoxifen in 50 µl corn oil at P16-P18 while in another set the same doses were 
given at P31-P36. In most cases administration of tamoxifen was given through 
intraperitoneal (IP) injection. However, in four cases, tamoxifen was delivered 
through gavage at P18. This was performed to determine which is the best 
method (IP or gavage) to achieve the maximum tdTomato expression in the 
spinal cord of RorBCreERT2; Ai9 mice.  
5.2.2 Animals and tissue processing for confocal microscopy 
All of the RorBCreERT2; Ai9 mice that received difference doses of tamoxifen were 
subsequently deeply anesthetised and perfused with freshly made 4% de-
polymerised formaldehyde as mention previously. Lumbar spinal cord segments 
were dissected and post-fixed for 2 hours. Then, lumbar spinal cords were cut 
into 60 µm thick transverse or parasagittal sections. Then sections were 
immersed in 50% ethanol for 30 minutes to enhance antibody penetration 
(Llewellyn-Smith and Minson, 1992). Initially, a few sections were mounted on 
glass slides and were viewed under the fluorescence microscope to assess the 
distribution and the number of tdTomato cells present per section. During the 
course of the study, it became apparent that animals treated with tamoxifen at 
P16-P18 had a far greater number of tdTomato cells from those which received 
tamoxifen at later stages (see below for details). Sections from some of these 
mice were then processed for immunocytochemistry, as described below. In all 
cases, sections were incubated in primary antibodies at 4oC for 5 days and 
overnight in secondary antibodies. Antibodies were diluted in PBS that contained 
0.3% Triton-X100 and 5% normal donkey serum.  
In addition, 2 RorBCreERT2; Ai34 spinal cords were obtained from Professor David 
Ginty from Harvard University. These mice received a single injection of 2 mg 
tamoxifen at P11 and were perfused in a similar way. Sections were then 
processed for multiple immunolabelling as described below.  
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5.2.2.1 Proportion of tdTomato cells that are CR- and Pax2-immunoreactive   
in the RorBCreERT2; Ai9 mouse 
To determine the relationship between inhibitory CR (Pax2+) cells and tdTomato+ 
cells in lamina II, transverse sections from 3 young adults RorBCreERT2; Ai9 mice of 
either sex (17-19 g) that had received tamoxifen at P18 were incubated in rabbit 
anti-Pax2 and mouse anti-CR antibodies to label inhibitory CR cells. These 
primary antibodies were revealed with Pacific Blue and Alexa 488, respectively. 
The tdTomato+ expression was visible without the use of antibody, due to the 
presence of bright native red fluorescence. Sections were mounted as described 
above and were viewed with a confocal microscope. Four transverse sections 
from each mouse were randomly selected as mentioned before. Sections were 
scanned through their full thickness with the 40x oil immersion lens and 1 μm z-
separation, with the aperture set to 1 Airy unit. Tile scans were used to capture 
the whole width of the superficial laminae of the dorsal horn. Confocal scans 
were analysed offline using Neurolucida for Confocal Software. The outline of 
the dorsal horn and the boundaries between laminae I-II were drawn. The lamina 
I/II boundary was drawn 20 µm below the dorsal white matter and the ventral 
extent of the CR-immunoreactive cells was used to determine lamina II/III 
border. Neurons present in the whole depth of the sections were analysed. All 
cell bodies of tdTomato-positive neurons found in laminae I-II were plotted onto 
the Neurolucida drawing. Then, the CR channel was viewed to determine the 
proportion of tdTomato-positive cells that were immunoreactive for CR. 
Following that, the channel corresponding to Pax2 was documented for each of 
the selected CR+/tdTomato+ neurons. In addition, to determine the proportion of 
the inhibitory CR (Pax2) neurons that were immunoreactive for tdTomato, cells 
that were immunoreactive for both CR and Pax2 were also counted before the 
channel representing tdTomato was viewed.  
5.2.2.2 Contacts between IB4-binding primary afferents and tdTomato-axonal 
boutons in RorBCreERT2; Ai34 mice 
In order to assess the extent to which axons of the RorB cells give rise to 
axoaxonic on non-peptidergic C-nociceptors, transverse sections from 2 
RorBCreERT2; Ai34 mice were incubated overnight in unconjugated IB4 (1:1000) at 
4oC followed by incubation with goat antibody to identify IB4 and rabbit anti-
VGAT to label inhibitory axonal boutons. These primary antibodies were revealed 
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with Pacific Blue and Alexa 488, respectively. The tdTomato was visible without 
the use of antibody due to the high level of native fluorescence. The binding of 
IB4 was used to reveal non-peptidergic C-nociceptors (Wang et al., 1994, 
Sakamoto et al., 1999). In the RorBCreERT2; Ai34 mice the expression of 
synaptophysin-tdTomato fusion protein resulted in axonal targeting of the 
tdTomato in RorB cells.  
Sections were mounted as described above and were viewed with a confocal 
microscope. Two sections from each mouse were randomly selected as 
mentioned previously. Sections were scanned with 63x oil immersion lens to 
produce z-series of 69 optical sections, with a z-separation of 0.3 μm and the 
aperture set to 1 Airy unit. Tile scans were used to capture the IB4-axonal band 
that was found in the middle of lamina II across the whole mediolateral width of 
the dorsal horn on 1 side. It is already known that IB4-labelled primary afferents 
terminate mainly in the central part of lamina II (Lorenzo et al., 2008). These 
image stacks were analysed offline using Neurolucida for confocal software. 
Eighty IB4-labelled afferent terminals were randomly selected from each section 
and plotted before the channel corresponding to tdTomato and VGAT were 
viewed. The presence or absence of tdTomato- and VGAT-positive profiles in 
contact with the IB4 boutons was noted.  
5.2.2.3 Contacts between non-peptidergic primary afferents and tdTomato-
positive axons and dendrites in RorBCreERT2; Ai9 mice 
To determine the proportion of tdTomato-axonal boutons that are in contact 
with non-peptidergic C-nociceptors and also the proportion of the excitatory 
synapses on the tdTomato cells that originated from these C-nociceptors, 
parasagittal sections from 3 RorBCreERT2; Ai9 young adult mice of either sex (17-21 
g) that had received tamoxifen at P35 were used for this part of the study. This 
was reacted to reveal IB4, prostatic acid phosphatase (PAP), mCherry, and 
Homer. This was achieved by incubating the sections at 4oC in rabbit anti-
mCherry to reveal tdTomato cells, goat anti-Homer to label glutamatergic 
synapses (Gutierrez-Mecinas et al., 2016b), biotinylated IB4 (IB4; 1 μg ml-1. 
Sigma-Aldrich, Gillingham, UK) and chicken anti-PAP. Both IB4 and the anti-PAP 
were used to identify non-peptidergic C-nociceptors (Zylka et al., 2008, Taylor-
Blake and Zylka, 2010). Primary antibodies were revealed with Rhodamine Red, 
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Alexa 647, avidin-Pacific Blue and Alexa 488, respectively. Then, sections were 
mounted as described above. Although both IB4 and PAP antibody label non-
peptidergic C-nociceptors, staining with the IB4 lectin was found to be variable 
in quality. The PAP antibody was therefore used to test whether it could provide 
an alternative to IB4 immunostaining. Two to three sections from each mouse 
were randomly selected and scanned with 63x oil immersion lens. Three 
tdTomato cells were selected from each animals and were scanned to produce z-
series of 40 optical sections (z-step of 0.3-μm and the aperture set to 1 Airy 
unit) to include large part of the dendritic and axonal arbors. In cases where two 
cells were scanned in the same section, this was sufficiently far apart, so that 
individual dendritic trees and axons of these cells could be analysed. The image 
stacks were analysed offline using Neurolucida for Confocal software. To define 
the proportion of excitatory synapses on the tdTomato cells derived from IB4- or 
PAP-labelled central terminals, 80 dendritic spines of tdTomato cells were 
selected from the image stacks and labelled while only the tdTomato channel 
visible. The channels representing Homer, IB4 and PAP were then viewed and 
the presence or absence of immunostaining was recorded for each of the 
selected dendritic spines. During the selection of dendritic spines, the channel 
representing Homer was not viewed to avoid selection bias, since the presence 
of Homer will outline central terminal of primary afferents, which often form 
glomeruli. Only dendritic spines with the presence of Homer were counted in the 
analysis.  
In order to determine the extent to which tdTomato-axonal boutons provide 
input onto IB4- or PAP-labelled primary afferents, 60 axonal boutons belonging 
to each tdTomato cells were identified. The channel revealing mCherry was first 
viewed, and boutons were plotted. The presence or absence of IB4 and/or PAP 
boutons in contact with the identified mCherry boutons was noted. 
5.2.3 Animals and tissue processing for electron microscopy 
Two male RorBCreERT2; Ai9 adult mice (24-26 g) and 2 RorBCreERT2; Ai34 adult mice 
of either sex (21-23 g), were deeply anesthetised with pentobarbitone and 
perfused through the left cardiac ventricle with fixative that contained 0.2% or 
0.5% glutaraldehyde and 4% freshly de-polymerised formaldehyde in PB. Lumbar 
spinal cord segments were dissected out from all animals and post-fixed for 2 
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hours with the same solution at 4oC before being transferred to PB. The lumbar 
segments were cut into 60 µm thick transverse sections using a vibrating blade 
microtome followed by immersion in 50% ethanol for 30 minutes to enhance 
antibody penetration (Llewellyn-Smith and Minson, 1992). They were also 
treated with 1% sodium borohydride for 30 minutes to reduce the damaging 
effects of glutaraldehyde on antigenicity (Kosaka et al., 1986). Then, the 
sections were rinsed extensively and incubated in mCherry anti-rabbit antibody 
(diluted 1:10,000 or 1:20,000 in PBS) for 72 hours, and in biotinylated donkey 
anti-rabbit antibody (Jackson Immunoresearch, 1:500; 24 hours) followed by 
avidin conjugated to horseradish peroxidase (Sigma, 1:1000; 24 hours). The PBS 
used for diluting these reagents did not contain Triton because it disrupts the 
membrane structure. The sections then were reacted with 3,3’-
diaminobenzidine (DAB) in the presence of hydrogen peroxide (Hughes et al., 
2012) to reveal the HRP-labelled mCherry-immunoreactive profiles. The sections 
were then osmicated in 1% osmium tetroxide (OsO4) for 20 minutes, stained with 
uranyl acetate (in 70% acetone), dehydrated in acetone, flat embedded in 
Durcupan resin between acetate foils and cured for 48 hours at 70oC. A single 
section from each animal reacted with each antibody concentration was 
selected, mounted on a stub of cured resin, and trimmed to an area that 
included laminae I-III of the dorsal horn. Ultrathin sections (silver interference 
colour, ~70 nm thickness) were cut with a diamond knife, collected on Formvar-
coated single slot girds and stained with lead citrate. Sections were viewed with 
a Philips CM100 transmission electron microscope (EM) equipped with digital 
camera. To investigate the relationship between tdTomato-axonal boutons and 
type I glomeruli in lamina II in RorBCreERT2; Ai9 and RorBCreERT2; Ai34, regions that 
contained numerous DAB profiles and type I glomeruli were examined with EM at 
high magnification. The protocol for tissue processing for EM study is shown in 
Figure 5-1. 
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Lumbar cords in 4% PF with 0.5% 
glutaraldehyde
Rinse in PBS 10 min x 3
Lumbar cords were cut into 60 µm 
thick sections
50% ethanol for 30 mins
Rinse in PBS 10 min x 3
1% Sodium borohydride for 30 min 
(1g in 100ml of PB)
Rinse in PBS 10 min x 9 Incubation in primary antibody (72h)
Rinse in PBS 10 min x 3
Incubation in biotinylated secondary 
antibody O/N
Rinse in PBS 10 min x 3
AV-HRP 1:1000 O/N
Rinse in PBS 10 min x 3
DAB reaction for 6 mins Osmicate section in 1% osmium tetroxide for 20 min
Rinse in distilled water x 3
Uranyl acetate in 70% acetone for 
30 mins
90% acetone for 10 mins
100% acetone for  10 mins x 3
100% acetone and Durcupan (50/50) 
(3h)
Durcupan O/N Embedding the sections and incubate for 48h
Selection of section and resin stub 
on section
Place stub in oven O/N
Trim block and section on 
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Figure 5-1 Tissue processing for Electron microscopy 
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5.3 Results 
5.3.1 Effects on tamoxifen dosage on tdTomato expression in 
RorBCreERT2; Ai9 mice  
A few transverse sections from lumbar segment of RorBCreERT2; Ai9 mice that have 
been treated with tamoxifen at difference ages were examined with the 
fluorescence microscope and the cells in the SDH on each side throughout the 
depth of the sections were counted. In all cases, there were tdTomato cells in 
the dorsal horn and the plexus of processes in the middle part of lamina II with 
the distribution similar to that seen in RorBeGFP mice with fewer cells seen in 
RorBCreERT2; Ai9 mice. However, the number of tdTomato cells and the 
completeness of the plexus were very variable between animals. In early 
experiments, RorBCreERT2; Ai9 mice received a single dose of 2 mg IP tamoxifen 
between P34-36. Surprisingly, it was found that this resulted in very few 
tdTomato cells. Following this finding, a single dose of 1 mg or 2 mg tamoxifen 
was administered earlier, between P16-P18, and in most cases there were much 
higher efficiency of recombination and therefore, more tdTomato cells were 
labelled. Interestingly, in a few cases, relatively few tdTomato cells were visible 
despite early administration of tamoxifen. In four cases in which 2 mg tamoxifen 
was administered by gavage at P18, sparse labelling tdTomato cells were 
identified. This finding showed that IP injection of tamoxifen was a better 
method to administer this drug in RorBCreERT2; Ai9 mice. The animals were 
classified as having sparse labelling tdTomato cells if fewer than 5 cells were 
presence on one side of the superficial laminae in a per 60 µm section. 
Although this was inconvenient for several of the studies to investigate these 
cells, it has the advantage that it provided a single cell labelling. This was used 
to investigate contacts between individual tdTomato cells and non-peptidergic 
primary afferents. In addition, the morphology of single tdTomato cells could be 
studied without the presence of dendrites or axons from other cells.  
5.3.2 Inhibitory CR cells in RorBCreERT2; Ai9 mice 
In this part of the study, tissues from animals with the high numbers of 
tdTomato cells labelling were used. Transverse sections from RorBCreERT2; Ai9 
mice were examined after immunostaining for CR and Pax2 were readily 
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identified in these sections. The tdTomato was reasonably bright, thus for the 
purpose of cells counting, immunostaining with mCherry antibody to reveal 
tdTomato cells were not applied. The distribution of cell bodies and dendrites 
that were CR-immunoreactive was similar to previous findings reported in 
chapter 3 and 4. The general distribution of tdTomato cells in the dorsal horn 
was similar to RorBeGFP mice but there were fewer cells labelled in RorBCreERT2; 
Ai9 mice (Figure 5-2 a). The somata of tdTomato cells were highly concentrated 
in lamina II mainly in the band that was presence in the middle of this lamina. 
This band was mainly formed by the dendrites of lamina II tdTomato cells. In 
sections that have been reacted with IB4, there was perfect overlap between 
this plexus of tdTomato dendrites with the IB4-labelled non-peptidergic C-
nociceptors. The similar band of dendrites were also observed in RorBeGFP mice. 
In addition, tdTomato cells were seldom seen in lamina I and scattered cells 
with sparser axonal plexus seen in lamina III and in the deeper laminae. There 
was a clear gap between the dendritic band in lamina II and tdTomato cells and 
processes found in deeper laminae, which was not seen in RorBeGFP mice. This 
strongly suggest that the plexus of dendrites and axons in this band in lamina II is 
derived from tdTomato cells in the superficial laminae and not from cells in 
deeper laminae (Figure 5-2). This is because very rarely profiles were seen 
passing from ventral part into the band in lamina II.  
Analysis on confocal sections on optimal labelling animals revealed that the 
great majority of tdTomato cells in laminae I-II were also immunoreactive for CR 
and Pax2. However, none of the tdTomato cells in the deeper laminae were CR-
immunoreactive. Most of the cells in lamina III were Pax2-positive with higher 
number of excitatory tdTomato cells (Pax2 negative) seen in the deeper 
laminae. Generally, fewer cells were found in RorBCreERT2; Ai9 mice compare to 
RorBeGFP mice. A total of 189 (range 39-82, n = 3 mice) tdTomato cells were 
identified in lamina II and 95% (range 92.3%-97.1%) of these cells were Pax2-
immunoreactive. Of this, 95% (range 92.4%-100%) of inhibitory tdTomato cells 
were immunoreactive for CR. In addition, 717 (range 221-263) inhibitory CR cells 
(Pax2+) were counted and of these only 24% (range 15.5%-28.1%) of inhibitory CR 
cells were tdTomato positive. 
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Figure 5-2 tdTomato, CR and Pax2 immunostaining from the dorsal horn of RorBCreERT2; Ai9 
that have the high numbers of tdTomato cells labelling. a tdTomato dendritic band is seen in 
the middle of lamina II. A clear gap is observed between band in lamina II and tdTomato cells and 
processes found in deeper laminae. b,c CR- and Pax2-immunostaining are similar to the findings 
from the above study. d merged image. The dashed lines represent the borders between laminae I-
III. Scale bar = 200 µm.  
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5.3.3 Contacts between IB4-labelled primary afferents and RorB 
axonal boutons in RorBCreERT2; Ai34 mice 
Four transverse sections (2 from each mouse) of RorBCreERT2; Ai34 mice were 
analysed after immunostaining for IB4, VGAT and mCherry were readily 
identified in these sections. As mentioned before, tdTomato axonal boutons 
were very small. In order to reveal the axons of tdTomato expressing cells, the 
native fluorescence was amplified by using an antibody (mCherry) which 
recognized tdTomato. The distribution of the IB4-labelled plexus was identical to 
that described in previous studies (Zylka et al., 2005, Gutierrez-Mecinas et al., 
2016b). A dense band of axons that were labelled with IB4 was seen in the 
middle of lamina II and occasionally profiles were seen superficial or deep to 
this. Meanwhile, mCherry antibody labelled axon terminals and intervaricose 
portion of tdTomato-expressing cells. The tdTomato-positive axonal boutons 
were found mostly in the middle of lamina II where they formed a dense band. 
This band was seen to overlapped perfectly the IB4 plexus, which corresponds 
largely to CMrgD afferents (Zylka et al., 2003, Zylka et al., 2005). Meanwhile, a 
more diffused tdTomato axonal plexus was seen in laminae III-V, and this 
presumably originated from the deeper tdTomato cells. The axonal boutons of 
tdTomato cells in lamina II were very small and they were weakly 
immunoreactive for VGAT. In the 2 RorBCreERT2; Ai34 mice, a total of 320 (160 per 
mouse) IB4 terminals were identified. Of this, 80% (range 80%-81%) were in 
contact with axonal boutons of tdTomato cells (Figure 5-3).  
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Figure 5-3 IB4-labelled central terminals contacting tdTomato axonal boutons. a About 80% 
of IB4-labelled boutons found in lamina II forming contacts b with tdTomato axonal boutons 
(arrow). The mCherry antibody used to immunostained RorB cells also labelled axon terminals and 
intervaricose portion of tdTomato-expressing cells. The tdTomato-positive axonal boutons were 
found mostly in the middle of lamina II where they formed a dense band. This band was seen to 
overlapped perfectly the IB4 plexus. c merged image. Scale bar = 2 µm.  
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5.3.4 Contacts between non-peptidergic C-nociceptors and 
tdTomato cells in RorBCreERT2; Ai9 mice 
In this part of the study, tissues from animals with sparsely labelled tdTomato 
cells were used. Parasagittal sections from RorBCreERT2; Ai9 mice were examined 
after immunostaining for IB4, PAP, Homer and mCherry were readily identified in 
these sections. MCherry antibody was used to amplified the native fluorescence 
in order to reveal tdTomato dendritic spines and axonal boutons. In sparsely 
labelled RorBCreERT2; Ai9 mice, individual tdTomato cells were seen mainly in 
lamina II, and scattered throughout deeper lamina. Individual tdTomato cell was 
seen in lamina II as well as in deeper laminae. In some cases, these cells were 
close together but more often they were sufficiently far apart that there was no 
overlap of the dendritic trees and axonal arbors. The dendritic trees of 
tdTomato cells extended rostracaudally within IB4/PAP band. The axons of these 
cells extended further than the dendritic trees within lamina II. The 
immunostaining for PAP and the distribution of the IB4-labelled plexus was 
identical to that seen in previous studies (Zylka et al., 2008, Taylor-Blake and 
Zylka, 2010, Shehab and Hughes, 2011). The plexus of PAP-labelled axonal 
terminals that were seen in lamina II perfectly matched the distribution of IB4 
plexus. In most cases, PAP-immunoreactivity and IB4-binding were co-localized 
in the axon terminals. However, in some boutons that were labelled with only 
IB4 or PAP were seen to have multiple Homer puncta surrounding the 
varicosities, and this most probably correspond to type I synaptic glomeruli 
(Figure 5-3 and Figure 5-4). In this part of the study, only isolated lamina II 
tdTomato cells that did not overlap with other labelled neuron were selected for 
further analysis.   
A total of 720 tdTomato dendritic spines were counted from 9 cells (3 cells from 
each animal). Among this, 595 (range 53-76) dendritic spines contained Homer 
and were analysed further. Around 63% (range 47.2%-76.5%) of the Homer puncta 
within these tdTomato-positive dendritic spines were in contact with boutons 
that were labelled with IB4 and/or PAP (Figure 5-4). This suggest that the 
majority of excitatory synapses onto dendritic spines of tdTomato cells are 
derived from non-peptidergic primary afferent nociceptors. During the course of 
this analysis, Homer puncta were also seen within the dendritic shaft of the 
tdTomato cells and these were in contact with IB4- and/PAP-positive boutons. 
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However, this was not analysed because in some cases it was difficult to be 
certain whether particular punctum was definitely located within dendritic shaft 
of the labelled cells. Of this, 47% (range 20.3%-69.1%) of the presumed primary 
afferent boutons were positive for both IB4 and PAP. Meanwhile 6% (range 1.5%-
19.2%) and 10% (range 0%-39%) of the presumed primary afferent boutons were 
positive for IB4 or PAP, respectively.  
To determine the proportion of tdTomato boutons that contacted IB4-/PAP-
labelled primary afferent terminal, a total of 540 tdTomato axonal boutons were 
identified from 9 cells of RorBCreERT2; Ai9 mice. Around 44% (range 40%-55%) of 
the tdTomato axonal boutons were in contact with primary afferents terminal 
that were positive for both IB4 and/or PAP (Figure 5-4). Within this population, 
25% (range 18.3%-31.7%) of the primary afferent terminals were positive for both 
IB4 and PAP. Meanwhile 11.3% (range 6.7%-18.3%) and 7.6% (range 3.3%-16.7%) of 
the terminal axonal boutons were positive only for IB4 or PAP antibody, 
respectively.    
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Figure 5-4 IB4 labelled primary afferents synaptic inputs to RorB cells. a showing dendritic 
spines of RorB cells, b that contains Homer puncta (arrow) c received excitatory synapse from IB4 
labelled axonal boutons (asterisks). d a merge imaged. Scale bar = 2 µm.  
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Figure 5-5 Axoaxonic contacts formed by RorB cells. a showing Homer, a postsynaptic marker, 
b surrounded the IB4 labelled central terminal, probably correspond to type I glomeruli and c 
received contact from RorB axons and presumbably form axoaxonic synapse (asterisk). b a merge 
imaged. Scale bars = 2 µm.  
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5.3.4 Electron microscopy findings 
This EM was carried out on tissues from RorBCreERT2; Ai9 and RorBCreERT2; Ai34 mice 
to look for evidence of synapses between RorB axonal boutons and central axons 
of type I synaptic glomeruli, which originate from non-peptidergic C-fibres 
(Gerke and Plenderleith, 2004, Bailey and Ribeiro-da-Silva, 2006). Type I 
glomeruli were identified as structures containing a dark central axonal boutons 
with variable sized vesicles and few mitochondria, which formed synapses with 
peripheral profiles. This profiles resemble those described in several previous 
studies (Todd, 1996, Ribeiro-Da-Silva and Coimbra, 1982, Bailey and Ribeiro-da-
Silva, 2006). Meanwhile, tdTomato-labelled axonal boutons could be recognised 
due to the presence of the DAB reaction product that resulted from 
immunostaining with mCherry antibody.  
Initially this study involved tissues from the RorBCreERT2; Ai34 mice which were 
chosen because the immunostaining for tdTomato was largely restricted to 
axonal boutons (due to the present of synaptophysin fusion protein). In this 
tissue many DAB-labelled axonal boutons were seen intermingled among type I 
glomeruli and they were often in contact with them. However, it was difficult to 
describe the type of synaptic contact between the DAB profiles and type I 
glomeruli due to the intensity of the DAB product in the presynaptic terminal 
which made it difficult to detect whether synaptic vesicles were clustered at the 
presynaptic zone. Unfortunately, there were very limited tissues available for 
RorBCreERT2; Ai34 mice and it was not possible to repeat reaction using lower 
concentration of primary antibody. To overcome this problem, tissues from the 
RorBCreERT2; Ai9 mice were also investigated and in this case, it was repeated 
multiple time with difference concentration of primary antibody to ensure that 
DAB deposition was light. In addition, not many DAB profiles were seen due to 
lack of cells and axonal boutons that were labelled after injection of tamoxifen 
in RorBCreERT2; Ai9 mice. Although this was resulted in improved in intensity of 
DAB labelling in the animals that was tested, the number of cells and axons were 
not particularly dense. This presumably reflecting the variability in Cre mediated 
recombination seen in this mouse line. The great majority of DAB labelled 
profiles within this tissue were found to be dendritic shaft. For these reasons, 
the frequency of synaptic contact between RorB axonal boutons and type I 
glomeruli was not assessed systematically. However, in many cases, RorB-axonal 
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boutons were seen forming axoaxonic contacts with the central boutons of type I 
glomeruli (Figure 5-6).  
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Figure 5-6 Electron microscopic images of axoaxonic synapse on central bouton of type I 
glomeruli from tamoxifen treated RorBCreERT2; Ai9 mice. a a dendritic spine receives a synapse 
from central axon of type I glomerular (Ci). b-d TdTomato-labelled axonal boutons could be 
recognised due to the presence of the DAB reaction product that resulted from immunostaining 
with mCherry antibody (arrow). b-d a bouton forming an axoaxonic synapse on Ci bouton. Scale 
bars: a, b, c and d = 500 nm. 
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5.4 Discussion 
The main findings of this study based on crosses of RorBCreERT2 with either Ai9 or 
Ai34 are that: (1) IP injection of tamoxifen in early or later stage of postnatal 
life resulted in a difference level of induction of tdTomato; (2) more than 90% of 
tdTomato cells in the SDH are inhibitory interneurons and immunoreactive for 
CR; (3) under optimal conditions, only a quarter of the inhibitory CR cells in 
lamina II were immunoreactive for tdTomato; (4) 80% of the IB4-labelled primary 
afferents central terminals were in contact with axonal boutons of tdTomato 
cells; (5) half of the excitatory synapses on the dendritic trees of tdTomato cells 
were derived from IB4-labelled and PAP-immunoreactive primary afferents; (6) 
44% of the tdTomato axonal boutons are in contact with non-peptidergic C-
nociceptors. In addition, EM study revealed that the axons belonged to the RorB 
cells formed axoaxonic synapses with those primary afferents.  
5.4.1 Tamoxifen-induced tdTomato in RorBCreERT2; Ai9 mice 
In the field of neuroscience, it is a very common practice to use transgenic 
animal models as a tool to investigate neuronal circuit; identification of 
functional population of cell; studying gene function; and for various other 
purposes (Nagy, 2000, Taniguchi et al., 2011, Häring et al., 2018, Huang et al., 
2018). The Cre-LoxP recombination system is a novel method to activate or 
deactivate genes at a specific time point. This technology has been around for 
more than twenty years and was used in the field of neurology since then (Orban 
et al., 1992, Tsien et al., 1996). It can either remove or activate gene function 
by precise excision of specific region within a gene so that a functional product 
is not produced or Cre-recombinase could take out a STOP cassette causing 
activation of a gene, respectively (Feil et al., 2009). Cre-recombinase was made 
inducible by binding with the mutated hormone-binding domains of the 
oestrogen receptor (Cre-ERT). Before tamoxifen is administered, Cre-ERT is 
inactive and is found in the cytoplasm, bound to heat shock protein-90. Cre-ERT 
can be activated by the synthetic oestrogen receptor ligand 4-hydroxytamoxifen 
(OHT) but not by endogenous oestrogen, estradiol. The binding of OHT onto Cre-
recombinase resulting in the translocation of the recombinase into the nucleus 
where it acts on the targets DNA (Hayashi and McMahon, 2002). In most of the 
studies using this Cre recombinase technology, tamoxifen is the drug of choice 
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for most induction protocols because it is much cheaper compared to OHT and 
furthermore, OHT is a metabolic product of tamoxifen. In addition, the half-life 
of tamoxifen is longer than 4-OHT, 12 hours and 6 hours, respectively (Robinson 
et al., 1991). Tamoxifen is an antagonist of the oestrogen receptor which is 
widely use clinically as a chemotherapeutic agent for breast cancer and is known 
to relatively safe (Jordan, 1992, Bernstein et al., 1999). From published 
literatures, there are variety of dosage regimens for administration of tamoxifen 
into any tamoxifen-inducible models (Danielian et al., 1998, Nakamura et al., 
2006). There are several ways to administer tamoxifen via injection 
(subcutaneous or intraperitoneal) or orally by gavage (Reinert et al., 2012, 
Huang et al., 2018, Park et al., 2008).  
Several varieties of Cre-ERT have been developed in order to reduce spontaneous 
translocation of this complex into the nucleus in the absence of tamoxifen and 
also to increase their sensitivity to tamoxifen and their recombination efficiency 
(Liu et al., 2010). For example, the Cre-ERTM recombinase contains the mouse 
oestrogen receptor ligand binding domain (ER-LBD) with a G525R mutation 
(Danielian et al., 1998), meanwhile Cre-ERT contains ER-LBD derived from human 
rather than mouse (Feil et al., 1996). Cre-ERT2 is a more recent Cre-ERT variant, 
which was used in this study. It contains triple mutation in the human ER-LBD 
and is a better choice since it was found that Cre-ERT2 can be induced with 
approximately 10 fold lower dose of OHT than Cre-ERT (Indra et al., 1999). 
In this part of the study, various methods were carried out to achieve expression 
of tdTomato in the maximum number of cells. Administration of tamoxifen 
through injection in young mice (P16-18) resulted in labelling of more cells then 
when tamoxifen was given to older animals. However, even when injection was 
administered in young mice, the number of cells were variable. This probably 
due to some leakage of tamoxifen noted after the removal of the injection 
needle from the injection site, which resulted in low dose being administered 
(Allen C Dickie unpublished observation). Interestingly, it was found that 
administration of tamoxifen at later stage of postnatal life (P31-36) consistently 
resulted in sparse labelling of tdTomato cells. In a different study carried out in 
the laboratory using other Cre-ERT2 (nNOSCreERT2) mouse line, it was found that 
treating the adult animals with tamoxifen resulted in large number of cells with 
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the expected distribution pattern consistent with the majority of nNOS cells 
being labelled (Huang et al., 2018). Probably that the RorB gene was 
downregulated between P18 and P36 and this resulted in fewer expression of 
tdTomato cells. However, this is thought not to be the case as for example that 
in situ hybridization shows large numbers of RorB mRNA positive cells in the 
superficial laminae of adult animals at P56 (Allen Brain Atlas). The reasons for 
this reduction in recombination efficiency is not known but it was seen in other 
Cre-ERT2 lines (Professor Hanns Ulrich Zeilhofer personal communication). Two 
different methods of administration of 2 mg tamoxifen through gavage or IP 
injection method at P18 were used in this study. Findings from the experiments 
that was carried out on RorBCreERT2; Ai9 mice showed that IP injection was a 
preferable choice due to higher recombination was achieved by using this 
method. On the contrary, some previous studies found that tamoxifen 
administration in young adult or adult mice by gavage or IP injection resulted in 
equivalent number of labelled cells (Huh et al., 2012, Wilson et al., 2014, 
Rotheneichner et al., 2017).  
Even in the optimal labelling experiments, although most of the tdTomato cells 
were immunoreactive for CR and Pax2, only a quarter of inhibitory CR (Pax2+) 
was labelled with tdTomato and fewer cells were found in RorBCreERT2; Ai9 mice 
than the RorBeGFP mouse line. Therefore, it is likely that RorB is expressed in 
higher number of cells than what was achieved in this study even with the best 
optimal labelling tissue. It is possible that to overcome this problem, tamoxifen 
could be given earlier than P16. However, administration of tamoxifen at earlier 
age could increase in mortality of the young mice due to tamoxifen toxicity and 
mother cannibalism (Lizen et al., 2015). Previous studies reported that induction 
of Cre-ERT2 could be achieved successfully at early postnatal stages but the 
tamoxifen dosage and administration protocols were largely varied (Ganat et al., 
2006, Pitulescu et al., 2010). Some studies have delivered tamoxifen 
intraperitoneally into pregnant mice (Boyle et al., 2008, Danielian et al., 1998). 
However, this technique could compromise the ability of mice to have natural 
birth and thus increase the mortality of both pregnant mice and new born mice 
as a result of difficult delivery (Boyle et al., 2008). Normally, high oestrogen 
level is needed to end the gestation and begin the delivery process. According to 
Shoda et al. (2015), tamoxifen has the ability to inhibit oestrogen level thus 
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explain the delivery defects. To avoid this problem, caesarean section could be 
performed to the tamoxifen-treated pregnant mouse at E18.5 and the pups are 
given to foster mothers (Lizen et al., 2015). Another downside of this technique 
is that foetal development could be affected due to the risk of injecting the 
foetuses, thus administration of tamoxifen by gavage into pregnant dam is more 
favoured (Lizen et al., 2015).  
5.4.2 The RorBCreERT2 mouse line  
RorBCreERT is a reliable mouse line that can be used to investigate homogenous 
population of inhibitory CR islet cells, which give rise to presynaptic inhibition of 
the central axons of the non-peptidergic C-nociceptors in type I synaptic 
glomeruli. At the beginning of the study, the mouse was crossed with reporter 
lines, Ai9 or Ai34. The RorBCreERT2; Ai9 cross labelled cell bodies and their 
processes (both axons and dendrites) with tdTomato, meanwhile RorBCreERT2; Ai34 
crosses labelled only the axons of the cells with tdTomato due to the present of 
synaptophysin fusion protein. In both lines, the tdTomato labelled cells or axons 
were seen throughout the SDH and in the deeper laminae. In this study, it was 
found that 95% of tdTomato cells in superficial laminae were inhibitory (Pax2+) 
in RorBCreERT2; Ai9 mouse cross and 95% of these were also immunoreactive for 
CR. In contrast, only 42% of eGFP cells in the superficial laminae of RorBeGFP 
mice were CR-immunoreactive. In addition, the RorBeGFP mice also labelled other 
inhibitory neuronal populations such as those that expressed galanin, NPY, nNOS 
and PV, in the SDH. However, in this part of the study although the vast majority 
of tdTomato-labelled cells in RorBCreERT2; Ai9 cross showed islet morphology, 
even with the best treatment regime (2 mg IP injection of tamoxifen at P18), 
only a quarter of the inhibitory CR cells were labelled with tdTomato. In 
contrast, 90% of the inhibitory CR cells were labelled with eGFP in RorBeGFP mice 
as reported in chapter 3. An important and surprising observation was that the 
RorBCreERT2; Ai9 cross labelled far fewer cells than the RorBeGFP mice. It is not 
clear why this should be different because both RorBeGFP and RorBCreERT2; Ai9 
mice are knock-in mouse lines. Thus, it will be expected that eGFP expression 
faithfully reflexes the expression of RorB. It is possible that the 24% that were 
labelled in RorBCreERT2; Ai9 cross represent a functionally distinct subset among 
inhibitory CR cells, although the reasons why this cells and not the other cells 
would be labelled in the Cre-ERT2 line is not known. Alternatively, it is maybe 
144 
 
 
 
that another 75% showed islet morphology and give rise to axoaxonic synapses 
and formed presynaptic inhibitory input onto CMrgD afferents. This seems likely 
because it was found that all inhibitory CR cells in CR::eGFP mice that were 
patch clamped and filled with Neurobiotin in electrophysiology experiments 
showed islet cells morphology (Smith et al., 2015). However, maybe there is a 
sampling bias in which Smith and colleagues only recorded on larger cells during 
the experiments.  
In a preliminary investigation we examined sections from RorBCreERT2 mice that 
was treated with tamoxifen and had received intraspinal injections of 
adenoassociated virus (AAV) coding for Cre-dependent form of enhanced green 
fluorescent protein (eGFP) as used previously (Gutierrez-Mecinas et al., 2017). It 
was found that there were numerous eGFP-positive cells that were concentrating 
in the SDH near the injection site and this were more numerous than the cells 
that were tdTomato in the RorBCreERT2; Ai9 cross. In comparison these cells were 
far more numerous than that seen with optimal labelling of tdTomato in 
RorBCreERT2; Ai9 cross, and this suggest that Cre-recombinase was expressed in a 
larger number of cells than were detected with that other RorBCreERT2 cross. An 
unanticipated finding was that in addition to this brightly labelled eGFP cells 
which were mainly inhibitory, there were also numerous weakly labelled cells at 
the injection site that were Pax2- and therefore presumably excitatory. This 
suggest that viral injection into RorBCreERT2 mouse resulted in expression beyond 
the population of inhibitory RorB cells which would make it very difficult to 
interpret the finding. One of the disadvantage of incomplete labelling of 
inhibitory CR cells in RorBCreERT2; Ai9 cross is that it makes it difficult to 
determine what proportion of inhibitory axoaxonic synapses on IB4-/PAP-labelled 
non-peptidergic primary afferents originate from these source. In addition, in 
future study that would need activation or inactivation of inhibitory CR islet 
cells to manipulate function of these cells and test the effect on behaviour of 
these animals, it would be advantages if all cells belong to this population were 
captured.  
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5.4.3 Contacts between tdTomato-axonal boutons and non-
peptidergic C-nociceptors in RorBCreERT2; Ai9 and 
RorBCreERT2; Ai34 mice 
Analysis that was carried out on RorBCreERT2; Ai34 tissues showed that the great 
majority (80%) of non-peptidergic primary afferents boutons that were labelled 
with IB4-lectin received at least one contact from tdTomato axonal boutons. It is 
likely that many of these represent axoaxonic synapses from the inhibitory CR 
cells onto the primary afferents. In addition, non-peptidergic C-nociceptors 
might receive presynaptic inhibition from other sources. A study by Doyle and 
Maxwell (1993) reported that 37.5% of NPY boutons form axoaxonic synapses on 
central terminal of synaptic glomeruli. Apart from this, it is possible that non-
peptidergic primary afferent boutons received axoaxonic synapses from choline 
acetyltransferase (ChAT)-immunoreactive neurons in which the cell bodies are 
mainly located in laminae III-V (Ribeiro-Da-Silva and Claudio Cuello, 1990). 
Meanwhile, Hughes et al. (2012) found that PV-labelled axon terminals formed 
axoaxonic synapse on central axons of type II glomeruli, never on type I 
glomeruli.  
Although it is possible to determine proportion of IB4-labelled boutons that 
received contact from tdTomato-axons, it was challenging to carry out the 
reverse analysis, to work out the proportion of tdTomato-labelled axons that 
were in contacts with IB4-positive boutons. Effectively, it was easy to identify 
tdTomato axonal boutons but it is difficult to make out the structure of IB4-
labelled boutons and to determine whether they represent axon terminals or 
intervaricose portions. Instead, this analysis was carried out in the RorBCreERT2; 
Ai9 mice in which there was a sparse labelling (as described below). This was 
partly due to suboptimal quality of IB4-labelling that was achieved in the tissues 
of RorBCreERT2; Ai34 mice. 
In the RorBCreERT2; Ai9 mice in which there was a sparse labelling, all the 
tdTomato cells that were found in lamina II showed islet cell morphology. In this 
part of the study, IB4-lectin and PAP-antibody were used to identify non-
peptidergic C-nociceptors. Previously, small diameter DRG neurons in rat were 
labelled using thiamine monophosphatase (TMPase), which is also known as 
Fluoride-Resistant Acid Phosphatase (FRAP) (Sanyal and Rustioni, 1974, 
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Silverman and Kruger, 1988). TMPase labelling was restricted to non-peptidergic 
unmyelinated neurons and a subset of peptidergic DRG neurons (Knyihár-Csillik 
et al., 1986). In addition, it labelled central boutons of unmyelinated primary 
afferents in lamina II (Hunt and Rossi, 1985). IB4 was used to distinguished 
different type of primary afferent and was found to labelled neurons that 
expressed TMPase. Later, IB4 became the marker of choice for non-peptidergic 
primary afferents since technically IB4 was easier to apply (Silverman and 
Kruger, 1990). More than 20 years later, it was found that in mice, TMPase is 
identical to transmembrane isoform of PAP (Zylka et al., 2008). PAP was 
discovered more than 80 years ago and has been widely used in prostate cancer 
studies since 1930s (Gutman and Gutman, 1938, Ostrowski and Kuciel, 1994). A 
study by Zylka et al. (2008) found that PAP was also expressed in nociceptive 
neurons. In mouse DRG cells, PAP was mainly expressed in non-peptidergic 
neurons that were also positive for IB4, MrgprD and P2X3 (Zylka et al., 2008). 
According to this paper, all MrgprD were PAP in the DRG neurons. Around 84% of 
IB4-labelled non-peptidergic and 15% of CGRP-positive peptidergic DRG neurons 
were immunoreactive for PAP (Taylor-Blake and Zylka, 2010). In the current 
study it was found that PAP-containing axons mainly terminated in lamina II and 
overlap perfectly with IB4-binding. A previous study reported that 67% of cells 
that bound IB4 and 10% of those that were CGRP-immunoreactive were labelled 
with PAP (Zylka et al., 2008). Meanwhile, there was limited overlap between 
PAP and CGRP in the spinal cord (Zylka et al., 2008, Taylor-Blake and Zylka, 
2010). Around 19% of PAP-labelled DRG neurons were immunoreactive for 
capsaicin and noxious heat receptor TRPV1 (Zylka et al., 2008).  
Two different types of analysis were carried out in sparsely labelled RorBCreERT2; 
Ai9 tissue. First, the proportion of excitatory synaptic input on individual 
tdTomato dendritic spines was determined and the result showed that around 
half of the excitatory synapses on these spines were derived from central 
boutons of non-peptidergic C-nociceptors that were labelled with both IB4 and 
PAP. Meanwhile ~6-10% of central terminals in lamina II that were labelled with 
IB4 or PAP were in contact with Homer puncta within tdTomato dendritic spines. 
However, in all cases the number of contacts between tdTomato dendritic spines 
and presumed primary afferent boutons that were positive for IB4 or PAP varied 
between individual cell. For example, some tdTomato cells had none or low 
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excitatory input from primary afferents that were labelled with either IB4+/PAP- 
or PAP+/IB4-, meanwhile in another cells, as high as ~40% of the excitatory input 
derived from those primary afferents. These results showed that there was a 
variability of contacts for each cells and this could reflect inadequate staining or 
penetration of the IB4 lectin or PAP antibody. However, this was not the case 
because the penetration and the staining of IB4 and PAP were equally good. This 
might represent population of primary afferents that may have slightly different 
function.  
Next, using the same animals, the proportion of tdTomato axonal boutons that 
were in contact with IB4- and/or PAP-labelled central terminals of C-nociceptors 
was determined. The fact that the quality of staining for IB4 was better in this 
tissue and together with the present of Homer puncta enable the identification 
of primary afferent terminals more clearly that what was seen in RorBCreERT2; 
Ai34 mice. Around 44% tdTomato axonal boutons formed contacts with IB4- 
and/or PAP-labelled central terminals of C-nociceptors. This finding suggest that 
the most likely source of presynaptic inhibition on type I glomeruli is from RorB 
cells in lamina II (Gerke and Plenderleith, 2004). The contacts between the 
axons for individual tdTomato cells and different neurochemical types of primary 
afferents (IB4+/PAP+ or IB4+/PAP- or PAP+/IB4-) were varied. This might reflex 
differences in input from different classes of C-nociceptors.   
Currently, there is no ideal marker that could labelled individual class of C-fibres 
and in both cases, MrgprD is a better marker for non-peptidergic C-nociceptors 
because it defined the real population of these primary afferents (Zylka et al., 
2005). Recent transcriptomic studies have suggested that the expression of the 
MrgprD defines a population of non-peptidergic C-nociceptors that are largely 
correspond to those previously identified by the IB4-binding (Usoskin et al., 
2014, Li et al., 2016). Zylka and colleagues found that both hairy and glabrous 
skin received innervation from MrgprD-labelled primary afferents and that they 
are the most abundant class of free nerve arbors that are restricted to the skin 
only (Zylka et al., 2005). Staining with IB4-lectin and PAP-antibody substantially 
overlap with non-peptidergic C-nociceptors but the relationship between axonal 
boutons that were labelled with IB4 and/or PAP and the expression of MrgprD is 
not known. Unpublished observation by Marami Mustapa and Andrew J Todd on 
MrgprD-YFP mouse sections that were reacted with eGFP, IB4 and PAP revealed 
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that in the medial part of the L3 dorsal horn, virtually all IB4-binding axonal 
boutons were YFP+, whereas in the middle/lateral parts there were significant 
numbers of IB4-labelled axonal boutons that were not YFP. Since the medial part 
of the dorsal horn in this segment receives input from the glabrous skin, 
meanwhile the middle and lateral part from hairy skin this suggest that hairy 
skin is innervated by primary afferents that bind IB4 but lack MrgprD.  
5.4.4 Discovery from EM study  
Previous studies have shown that profiles that are presynaptic to central axons 
of type I glomeruli were immunoreactive for GABA but not for glycine 
(McLaughlin et al., 1975, Barber et al., 1978, Todd, 1996). Type I synaptic 
glomeruli are mainly found in the middle part of lamina II and these are thought 
to correspond largely to axons that bind IB4 (Gerke and Plenderleith, 2004). As 
described previously in chapter 3, both dendrites and axons of inhibitory CR cells 
were perfectly overlap with IB4 plexus. Therefore, it is possible that presynaptic 
inhibition on central axons of type I glomeruli is mediated by axoaxonic and 
dendroaxonic synapses that are mostly derive from this population of cells. In 
this part of the study, EM was carried out to determine whether axons of RorB 
cells form axoaxonic synapses on the central axons of type I synaptic glomeruli. 
In a few cases there was clear area of contact between DAB profiles and central 
axons of type I glomeruli seen in the EM tissue. In all cases the DAB-
immunoreaction product was rather intense which made it difficult to resolve 
the presence of vesicles within the DAB-labelled profiles. Although the 
RorBCreERT2; Ai34 cross had apparently more numerous axons, unfortunately the 
quality and structural preservation was less good in this tissue which made it 
more challenging to identify potential axoaxonic synapses. Meanwhile, the 
ultrastructure was better in RorBCreERT2; Ai9 tissue. However, the frequency of 
labelled axons was much lower which made it relatively difficult to find 
examples where they made contact with central axons of type I synaptic 
glomeruli. It is difficult to know why the axonal labelling in RorBCreERT2; Ai34 
cross were more numerous than RorBCreERT2; Ai9 mice. In particular, this is 
because cell bodies were not reveal in RorBCreERT2; Ai34 tissue and therefore it is 
not possible to compare the number of labelled cells between these two 
different lines. It is possible that it reflexes a difference proportion of cells in 
which Cre-recombinase was activated and made to go into nucleus. 
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Alternatively, it might be that the axonal targeting due to the synaptophysin 
fusion protein results in more complete axonal labelling. In addition, it is 
possible that there are slight differences in the protocol for tamoxifen treatment 
may have resulted in different on axonal labelling between these two crosses. 
During the course of the study, another method of tissue processing was applied. 
The technique of freeze-thawing over liquid nitrogen (Hughes et al., 2000) was 
carried out in order to get a better penetration of antibody in RorBCreERT2; Ai9 
tissue. However, this method was not carried out further because it did not 
result in increase in the number of DAB profiles.  
Further research would be needed to investigate synaptic connection between 
axons of inhibitory CR islet cells and central axons of type I glomeruli. In future 
investigations, it might be possible to repeat the EM tissue processing using 
RorBCreERT2; Ai34 mice and vary the immunocytochemical processing to obtain 
optimal staining. However, the Ai34 mouse line is not currently held in the 
University of Glasgow. Although it will be a considerable interest to investigate 
axonal projections in other Cre-recombinase mouse line. However, most of other 
Cre mouse lines that are used in this laboratory are not Cre-ERT2 and therefore 
crossing them with the Ai34 will resulted in axonal labelling not only in cells that 
permanently expressed gene of interest but also in cells that transiently 
expressed it, which will make it much more difficult to interpret the findings. 
Therefore, the Ai34 mouse line would only be a value in very limited number of 
cases such as RorB in which the Cre-ERT2 line is available. This makes it 
uneconomical to carry out this experiments. An alternative approach for looking 
at axonal labelling would be to use intraspinal injection of AAV that code for 
Cre-dependent form of a fluorescence protein conjugated to synaptophysin 
expressing viruses into RorBCreERT2 mice. However, as noted above intraspinal 
injection in the RorBCreERT2 mouse line resulted in an unexpected pattern of 
expression in which both inhibitory neurons but also excitatory cells were 
labelled and this made it difficult to interpret.    
A recent study reported that a relatively small number of substance P cells 
identified by either PPTA-immunoreactivity or intraspinal injections of an AAV 
coding for a Cre-dependent form of eGFP (AAV.flex.eGFP) into Tac1 Cre mice 
were inhibitory (Pax2+)(Gutierrez-Mecinas et al., 2017). Gutierrez-Mecinas and 
colleagues found that after the AAV.flex.eGFP virus was injected into the Tac1Cre 
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mouse, around 11% of eGFP-labelled cells were inhibitory (Pax2+) neurons. It was 
found that at the rostral and caudal end of the injection site in this animals, 
there is a region that contains plexus of eGFP-labelled axons in lamina II. Axons 
in the plexus were weakly labelled with VGAT and they are found to be closely 
associated with IB4-binding (Andrew J Todd unpublished observation). This 
suggest that inhibitory substance P cells in Tac1Cre mouse may correspond to the 
RorB+/CR+ cell populations since tdTomato axonal boutons in RorBCreERT2; Ai34 
mice were also found to be weakly labelled for VGAT. Furthermore, the majority 
of inhibitory substance P cells seen in Tac1Cre mouse are immunoreactive for CR 
(Olivia Davis unpublished data). In addition, a recent study using single cell RNA 
sequencing to classify spinal cord neurons in the mouse dorsal horn identified 
some inhibitory CR neurons contain Tac1 mRNA that correspond to GABA 9 
population identified in this study (Häring et al., 2018). Häring and colleagues 
showed that these neurons were found mainly in lamina II and scattered in the 
deeper laminae. Interestingly, they also reported that these cells were activated 
by noxious heat. The Tac1Cre mouse line may there for be a promising tool that 
can be used to investigate ultrastructure and synaptic connection between these 
axons and central axons of type I synaptic glomeruli.  
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6 The effect of sciatic nerve transection on 
inhibitory CR islet cells in RorBCreERT2; Ai9 mice  
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6.1 Introduction  
According to the International Association for the Study of Pain (IASP), pain is 
defined as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage”. 
Various stimuli such as mechanical and thermal stimuli, including environmental 
and endogenous chemical irritants are detected by the nervous system. Once 
these stimuli become intense, they will cause acute pain. This is a very 
important protective reflex for the survival of both human and animal. However, 
in many cases adaptations of the pain pathway will leads to hypersensitivity, and 
when the pain persists for more than three months this condition is known as 
chronic pain (Basbaum et al., 2009). Chronic pain state is characterised by 
spontaneous pain, as well as by allodynia, where pain is perceived following a 
normally innocuous stimulus and hyperalgesia, where the patient experiences an 
increased pain intensity to noxious stimuli (Callin and Bennett, 2008). There is 
evidence that showed information transmitted by low threshold 
mechanoreceptor afferents is partly responsible for mechanical allodynia 
(Torsney and MacDermott, 2006, Peirs et al., 2015, Löken et al., 2017). Chronic 
pain represents a major clinical, social and economic problem (Phillips, 2003). 
More than 20% of people are affected, and every year there will be 10% of world 
populations that are newly diagnosed with chronic pain (Goldberg and McGee, 
2011). This may represent underestimate since in the UK it was found that 43% 
of people suffer from chronic pain (Fayaz et al., 2016). Until now there is no 
standard protocol that can be used for pain management (Ashburn and Staats, 
1999) and in many cases, patients do not received adequate treatment for their 
pain (Elliott et al., 1999). Pharmacotherapy with commonly use drugs such as 
non-steroidal anti-inflammatory drugs (NSAIDs) and opiates to treat chronic pain 
has a limited success (Woolf and Mannion, 1999). Therefore, the mechanisms 
involved in the development of chronic pain need to be understood to allow for 
appropriate treatment for patient who suffer from this condition. The spinal 
cord is a potential target for pharmacological treatment for chronic pain since 
all primary afferents fibres, including nociceptors and the low threshold 
mechanoreceptor synapse here, providing sensory information conveyed to the 
brain. The changes that take place in the nervous system following the 
development of chronic pain are still not well understood.  
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Peripheral nerve injury (PNI) is associated with the development of chronic 
neuropathic pain. Unfortunately, the mechanisms through which PNI leads to 
neuropathic pain are still poorly understood. However, several possible changes 
in the spinal cord that might underlie neuropathic pain have been suggested by 
different research groups. An early suggestion was sprouting of afferent fibres 
(Woolf et al., 1992) but now it was thought not to be true (Hughes et al., 2003). 
Other mechanisms include central sensitization that was resulted from changes 
in synaptic transmission, increase excitatory circuit activity and decrease in 
inhibitory response within the dorsal horn (Woolf and Mannion, 1999). One 
example for central sensitization is long term potentiation (LTP) (Luo et al., 
2014). An alternative proposed mechanism involve loss of inhibition 
(disinhibition) (Yaksh, 1989, Ibuki et al., 1996, Eaton et al., 1998).  
One possible mechanism early on was that Woolf et al. (1992) suggested that 
central terminals of Aβ-primary afferent fibres sprout dorsally into lamina II 
after peripheral axotomy. In intact peripheral nerve, CTb is transported only by 
myelinated afferents and this results in transganglionic labelling in deeper 
laminae where myelinated afferents terminate. However, following peripheral 
nerve injury CTb-labelling was also seen in superficial laminae (Woolf et al., 
1992). Woolf and colleagues proposed that this resulted from sprouting of Aβ-
fibres into the SDH. In addition, they identified individual Aβ primary afferents 
that had axons extent throughout laminae I-III in nerve injured but not in naïve 
rats. In contrast, Yong-Guang et al. (1999) reported that CTb is taken up and 
transported by injured C-fibres, and that this probably accounts for the novel 
labelling in lamina IIo seen after nerve injury. In addition, a few studies found 
that following PNI, there was no change in the arborisation patterns of intra-
axonally labelled Aβ-fibres (Hughes et al., 2003, Woodbury et al., 2008). Most 
probably that the axons of Aβ-primary afferent fibres that was thought to sprout 
into lamina II (Woolf et al., 1992) are the same as myelinated nociceptors that 
has been shown to extent into lamina I in normal animals (Woodbury et al., 
2008).  
Repetitive stimulation of presynaptic fibres can lead to long term-potentiation, 
lasting for more than 3 hours (Luo et al., 2014). LTP is a form of long-term 
synaptic plasticity due to a persistent increase in the strength of synaptic 
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connections (Todd, 2010). It was first described in the hippocampus and is 
believed to be involved in learning and memory function (Bliss and Collingridge, 
1993). Later studies found that there is a possibility that LTP is induced in pain 
pathways and contribute to hyperalgesia (Sandkühler, 2009, Sandkühler and 
Gruber-Schoffnegger, 2012). Spinal LTP involves presynaptic mechanisms and the 
opening of receptors that involve in the development of neuropathic pain such 
as NMDA receptors and low-threshold (T-type) voltage-gated calcium channels 
(Ikeda et al., 2003, Ikeda et al., 2006).   
Following peripheral nerve injury, there will be changes in synaptic transmission 
within the spinal cord in which enhancement of excitatory and reduction of 
inhibitory synaptic processes occurred (Woolf, 1983, Woolf and Mannion, 1999, 
Kuner, 2010, Prescott et al., 2014). One of the possible causes for this altered 
activity results from changes in the production of voltage-gated K+ (Coull et al., 
2003, Kahle et al., 2014) which will be explained further below (see discussion). 
According to Masuda et al. (2016), after peripheral nerve injury, adenosine 
triphosphate (ATP) release from dorsal horn neurons is increased due to 
upregulation of the vesicular nucleoside (VNUT) which normally transported 
cystolic ATP into synaptic vesicles. Subsequently, ATP will stimulate purinergic 
receptor P2X4 which then causes the release of brain-derived neurotrophic 
factor (BDNF) from microglia (Trang et al., 2009). Coull et al. (2005) found that 
following peripheral nerve injury, BDNF release from ATP-stimulated microglia 
causes a depolarizing shift in the anion gradient in lamina I neurons, which 
reverse the ability of GABA to hyperpolarized. An interruption in the 
communication between BDNF and its receptor, tropomyosin receptor kinase B 
(TrkB) will prevent microglia-induced tactile allodynia and the shift in the anion 
gradient (Coull et al., 2005).  
Transmission of sensory information is disturbed following nerve injury due to 
the less activation of GABAergic and/or glycinergic neurons in the spinal cord 
(Torsney et al., 2006, Prescott et al., 2014). As mention before, superficial 
laminae are the termination sites for nociceptors such as C- and Aδ-fibres that 
convey noxious information (Todd, 2010). Meanwhile, tactile and innocuous 
information is carried by Aβ primary afferents that terminated in laminae III-IV 
(Abraira et al., 2017). Normally, GABAergic and glycinergic inhibition prevent a 
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pre-existing excitatory communication between Aβ-fibres and nociceptors (Lu et 
al., 2013). However, this strong feedforward inhibitory circuit is disrupted 
following peripheral nerve injury, thus allowing a low-threshold 
mechanoreceptive pathway in laminae III-IV to gain access to the nociceptive 
pathway in the superficial laminae. These findings explained why touch is 
perceived as pain in tactile allodynia (Lu et al., 2013).  
In another studies, it has been suggested that one of the cause for chronic pain 
was a change in expression of peptides in low threshold myelinated afferents 
following peripheral nerve injury (Noguchi et al., 1994, Noguchi et al., 1995, 
Neumann et al., 1996). Normally, substance P is found in small dorsal root 
ganglia neurons which correspond to nociceptors. However, it was reported that 
peripheral axotomy resulted in increased expression of pronociceptive peptides 
such as CGRP and substance P in medium and large sized dorsal root ganglia 
neurons including some that projected into gracile nucleus (Noguchi et al., 
1994). In another study by Noguchi and colleagues, they found substance P which 
normally contribute to pain was upregulated by affected Aβ-primary afferent 
fibres following PNI (Noguchi et al., 1995). However, Hughes et al. (2007) 
reported that, following various type of nerve injury (sciatic nerve transection 
(SNT), spinal nerve ligation (SNL) or chronic constriction injury (CCI)), there was 
no expression of pronociceptive peptides such as substance P or CGRP in Aβ-axon 
terminals in the dorsal horn. Electrical stimulation of Aβ afferents in nerve 
injury models did not cause internalisation of NK1r in dorsal horn neurons which 
suggest that substance P was not released from Aβ-fibres following nerve injury, 
therefore, this showed that this peptide does not cause allodynia in the 
respected models (Hughes et al., 2007). 
Another mechanism that is believed to be involved in the development of 
chronic pain is a reduced activity in inhibitory pathway (disinhibition). 
Disinhibition could contribute to allodynia, hyperalgesia and spontaneous pain 
(Sandkühler, 2009). Torsney and MacDermott (2006) suggested that tactile 
allodynia could result from a loss of inhibition on excitatory interneurons that 
transmit LTMR inputs to lamina I projection neurons. They propose that there is 
polysynaptic pathway that conveys low threshold mechanoreceptor input to this 
lamina I cells. Subsequently this was shown to involve at least 3 different classes 
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of excitatory neurons; those that expressed PKC gamma as well as two 
morphologically defined populations, central and vertical cells (Lu et al., 2013).  
Several different mechanisms were proposed to explain peripheral nerve injury 
and one of the proposed mechanism was a significant death of inhibitory 
neurons. For example, both Ibuki et al. (1996) and Eaton et al. (1998) reported 
that by using immunocytochemistry technique, there was a substantial loss of 
GABAergic neurons from the dorsal horn after CCI. Interestingly, this was seen on 
both sides of the spinal cord after a unilateral nerve injury even though 
behavioural signs of neuropathic pain were more restricted on the ipsilateral 
side. On the other hand, Castro-Lopes et al. (1993) showed that sciatic nerve 
transection causes a progressive loss of GABAergic neurons on the ipsilateral side 
with eventually 20% reduction in the number compared to the contralateral side.  
Moore et al. (2002) also reported the presence of apoptotic neurons and 
provided evidence that this might be GABAergic neurons that were undergoing 
cell death. Sugimoto et al. (1990) proposed that increased activity of primary 
afferent fibres following peripheral nerve injury leading to neuronal death. 
Based on these findings, it has been suggested that death of inhibitory 
interneurons after nerve injury contributed to neuropathic pain (Whiteside and 
Munglani, 2001, Moore et al., 2002, Scholz et al., 2005). Despite this evidence, 
this finding is controversial since other studies have failed to find evidence for 
GABAergic neurons cells death (Polgár et al., 2003, Polgár et al., 2004, Polgár 
and Todd, 2008). In addition, other mechanism for disinhibition have also been 
proposed (see discussion).  
In a preliminary study using the Nociceptin::eGFP mouse, sciatic nerve 
transection was performed and 4 weeks after surgery, it was found that IB4-
labelled boutons had disappeared from the denervated part of lamina II. This 
indicated that CMrgD afferents have lost their synaptic connection. It was also 
notice that the dense band of eGFP+ dendrites that was normally present in 
lamina II was much reduced in the denervated sciatic nerve region. This suggest 
that there was a significant changes affecting the inhibitory CR cells which might 
be related to the fact that these cells received most of their input from CMrgD 
afferents and axons of inhibitory CR cells form axoaxonic synapse on these 
afferents. A similar finding was seen in the preliminary study using RorBCreERT2; 
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Ai9 mouse in which a band of tdTomato cells become less dense in the 
denervated region in lamina II. The aim of this part of the study is to determine 
the effect of PNI on inhibitory CR cells in lamina II of RorBCreERT2; Ai9 mice. The 
hypothesis is that there is loss of these cells after PNI based on the previous 
studies reporting on cells death (Ibuki et al., 1996, Moore et al., 2002, Eaton et 
al., 1998). An additional alternative that was considered was that cells will 
survive but will undergo structural changes especially involving their dendritic 
arborisation following PNI.  
6.2 Materials and methods  
6.2.1 Animals and operative procedures  
Ten young adults RorBCreERT2; Ai9 mice of either sex (15-20 g) that had received 
2mg of intraperitoneal tamoxifen at P16-P18 (n=7) or P32 (n=3) were used for 
this part of the study. As mentioned previously, early administration of 
tamoxifen at P16-P18 will lead to labelling of many more cells with tdTomato. In 
contrast, tamoxifen treatment at P32 results in sparse labelling of tdTomato 
cells. The animals that were treated with tamoxifen at P16-18 were used for cell 
counting, while those that received tamoxifen at P32 were used for 
morphological analysis. Unilateral sciatic nerve transection was then performed 
on these mice as described in a previous study by Wall et al. (1979). The mice 
were anaesthetized with isoflurane. They were then placed on a heating pad in 
order to maintain their body temperature. Their heads were fixed in a 
stereotaxic frame, after which the anaesthetic was administered through a mask 
attached to the frame. The left sciatic nerve was exposed at mid-thigh level, 
proximal to the nerve trifurcation and a ligature was secured tightly around the 
nerve at this level. Approximately 2-3 mm of the nerve between the two 
ligatures was then removed to prevent the nerve from re-joining. After the 
nerve had been sectioned, the skin was then closed by stapling.  
6.2.2 Tissue processing of RorBCreERT2; Ai9 mice 
After a four-week post-operative recovery period, the mice were re-
anaesthetized with pentobarbitone and perfused with 4% formaldehyde as 
described previously. In the mouse, L3, L4 and L5 spinal nerves make up the 
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sciatic nerve (Rigaud et al., 2008). Therefore, for this part of the study, lumbar 
spinal cord segments from L3-L5 were dissected out and post-fixed for 2 hours. 
From the mice that were treated with tamoxifen at P16-18, each of the lumbar 
segments was notched on the lateral part of the ventral horn on the side 
contralateral to the injury in order to allow the two sides to be distinguished. 
Then, lumbar spinal cords were cut into 60 µm thick transverse sections. From 
the mice that were treated with tamoxifen at P32, the left and right side of the 
spinal cord were separated and cut into 60 µm thick parasagittal sections. In all 
cases, sections were then immersed in 50% ethanol for 30 minutes. Sections 
were then processed for immunocytochemistry, as described below. In all cases, 
sections were incubated in primary antibodies at 4oC for 5 days and overnight in 
secondary antibodies. Antibodies were diluted in PBS that contained 0.3% Triton-
X100 and 5% normal donkey serum. 
6.2.3 The number of inhibitory CR+/tdTomato+ cells on the injured 
and intact side of the spinal cords  
To examine the effect of sciatic nerve transection on tdTomato neurons on the 
injured and intact side of the spinal cords, transverse sections from the L4 or L5 
segments of 6 of the nerve injured RorBCreERT2; Ai9 mice that had received 
tamoxifen at P16-18 were used. Sections from both segments from each animal 
were incubated in rabbit anti-Pax2, chicken anti-PAP and mouse anti-CR 
antibodies. These primary antibodies were revealed with Pacific Blue, Alexa 488 
and Alexa 647, respectively. The tdTomato expression was visible without the 
use of antibody, due to the presence of bright native red fluorescence. Sections 
were mounted as described above and were viewed with a confocal microscope. 
The PAP antibody was used to reveal non-peptidergic C-nociceptors (Zylka et al., 
2008, Taylor-Blake and Zylka, 2010). Previous studies involving PNI have shown 
that IB4-binding was down-regulated by the primary afferents allowing the 
denervated area to be identified (Shehab et al., 2008, Shehab, 2014). These two 
markers mostly labelled the same population of non-peptidergic C-nociceptors. 
However, in the present study PAP antibody was used instead of IB4-lectin 
because it was found to give a clearer indication of the denervated region in 
lamina II. Between four to seven sections from each mouse were selected based 
on the depletion of the PAP band in lamina II (Figure 6-1). Sections in which this 
depletion effected at least two third of the PAP plexus on the side ipsilateral to 
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the injury were selected for analysis. This selection was made before the 
channel for tdTomato was viewed. For each section both ipsilateral and 
contralateral side of dorsal horn were scanned through their full thickness with 
the 40x oil immersion lens and 1 μm z-separation, with the aperture set to 1 Airy 
unit. Tile scans were used to capture the whole width of the superficial laminae 
of the dorsal horn. Confocal scans were analysed offline using Neurolucida for 
Confocal Software. The outline of the dorsal horn and the boundaries between 
laminae I-II were drawn. The lamina I/II boundary was drawn 20 µm below the 
dorsal white matter and the ventral extent of the CR-immunoreactive cells was 
used to determine lamina II/III border. The mediolateral extent of the region 
from which the PAP plexus was absence was delineated by drawing two parallel 
lines that were orthogonal to the laminar boundaries (Figure 6-2). Analysis was 
carried out on inhibitory CR+/tdTomato+ cells that were found between the two 
lines, corresponding to the region from which PAP was depleted on the 
ipsilateral side. The equivalent region on the contralateral side was examined on 
the same way. All of the tdTomato cell bodies in lamina II within this region 
were plotted onto the Neurolucida drawing throughout the whole depth of the 
sections. Then, the CR and Pax2 channels were viewed to determine the 
proportion of tdTomato cells that were immunoreactive for either of these 
proteins. In addition, to determine the proportion of the inhibitory (Pax2+) CR 
neurons that were labelled with tdTomato, cells that were immunoreactive for 
both CR and Pax2 were also counted while the channel representing tdTomato 
was switched off. To avoid experimenter bias, the analysis was carried out blind 
to whether the dorsal horn was ipsilateral or contralateral to the nerve injury. 
This was achieved by flipping the confocal images from the ipsilateral dorsal 
horn so that the two side appeared similar before the analysis was carried out.   
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Figure 6-1  Transverse section of RorBCreERT2; Ai9 mice that had undergone SNT on the left 
side. a the density of tdTomato band was much reduced in the area where PAP depletion occur on 
the ipsilateral side to the nerve injury. The number of tdTomato cells seen is less than what is seen 
in RorBeGFP mice. However, the number of tdTomato cells on the side ipsilateral to the nerve injury 
is similar to the contralateral side. b PAP plexus is absent on the left side of the dorsal horn in 
which the nerve injury is performed. c merged image. Scale bar = 200 µm.  
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Figure 6-2 The effect of sciatic nerve transection on the SDH neurons in RorBCreERT2; Ai9 
mice. a almost two third of the PAP plexus is depleted on the side ipsilateral to the nerve injury. b 
the tdTomato band is present throughout lamina II, however, the intensity of the band is reduced on 
the side ipsilateral to the injury. c Pax-immunostaining is comparable to what is seen in intact 
animal. d merged image. The dashed lines represents the dorsal and ventral borders of lamina III. 
Scale bar = 200 µm. 
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6.2.4 Proportion of inhibitory CR+ cells among all neurons in 
lamina II 
TdTomato in the RorBCreERT2; Ai9 mouse does not label all inhibitory CR cells in 
laminae I-II even when these animals are treated with tamoxifen at P16-18. 
Because of this, an additional analysis using a stereological technique was 
carried out to determine the proportion of neurons that were inhibitory CR cells 
on the two side following nerve injury (Gutierrez-Mecinas et al., 2016a, Boyle et 
al., 2017). This analysis was carried out on a different set of sections from the 
animals described above and one additional animal that has undergone nerve 
injury. These sections have been reacted with Pax2, CR, and NeuN antibodies. 
The NeuN antibody was needed to reveal all neurons and DAPI to label the 
nuclei, thus allowing the proportion of neurons that were CR+/Pax2+ to be 
determined. However, because these antibodies used up all of the available 
channel on the confocal microscope, the PAP antibody was not included in this 
immunoreaction protocol. In the previous set of experiment, it had been found 
that the depletion of the PAP plexus was greatest at the caudal half of the L4 
segment. For this reason, in this part of the study sections from caudal part of 
L4 were chosen for analysis, based on the outline of the grey matter. The rabbit 
anti-Pax2, goat anti-CR and mouse anti-NeuN were revealed with Alexa 647, 
Alexa 488, and Rhodamine Red, respectively. Following the immunocytochemical 
reaction, the sections were incubated in DAPI for 10 min for nuclear staining. 
NeuN-immunoreactivity and tdTomato reaction were both revealed in the same 
channel (red fluorescence). However, this did not result in difficulty in 
identifying neurons that were labelled with Neun antibody since tdTomato 
expression was restricted in neurons.    
Sections were mounted as described above and were scanned with a confocal 
microscope. Initially, all sections on the slide were scanned with the 5x lens to 
capture the entire spinal cord and allow sections from the caudal part of the L4 
segment to be identified. The three most caudal sections were then selected 
and scanned with the 40x oil immersion lens, 1 µm z-step and the aperture set 
to 1 Airy unit, to produce a z-stack of 30 optical sections. Tile scans were used 
to capture the whole width of laminae I-III on both sides. These scans were 
analysed offline using Neurolucida for Confocal Software. The outline of the 
dorsal horn and the boundaries between laminae I-II were drawn as described 
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above. All cell nuclei (identified by both Neun and DAPI) that had their bottom 
surface between reference and look up sections (10th and 20th optical sections, 
respectively) were plotted onto the Neurolucida drawing and neurons with nuclei 
present in the look-up section were then excluded (Polgár et al., 2013a, Iwagaki 
et al., 2013). The channels corresponding to CR and Pax2 were then viewed, and 
the presence or absence of each type of staining on the selected cells was 
documented. To avoid experimenter bias, the analysis was carried out blind to 
whether the dorsal horn was ipsilateral or contralateral to nerve injury. This was 
achieved by flipping the confocal images from the ipsilateral dorsal horn so that 
the two side appear similar before the analysis was carried out.   
6.2.5 Morphology of CR+/tdTomato+ cells after SNT  
To compare the morphology of CR+/tdTomato+ cells on the injured and intact 
side of the spinal cord after SNT, parasagittal sections from 3 RorBCreERT2; Ai9 
mice that had received tamoxifen at P32 were used. All the sections were 
incubated with rabbit anti-mCherry, goat anti-CR, and chicken anti-PAP. These 
primary antibodies were revealed with Rhodamine Red, Pacific Blue and Alexa 
488, respectively. Sections were mounted as described above and were viewed 
with a confocal microscope. On the side contralateral to the nerve injury 
tdTomato cells within the PAP plexus were selected to ensure that they were 
located in lamina II. Since this plexus was not present on the nerve injured side, 
CR-immunoreactivity, which was found mainly in lamina II, was used as a guide 
to identify tdTomato cells in this lamina. A total of nine CR+/tdTomato+ cells on 
the ipsilateral side and five CR+/tdTomato+ cells on the contralateral side were 
scanned and analysed. Scanning was started with the 5x lens to confirm the 
laminar location of the cell within the section. They were then scanned through 
the 63x oil immersion lens at 0.5 µm z-separation with the aperture set to 1 Airy 
unit. In each case, tile scans were obtained in order to capture all of the 
labelled cell that were present in the section. The maximum intensity projection 
of the confocal scanned image was used to determine the RC and DV extent of 
the dendritic trees of the cells. Both the RC and DV length were measured using 
Quick Line Measure tool in Neurolucida software. 
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6.3 Results  
6.3.1 Quantitative analysis of the inhibitory CR+/tdTomato+ cells 
following SNT 
In this part of the study, tissues from animals that received 2mg IP tamoxifen at 
P16-P18 was used because early administration of tamoxifen resulted in more 
labelling of tdTomato cells in RorBCreERT2; Ai9 mice and to determine whether 
there is loss of inhibitory CR+/tdTomato+ cells after SNT, it is necessary to work 
with animals in which numerous tdTomato cells were labelled.  
On the side contralateral to nerve injury, the PAP axonal band could be seen 
through the mediolateral extent of lamina II, appeared similar to animals that 
had not undergone nerve injury (see chapter 5). Meanwhile, on the side 
ipsilateral to nerve injury, the PAP band was only present on the extreme lateral 
part of the dorsal horn and was missing from the medial part. This presumably 
reflex the loss of PAP correspond to the area of sciatic nerve territory. The 
general distribution of somata of tdTomato cells in the dorsal horn was 
comparable with that seen in RorBCreERT2; Ai9 mice that had not undergone SNT 
(see chapter 5). The dendritic and axonal band of tdTomato cells in lamina II 
was present on the side ipsilateral to SNT as well as on the contralateral side. 
However, the density of tdTomato band was much reduced in the area where 
PAP depletion on the side ipsilateral to nerve injury. A clear gap between the 
band in lamina II and tdTomato cells and processes found in deeper laminae was 
also seen on both side of the dorsal horn, as described previously. The 
distribution of cell bodies and dendrites that were CR-immunoreactive was 
similar to findings described in the previous chapters and reported in other 
studies (Albuquerque et al., 1999, Smith et al., 2015).  
Quantitative analysis of tdTomato cells in RorBCreERT2; Ai9 mice that had 
undergone SNT was carried out between 4-7 sections per animal, and the results 
was shown in Table 6-1. A total of 246 (range 28-64) and 262 (range 26-61) 
tdTomato cells in lamina II were counted on side ipsilateral and contralateral to 
SNT, respectively (n = 6 mice) and this gave the mean number of cells per 
section of 7.48 on the side ipsilateral and 7.97 on the side contralateral to nerve 
injury, as shown in the table. In order to compare these animals effectively with 
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un-operated animals, a separate analysis was carried out on 6 intact RorBCreERT2; 
Ai9 mice that received tamoxifen at P16-18 (3 of these animals were previously 
described in chapter 5 and another additional 3 were used on this part of 
analysis). The number of cells per section in intact animals was estimated to be 
mean of 15.65 (range 9.75-20.67). One-way analysis of variance was performed 
followed by Holm-Sidak post-hoc for multiple-comparison test showed that 
number of cells in RorBCreERT2; Ai9 mice that did not undergo nerve injury were 
significantly different from the number of cells seen in the side ipsilateral (p = 
0.0026) and contralateral (p = 0.0028) to the injury. However, both side 
ipsilateral and contralateral to SNT did not vary (p = 0.8064).  
Observations on confocal sections revealed that the great majority of tdTomato 
cells in the superficial laminae on both side ipsilateral and contralateral to nerve 
injury were also immunoreactive for CR and Pax2. This accounted for 212/246 
(86.2%) and 219/262 (83.6%) on the side ipsilateral and contralateral to nerve 
injury, respectively. A paired t-test showed that there was no significant 
difference between the total number of inhibitory CR+/tdTomato+ (p = 0.6416) 
cells in lamina II on the side ipsilateral and contralateral to nerve injury. None 
of the tdTomato cells in the deeper laminae were CR-immunoreactive as seen in 
intact animals.  
6.3.2 Quantitative analysis of the inhibitory CR cells following 
SNT 
This part of the study was carried out on tissues from RorBCreERT2; Ai9 mice that 
were used above together with one additional animal in order to determine 
whether there is loss of inhibitory CR cells in the SDH of these animals following 
SNT. NeuN- and Pax2-immunostaining were seen throughout the dorsal horn on 
the side ipsilateral and contralateral to SNT. As reported previously, numerous 
NeuN-immunoreactive cells were seen in the SDH (Todd et al., 1998). 
Combination of NeuN antibody and DAPI was used to identify neuronal nuclei. 
Meanwhile, Pax2 and CR antibody were used in this part of the study to identify 
inhibitory CR neurons in the superficial laminae. As described previously, most of 
the cell bodies and dendritic plexus of CR-immunoreactive neurons were located 
mostly in lamina II, although occasionally cells were seen in laminae I and III. 
The density of CR dendritic and axonal plexus in the SDH appear the same on 
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both ipsilateral and contralateral side following SNT. Similar to what was seen in 
un-operated animals, a minority of CR cells were Pax2+ in the SDH. The 
penetration of all antibodies could be seen throughout the full thickness of the 
optical sections.  
Quantitative data obtain using the disector method in this part of the study are 
shown in Table 6-2. A total of 4378 and 4291 neurons (n=7) were analysed in 
laminae I-II on the side ipsilateral and contralateral of SNT, respectively. Of 
these, 1046 (23.9%) and 1054 (24.6%), respectively, were inhibitory interneurons 
as defined by the presence of immunostaining for Pax2. The total numbers of 
inhibitory (Pax2+) CR cells identified in laminae I-II on the side ipsilateral and 
contralateral to nerve injury were 246 and 240, respectively. Quantitative 
analysis revealed that, inhibitory (Pax2+) CR cells constituted 5.6% of neuronal 
populations in laminae I-II on the ipsilateral side and 5.6% of those on the 
contralateral side (Table 6-2). A paired t-test showed that there was no 
significance difference between the total number of NeuN in laminae I-II (p = 
0.4300) on the side ipsilateral and contralateral of SNT. Similarly, there was no 
significant difference in the proportion of all neurons that were Pax2 in laminae 
I-II (p = 0.5076) on the side ipsilateral and contralateral to nerve injury. The p 
value for the proportion of all neurons that were inhibitory (Pax2+) CR cells in 
laminae I-II was not significantly different (p = 0.9852) and this showed that the 
proportion of these cells among all neurons on the side ipsilateral and 
contralateral did not change following SNT.  
6.3.3 Morphological analysis of CR+/tdTomato+ cells 
In this part of the study, tissue from animals that had received 2mg IP tamoxifen 
at P32 was used because late administration of tamoxifen showed sparse 
labelling of tdTomato cells in RorBCreERT2; Ai9 mice. This was important because 
it allow the analyses of individual cell. Parasagittal sections from these animals 
were examined after immunostaining for mCherry, CR, and PAP were readily 
identified in these sections. In this part of the study, the mCherry antibody was 
used to amplify the native fluorescence. This was performed to reveal the finest 
dendritic and axonal processes. The general distribution of tdTomato cell bodies 
in the dorsal horn was comparable with that was seen in intact RorBCreERT2; Ai9 
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mice in which there was a sparse labelling of tdTomato cells, as described 
previously in chapter 5.  
On the side ipsilateral to the nerve injury, the axonal band of PAP was absent in 
many sections and this correspond to the region innervated from the sciatic 
nerve. On this side tdTomato cells were selected from section in which the PAP 
band was absent. Because of the lack of PAP plexus, the distribution of CR-
immunostaining which was largely restricted to lamina II, was used to identify 
tdTomato cells on the denervated side. On the contralateral side the PAP-band 
was intact and to allow for comparison, cells were chosen from sections in the 
medial part of the dorsal horn which can be identified by the present of white 
matter, dorsal to the lamina I. On initial observation of the cells, there was no 
obvious differences in the size of the dendritic trees of the neurons between the 
ipsilateral and contralateral side to the nerve injury. The distribution of cell 
bodies and dendrites that were CR-immunoreactive was similar with previous 
findings reported in the previous chapters and studies (Albuquerque et al., 1999, 
Smith et al., 2015). Isolated tdTomato cells that were immunoreactive for CR 
was chosen for neuronal reconstruction using Neurolucida software.  
The tdTomato cells in lamina II on the side ipsilateral and contralateral to the 
nerve injury showed islet cell morphology (Figure 6-3), confirmed by extensive 
rostrocaudal extension of the dendritic trees and the limited dorsoventral 
arborisation of the cells as described previously (Grudt and Perl, 2002, Yasaka et 
al., 2007, Yasaka et al., 2010). The RC and DV extent of 9 and 5 cells on the side 
ipsilateral and contralateral to the nerve injury, respectively, were measured. 
On the ipsilateral side of the injury, the RC and DV extent of the dendritic trees 
of these cells were 261.1 µm ± 24.19 (mean ± SD) and 40.32 µm ± 19.15 (mean ± 
SD), respectively. Meanwhile, on the side contralateral to the nerve injury, the 
values for RC and DV length were 283.2 µm ± 82.22 (mean ± SD) and 34.94 µm ± 
14.31 (mean ± SD), respectively. A two sample unpaired t-test showed that there 
was no significant difference in either the RC (p = 0.4559) or the DV (p = 0.5953) 
extent between the cells on either side. Information on the dendritic dimensions 
of all cells is shown in Table 6-3.  
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         Table 6-1 Number of tdTomato cells counted on the side ipsilateral and contralateral to the nerve injury  
Ipsilateral Contralateral 
Animal Number of  
sections analysed 
Number of  
tdTomato cells 
Number of cells per 
section 
Number of  
tdTomato cells 
Number of cells per 
section 
1 4 45 11.25 46 11.50 
2 4 28 7.00 28 7.00 
3 6 29 4.83 42 7.00 
4 6 51 8.50 61 10.17 
5 7 29 4.14 36 5.14 
6 7 64 9.14 49 7.00 
Mean  7.48 
 
7.97 
        The numbers represent a total number of cells counted in the side ipsilateral and contralateral to SNT.   
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Table 6-2 Numbers of NeuN, Pax2 and inhibitory CR+ cells in laminae I- II on the side ipsilateral and contralateral to the nerve injury  
Lamina Number of 
neurons counted 
Pax2 cells Inhibitory(Pax2+) 
CR+ cells 
% of neurons that 
were Pax2+ 
% of neurons that 
were CR+/Pax2+ 
Ipsilateral      
I 76.1 (62-92) 21 (17-28) 2.4 (0-5) 27.6 (21.5-32.3) 3.2 (0-6.9) 
II 
I-II 
549.3 (496-597) 
625.4 (561-676) 
128.4 (105-147) 
149.4 (126-175) 
32.7 (13-44) 
35.1 (13-49) 
23.4 (20.8-25.7) 
23.9 (20.9-26.4) 
6.0 (2.6-8.6) 
5.6 (2.3-8.4) 
Contralateral        
I 75.6 (62-99) 19 (15-26) 3.3 (1-6) 25.1 (20-31) 4.3 (1-6.5) 
II 
I-II 
537.4 (444-590) 
613 (519-661) 
131.6 (121-144) 
150.6 (137-170) 
31 (19-44) 
34.3 (20-48) 
24.5 (21-26.2) 
24.6 (21.4-26.8) 
5.7 (3.7-7.8) 
5.6 (3.5-7.7) 
      Numbers of cells counted or percentages of cells are shown in the table. Values are the mean cell counts for 7 mice with ranges in parentheses.
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Table 6-3 CR+/tdTomato+ cells dendritic dimensions on the side ipsilateral and contralateral 
to the nerve injury 
Ipsilateral (n = 9) 
Cells RC extent (µm) DV extent (µm) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
280.8 
227.5 
266 
291.3 
260.1 
277.9 
217.3 
264.3 
265.1 
51 
44 
68.2 
42.5 
30.2 
14.1 
16.8 
31.3 
64.8 
Contralateral (n = 5) 
Cells RC extent (µm) DV extent (µm) 
1 
2 
3 
4 
5 
321.2 
300.1 
253.3 
380.6 
161 
58.3 
38.3 
29.4 
22.5 
26.2 
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Figure 6-3 A typical islet cell morphology of RorB cell found in the middle of lamina II on the 
side ipsilateral to the nerve injury. Maximal projection of tdTomato cell shows that the 
rostrocaudal (RC) and dorsoventral (DV) extent of the cell appear to be normal and resemble islet 
cell morphology. Scale bar = 100 µm.   
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6.4 Discussion 
The main findings of this study are that following SNT: (1) there is no difference 
on the number of lamina II tdTomato cells that are CR+ and Pax2+ on the 
ipsilateral and contralateral side; (2) the proportion of all neurons that are CR+ 
and Pax2+ in laminae I-II do not differ on both side (3) the dendritic extent of 
tdTomato cells does not change in the area where PAP was depleted.   
6.4.1 No loss of cells after PNI 
Despite many evidence showed that there was cells death following peripheral 
nerve injury (Ibuki et al., 1996, Eaton et al., 1998, Moore et al., 2002, Yowtak et 
al., 2013), this current study found that there is no loss of neurons after four 
weeks of SNT. This is consistent with other studies that failed to see any loss of 
cells or alteration in the overall number of neurons that were GABA 
immunoreactive in laminae I-III of the rat following CCI (Polgár et al., 2003, 
Polgár et al., 2004). Even though they cannot rule out any cell death, the 
animals used in their studies showed signs of thermal hyperalgesia. In addition, 
it was found that no reduction in cell counts in laminae I-III after four weeks of 
spared nerve injury (Polgár et al., 2005). In another study using spared nerve 
injury model of neuropathic pain, it was reported that after 1 week of surgery, 
apoptosis of cells was detected using TUNEL-staining in the white and grey 
matter of the dorsal spinal cord on the side of the injury. However, those 
apoptotic cells also expressed Iba-1 and this showed that spared nerve injury 
affected microglia rather than neurons. In addition, a study using quantitative 
immunogold method found that there was no change on GABA-immunoreactivity 
in the inhibitory axonal boutons in laminae I-II on the ipsilateral and 
contralateral side of spared nerve injury (Polgár and Todd, 2008). All of these 
findings suggest that neuropathic pain could develop without the need for 
neuronal death.  
Because of the lack of cell death, an alternative explanation for the loss of 
inhibition has been look for. A few studies have shown that there was no 
depletion of GABA type A receptor following peripheral nerve injury (Moore et 
al., 2002, Polgár and Todd, 2008). Coull et al. (2003) suggested that efficiency 
of GABA as the inhibitory transmitter was reduced due to the changes in the 
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concentration of anion across the neuronal membranes as a result of down-
regulation of potassium-chloride exporter 2 (KCC2). In normal condition, KCC2 in 
spinal cord dorsal horn neurons maintains a low intracellular chloride (Cl-) 
concentration. A pathological reduction in functional expression of KCC2 will 
results in the accumulation of Cl- within the neurons (Coull et al., 2003). The 
equilibrium potential for Cl- would be less negative and this will lead to central 
disinhibition of GABA type A receptor and glycine receptor due to a loss of 
hyperpolarizing action of these receptors (Coull et al., 2003). Despite this 
finding, it has been reported that GABA type A receptor agonist reduce tactile 
allodynia and hyperalgesia in neuropathic pain model (Hwang and Yaksh, 1997, 
Malan et al., 2002).  
Dorsal horn excitability may increase following chronic constriction injury or 
axotomy of the sciatic nerve (Lu et al., 2009). Several studies have shown that 
these animal models causes increased excitatory input to putative excitatory 
delay firing and transient firing neurons and decreased excitatory firing to 
putative inhibitory tonic firing neurons (Chen et al., 2009, Lu et al., 2009, Bailey 
and Ribeiro-da-Silva, 2006). Leitner et al. (2013) found that peripheral nerve 
injury generates Ca2+ dependent signalling pathways in GABAergic neurons in the 
spinal cord. This results in a widespread reduction of their excitatory drive. 
Leitner and colleagues also found that Aδ- and C-fibres input on GABAergic 
neurons is decreased during noxious stimulation, thus weaken the normal 
feedforward inhibition. 
Neuropathic animal models are needed to understand the process involved in 
chronic pain. Once the mechanism is understood, then successful 
pharmacotherapies for treating chronic pain could be developed. The 
neuropathic animal models ideally should include behavioural signs that result 
from allodynia, hyperalgesia and spontaneous pain. There are several different 
types of animal models have been developed including chronic constriction 
injury (Bennett and Xie, 1988); partial sciatic nerve ligation (Seltzer et al., 
1990); spinal nerve ligation (Kim and Chung, 1992) and spared nerve injury 
(Decosterd and Woolf, 2000). Chronic constriction injury represents an 
entrapment neuropathy in which there is a preferential loss of large fibres. 
Spared nerve injury and spinal nerve ligation, both involve ligation and 
177 
 
 
 
transection parts of the lumbar or sciatic nerve. These were developed because 
the finding of partial nerve injury in human is much more likely to result in 
neuropathic pain than the complete nerve transection. The complete transection 
of sciatic nerve allowed the three branches of sciatic nerve (common peroneal, 
tibial and sural nerve) to have the same degree of injury (Cheng et al., 2015). 
This model was chosen because the effect of this type of surgery on the dorsal 
horn was extensive. This result in the depletion of CMrgD boutons from two thirds 
of the dorsal horn thus allowing a larger region in which any anatomical changes 
can be detected. In particular, this was needed since a relatively small number 
of cells expressed tdTomato in RorBCreERT2; Ai9 mice. The present finding strongly 
suggests that there is no loss of cells after peripheral nerve injury. However, 
since less extensive nerve injury is more likely to cause neuropathic pain, it is 
recommended to apply partial sciatic nerve injury or chronic constriction injury 
in order to test whether there are any changes in tdTomato cells.   
6.4.2 No change in the morphology of the cells 
Coderre et al. (1993) suggested there is a possibility that dorsal horn neuronal 
circuit reorganisation is responsible for the development of chronic pain. In the 
preliminary study using Nociceptin::eGFP mouse, following 4 weeks after SNT, it 
was found that the density of eGFP dendritic plexus in lamina II was greatly 
reduced in the denervated sciatic nerve territory which suggests there was a 
change on the morphology of the cells. It is possible that the cells were not dead 
but down-regulate eGFP. Meanwhile, in the present study, it was found that the 
density of tdTomato band was much reduced in the area where PAP depletion on 
the side ipsilateral to nerve injury. The reduction of the dendritic plexus of the 
eGFP and tdTomato cells in the region where the primary afferent terminal was 
depleted can either be explained by the loss of cells or alternatively by the same 
number of cells having less complex dendritic trees (fewer dendrites). Since we 
have shown that there is no loss of cells, the only reason for explanation seems 
to be that each cell generates less dendrites. It might, therefore, be expected 
that the overall dimension of the cell (RC and DV extent) would have been 
reduced.  
However, in the current study, it was found that there were no changes in the 
RC and DV extent as well as RC:DV ratio of the cells in the side ipsilateral and 
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contralateral to the nerve injury. The possible explanation for this is that there 
is a genuine reduction in the dendritic extent of the cells, but this is not being 
detected because there is a considerable degree of variability of RC and DV 
extent between different cells. A lot of observations on the cells must be done 
in order to see this variability. This would require more extensive analysis, but 
unfortunately, we did not examine large enough sample. Alternatively, the cells 
genuinely do not show a change in their RC and DV extent but the density of 
dendrites within that volume that they occupied become less complex 
presumably due to loss of dendritic branches. Polgár et al. (2003) reported that 
there was no loss of cells following PNI, however, maybe there is a possibility 
that there is a change occur in the synaptic elements leading to loss of synaptic 
connections of GABAergic axon terminals. Given the very high proportion of 
synaptic input into the cells derived from CMrgD afferents boutons which appear 
to have vanished after the nerve injury, it is expected that these cells might 
undergo significant dendritic change and it could also be that the axonal boutons 
of these cells were reduced. The limitation in this part of the study was that the 
restructuring of the dendritic spines could not be resolved as shown by Tan et al. 
(2008) that found there were alteration and redistribution of dendritic spines of 
neurons in the spinal cord following PNI. Although the findings in this study are 
similar with the previous studies that were carried out in this laboratory (Polgár 
et al., 2003, Polgár et al., 2004, Polgár et al., 2005), the future studies should 
investigate dendritic spines in order to evaluate any ultrastructural 
reorganisation. 
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7 Concluding remarks  
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The superficial laminae receive innervation from various types of primary 
afferents that detect noxious and pruritic stimuli. Information that is carried 
from peripheral tissues is modulated by internal neuronal circuits within the 
spinal cord before being transmit to the brain via projection neurons. Melzack 
and Wall (1965) suggested that lamina II of the dorsal horn, play a major role in 
modulating somatosensation by inhibiting primary afferent inputs before 
transmitting it to the higher centre. Countless studies have been carried out to 
investigate the pathway on how the superficial dorsal horn neurons modulate the 
nociceptive input with the ultimate aim to identify novel targets for the 
treatment of pathological pain states. 
Interneurons can be divided into excitatory and inhibitory classes and for this 
project, the focus was on inhibitory cells in the SDH. Most inhibitory 
interneurons generate postsynaptic inhibition through axodendritic synapses, but 
many primary afferent axons receive GABAergic presynaptic inhibition through 
axoaxonic synapses (Eccles et al., 1962b, Barber et al., 1978, Todd, 1996). The 
initial aim of this project was to characterise inhibitory CR islet cells in 
superficial laminae and to investigate whether these neurons are a major source 
of axoaxonic synapses on the CMrgD afferents that formed the central axons of 
type I synaptic glomeruli. To achieve this aim, this study initially used various 
transgenic mouse lines and crosses, including those that express transgenes 
under control of the Nociceptin and RorB promoters. This was done in order to 
identify suitable mouse line that captures inhibitory CR islet cells. This is  
important because the majority of CR expressing cells are excitatory 
interneurons with only a small proportion being inhibitory (Smith et al., 2015).  
To understand the morphology of inhibitory CR cells in great details, a BAC 
transgenic mouse line, Nociceptin::eGFP mouse was used since it was found that 
the great majority of inhibitory interneurons in the SDH was captured by these 
mice. Inhibitory CR cells formed a band of dendrites and axons that were 
perfectly overlap with IB4 plexus, thus showed that there were higher chances 
that these cells form a contact with non-peptidergic C fibres that mainly 
terminated in the middle of lamina II. We found that inhibitory CR cells make up 
a small proportion of total neuronal populations in the dorsal horn since the 
great majority of calretinin cells are excitatory interneurons. Grudt and Perl 
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(2002) found four major types of cells including islet cells that are found to be 
GABA-immunoreactive. Parallel to these finding, we found that inhibitory CR 
cells that had undergone whole cell recordings and that were labelled with 
Neurobiotin and subsequently reconstructed were found to have islet 
morphology. This finding is consistent with what was seen in a previous study by 
Smith et al. (2015) in which they reported that atypical (inhibitory) CR cells 
were mainly had islet morphology. During the course of the study, it was found 
that RorBeGFP mice labelled the great majority of inhibitory CR cells in SDH 
compared to Nociceptin::eGFP mouse line. Furthermore, the proportion of eGFP-
positive cells that were labelled with both CR and Pax2 in RorBeGFP mice was 
much higher compare to Nociceptin::eGFP mice. Both the RorBeGFP and 
Nociceptin::eGFP mouse lines are trusted tools for investigating inhibitory CR 
cells because almost all eGFP cells in both animals were Pax2+ and many 
inhibitory CR cells were captured. Therefore, RorBeGFP mice appeared to be a 
better choice for investigating the inhibitory CR cells than Nociceptin::eGFP 
mice. Consistent with the data reported by Smith et al. (2015) it was found that 
in this mice 15% of CR-immunoreactive cells in the SDH co-expressed Pax2 and 
this accounted for around a quarter of Pax2 positive cells.  
Neuropeptides may be differentially expressed by distinct functional populations 
of interneurons since the laminar distribution of dorsal horn neurons that contain 
these different peptides various significantly. For example, NPY-expressing cells 
are found in lamine I-III, galanin in lamina I and II outer and CR are mainly found 
in lamina II. There are many neurochemical markers available to classify 
interneurons in laminae I-III. However, it is unlikely that any one of these 
markers can be used to identify the specific functional population. One method 
that has been performed to identify discrete populations is by using a 
neurochemical marker that are expressed in non-overlapping subsets in either 
inhibitory or excitatory interneurons. Using this method, we found that almost 
none of inhibitory CR cells were positive for galanin, PV, nNOS and NPY. Only 
half of the inhibitory CR islet cells in the SDH were labelled with sst2A antibody. 
However, it is not known whether those cells that expressed sst2A were any 
different from the ones that do not express somatostatin receptor. Previous 
studies have shown that sst2A receptor is differentially distributed among 
inhibitory interneuron populations. Specifically, it is expressed by most galanin, 
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dynorphin and nNOS cells but relatively few by NPY and none by PV. Recently, 
Gutierrez-Mecinas et al. (2019) found that virtually all of the inhibitory Tac-1 
expressing neurons co-expressed calretinin in lamina II of  the dorsal horn. This 
finding is further supported by transcriptomic studies that identified cells that 
are positive for Calbindin (Calb2) among the inhibitory neurons (DI-1 and Gaba 8-
9, respectively) (Häring et al., 2018, Sathyamurthy et al., 2018). The DI-1 group 
of cells strongly expressed Tac-1 (Sathyamurthy et al., 2018) with high level of 
expression seen GABA 9 cluster (Häring et al., 2018).  
To investigate the synaptic connection between CR islet cells with CMrgD 
afferents, the RorBCreERT2 mouse line with tamoxifen induction were used. A 
particular advantage of the Cre-recombinase transgene compare to eGFP is that 
it allows labelling with fluorescence reporter lines or viruses but also 
manipulation of the function of the cells to occur for example using optogenetics 
(Xu et al., 2008) or chemogenetics (Koga et al., 2017). This type of experiment 
will be carry out in the future. In this part of the study, RorBCreERT2 mouse was 
crossed with the reporter lines Ai9 or Ai34. The neuronal cell bodies together 
with their processes were labelled with tdTomato in the RorBCreERT2; Ai9 cross, 
meanwhile in RorBCreERT2; Ai34 cross only the axons were labelled with tdTomato 
due to the expression of synaptophysin fusion protein which directs the resulting 
protein to axon terminal. This series of experiment began with an investigation 
into the optimal method for labelling cells in the RorBCreERT2; Ai9 cross. It was 
found that giving tamoxifen in the early postnatal age (P16-18), consistently 
resulted in more labelling of cells than when tamoxifen was giving at the later 
ages (P32-36). The reasons for this are not known since numerous RorB mRNA 
positive cells are seen in the superficial dorsal horn of P56 mice in Allen Brain 
Atlas. Presumably in some cases, this results in failure of tamoxifen to cause 
recombination in some cells particularly when it was given in later stages. 
However, almost all tdTomato cells in the SDH were immunoreactive for Pax2 
and CR in this mouse cross. Thus showed that this mouse line was highly 
selective for inhibitory CR cells.  
Although it is not possible to target all of the inhibitory CR cells in this mouse 
line, it was still very useful because in particular when sparse labelling was 
achieved (IP administration of tamoxifen at P32-36), and this allowed details 
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anatomical analysis of individual cells. Therefore, RorBCreERT2; Ai9 crosses that 
received IP injection of tamoxifen at P35 were then used to investigate the 
synaptic connection of inhibitory CR islet cells with unmyelinated primary 
afferents. This analysis shown that around half of the excitatory synaptic input 
onto the dendritic spines of tdTomato cells originated from these afferents, 
meanwhile some tdTomato-positive axonal boutons were seen to form contacts 
with these primary afferents. In a separate analysis that was carried out on 
RorBCreERT2; Ai34 mouse crosses it was found that the great majority of non-
peptidergic C fibres received at least one contact from tdTomato axonal 
boutons. Electron microscopic study on RorBCreERT2; Ai9 and RorBCreERT2; Ai34 mice 
revealed that there were many contacts between DAB-labelled profiles and 
central axons of type I synaptic glomeruli.   
In this study, SNT was carried out in RorBCreERT2; Ai9 mouse lines following the 
findings in the preliminary study that showed a reduction in the density of eGFP 
plexus in the sciatic nerve territory at the side ipsilateral to the nerve injury in 
Nociceptin::eGFP mice. Although many previous studies reported that there is 
loss of SDH neurons in different types of neuropathic pain models (Ibuki et al., 
1996, Moore et al., 2002, Eaton et al., 1998, Yowtak et al., 2013), this has been 
controversial since works reported by Polgár et al. (2003, 2005 and 2008) have 
found no evidence of neuronal loss following various type of nerve injury. 
Consistent with the finding by Polgár and colleagues there was no reduction in 
the number of tdTomato cells between the side ipsilateral or contralateral in the 
nerve injured RorBCreERT2; Ai9 mice, suggesting that there is no loss of neurons. 
Since there was a reduction in the plexus, this would suggest that the dendritic 
trees of individual cells must have been altered. However, finding from this 
study showed that there was no change noted on the RC and DV extent of 
dendritic arbors of individual tdTomato cells on either side.  
Two studies were carried out to investigate the functional role of dorsal horn CR 
cells in modulating nociceptive input (Duan et al., 2014, Peirs et al., 2015). The 
majority of CR expressing neurons are excitatory and activating these cells in 
lamina II caused a reduction of von Frey thresholds and guarding of the affected 
paw (Peirs et al., 2015). Meanwhile in another study it was found that ablation 
of CR expressing cells caused enhanced paw withdrawal thresholds to noxious 
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mechanical stimuli (Duan et al., 2014). Both of these studies suggest CR positive 
cells open the gate to the innocuous tactile input with nociceptive circuits and 
cause allodynia. In normal condition, this connection is not activated because 
stimulation by light touch do not cause pain. However, certain pathological 
condition can activate this pathway. As a conclusion, reducing or silencing the 
activity of CR expressing cells could resolve allodynia. Meanwhile, modifying 
their properties would alter responses in chronic pain states.   
Although it has long been known that unmyelinated nociceptors received 
axoaxonic synapses from GABAergic interneurons, until now the source of these 
synapses is not known. The findings of the present study address this gap in 
knowledge. Using multiple mouse lines to investigate CR-expressing inhibitory 
interneurons in the SDH, we showed that these cells have islet morphology and 
most probably forms axoaxonic synapses on CMrgD afferents that form the central 
axons of type I synaptic glomeruli (Figure 7-1). Intriguingly, it appears that there 
is a changes in these cells after nerve injury although this is not a result of loss 
of the cells and further investigations is needed to investigate whether it reflex 
changes in the dendritic arbors.  
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Figure 7-1 Neuronal circuits in the dorsal horn of the spinal cord. 
A diagram showing the complexity of the identified dorsal horn synaptic circuit between primary 
afferents, local dorsal horn neurons and projection neurons in laminae I-III. Results from this study 
found that inhibitory calretinin (CR) islet cells (brown) that can be found mainly in lamina II is seen 
forming axoaxonic synapse with central boutons of type I glomeruli (black). The inhibitory CR cells 
also receive excitatory input from the same primary afferents that belonged to a group of C fibres 
that expressed Mas-related-G-protein coupled receptor member D (CMrgD). Modified from Todd 
2010. 
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